10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended September 30, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

VECTOR GROUP LTD.

(Exact name of registrant as specified in its charter)

Delaware	1-5759	65-0949535
(State or other jurisdiction of incorporation	Commission File Number	(I.R.S. Employer Identification No.)
incorporation or organization)

4400 Biscayne Boulevard

Miami, Florida 33137

305-579-8000

(Address, including zip code and telephone number, including area code,

of the principal executive offices)

Securities Registered Pursuant to 12(b) of the Act:

Title of each class:	Trading	Name of each exchange
	Symbol(s)	on which registered:
Common stock, par value $0.10 per share	VGR	New York Stock Exchange

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes o No

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

x Yes o No

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☒ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging Growth Company

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

    Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes x No

    At November 2, 2020, Vector Group Ltd. had 153,293,358 shares of common stock outstanding.

VECTOR GROUP LTD.

FORM 10-Q

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Vector Group Ltd. Condensed Consolidated Financial Statements (Unaudited):
Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019	2
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2020 and 2019	3
Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2020 and 2019	4
Condensed Consolidated Statements of Stockholders' Deficiency for the three and nine months ended September 30, 2020 and 2019	5
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 and 2019	7
Notes to Condensed Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	46
Item 3. Quantitative and Qualitative Disclosures About Market Risk	63
Item 4. Controls and Procedures	63
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	64
Item 1A. Risk Factors	64
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	65
Item 6. Exhibits	66
SIGNATURE	67

1

VECTOR GROUP LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

	September 30, 2020		December 31, 2019
ASSETS:
Current assets:
Cash and cash equivalents	$	451,071	$	371,341
Investment securities at fair value	124,092		129,641
Accounts receivable - trade, net	43,999		36,959
Inventories	94,548		98,762
Other current assets	38,713		44,911
Total current assets	752,423		681,614
Property, plant and equipment, net	76,067		82,160
Investments in real estate, net	9,786		28,317
Long-term investment securities at fair value	31,619		45,781
Investments in real estate ventures	102,458		131,556
Operating lease right-of-use assets	147,959		149,578
Goodwill and other intangible assets, net	207,618		265,993
Other assets	115,048		120,090
Total assets	$	1,442,978	$	1,505,089
LIABILITIES AND STOCKHOLDERS' DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	10,684	$	209,269
Current portion of fair value of derivatives embedded within convertible debt	—		4,999
Current payments due under the Master Settlement Agreement	145,472		34,116
Income taxes payable, net	19,113		5,138
Current operating lease liability	22,485		18,294
Other current liabilities	194,028		189,317
Total current liabilities	391,782		461,133
Notes payable, long-term debt and other obligations, less current portion	1,395,964		1,397,216
Non-current employee benefits	61,341		67,853
Deferred income taxes, net	28,509		33,695
Non-current operating lease liability	159,200		156,963
Payments due under the Master Settlement Agreement	18,130		17,275
Other liabilities	50,171		55,970
Total liabilities	2,105,097		2,190,105
Commitments and contingencies (Note 9)
Stockholders' deficiency:
Preferred stock, par value $1 per share, 10,000,000 shares authorized	—		—
Common stock, par value $0.1 per share, 250,000,000 shares authorized, 153,293,358 and 148,084,900 shares issued and outstanding	15,329		14,808
Accumulated deficit	(656,781)		(678,464)
Accumulated other comprehensive loss	(20,667)		(21,808)
Total Vector Group Ltd. stockholders' deficiency	(662,119)		(685,464)
Non-controlling interest	—		448
Total stockholders' deficiency	(662,119)		(685,016)
Total liabilities and stockholders' deficiency	$	1,442,978	$	1,505,089

The accompanying notes are an integral part of the condensed consolidated financial statements.

2

VECTOR GROUP LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Revenues:
Tobacco*	$	318,850	$	303,260	$	918,429	$	854,517
Real estate	228,981		201,530		529,650		609,629
Total revenues	547,831		504,790		1,448,079		1,464,146
Expenses:
Cost of sales:
Tobacco*	204,101		209,192		615,458		590,956
Real estate	170,474		136,264		374,625		408,694
Total cost of sales	374,575		345,456		990,083		999,650
Operating, selling, administrative and general expenses	77,019		92,374		238,600		278,047
Litigation settlement and judgment expense	—		240		53		895
Impairments of goodwill and intangible assets	—		—		58,252		—
Restructuring charges	320		—		3,281		—
Operating income	95,917		66,720		157,810		185,554
Other income (expenses):
Interest expense	(28,163)		(32,963)		(93,148)		(103,236)
Change in fair value of derivatives embedded within convertible debt	—		6,182		4,999		20,319
Equity in earnings (losses) from investments	1,840		(468)		54,199		(791)
Equity in (losses) earnings from real estate ventures	(8,536)		8,050		(27,301)		12,002
Other, net	(5,096)		2,223		(8,116)		14,444
Income before provision for income taxes	55,962		49,744		88,443		128,292
Income tax expense	17,823		13,736		27,761		37,944
Net income	38,139		36,008		60,682		90,348
Net income attributed to non-controlling interest	—		—		—		(80)
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Per basic common share:
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.25	$	0.23	$	0.39	$	0.57
Per diluted common share:
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.25	$	0.23	$	0.39	$	0.56

* Revenues and cost of sales include federal excise taxes of $120,320, $122,951, $354,629, and $347,527, respectively.

The accompanying notes are an integral part of the condensed consolidated financial statements.

3

VECTOR GROUP LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands)

Unaudited

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income	$	38,139	$	36,008	$	60,682	$	90,348
Net unrealized (losses) gains on investment securities available for sale:
Change in net unrealized (losses) gains	(242)		2		(262)		725
Net unrealized losses (gains) reclassified into net income	1		(19)		434		(56)
Net unrealized (losses) gains on investment securities available for sale	(241)		(17)		172		669
Net change in pension-related amounts
Amortization of loss	463		491		1,390		1,439
Net change in pension-related amounts	463		491		1,390		1,439
Other comprehensive income	222		474		1,562		2,108
Income tax effect on:
Change in net unrealized (losses) gains on investment securities	65		(1)		71		(199)
Net unrealized losses (gains) reclassified into net income on investment securities	—		5		(117)		15
Pension-related amounts	(125)		(134)		(375)		(394)
Income tax provision on other comprehensive income	(60)		(130)		(421)		(578)
Other comprehensive income, net of tax	162		344		1,141		1,530
Comprehensive income	38,301		36,352		61,823		91,878
Comprehensive income attributed to non-controlling interest	—		—		—		(80)
Comprehensive income attributed to Vector Group Ltd.	$	38,301	$	36,352	$	61,823	$	91,798

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

VECTOR GROUP LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Dollars in Thousands, Except Share Amounts)

Unaudited

	Vector Group Ltd. Stockholders' Deficiency
				Additional Paid-In				Accumulated Other Comprehensive		Non-controlling
	Common Stock					Accumulated
	Shares	Amount		Capital		Deficit		Loss		Interest		Total
Balance as of July 1, 2020	153,484,477	$	15,348	$	—	$	(663,723)	$	(20,829)	$	—	$	(669,204)
Net income	—	—		—		38,139		—		—		38,139
Total other comprehensive income	—	—		—		—		162		—		162
Distributions and dividends on common stock ($0.20 per share)	—	—		(366)		(31,197)		—		—		(31,563)
Restricted stock grant	20,000	2		(2)		—		—		—		—
Surrender of shares in connection with restricted stock vesting	(211,119)	(21)		(2,103)		—		—		—		(2,124)
Stock-based compensation	—	—		2,471		—		—		—		2,471
Balance as of September 30, 2020	153,293,358	$	15,329	$	—	$	(656,781)	$	(20,667)	$	—	$	(662,119)

	Vector Group Ltd. Stockholders' Deficiency
				Additional Paid-In				Accumulated Other Comprehensive		Non-controlling
	Common Stock					Accumulated
	Shares	Amount		Capital		Deficit		Loss		Interest		Total
Balance as of July 1, 2019	140,953,900	$	14,095	$	—	$	(597,786)	$	(23,493)	$	488	$	(606,696)
Net income	—	—		—		36,008		—		—		36,008
Total other comprehensive income	—	—		—		—		344		—		344
Distributions and dividends on common stock ($0.38 per share)	—	—		(414)		(58,310)		—		—		(58,724)
Restricted stock grant	—	—		—		—		—		—		—
Surrender of shares in connection with restricted stock vesting	(200,926)	(19)		(1,934)		—		—		—		(1,953)
Effect of 2019 stock dividend*	7,037,649	704		—		(704)		—		—		—
Stock-based compensation	—	—		2,348		—		—		—		2,348
Balance as of September 30, 2019	147,790,623	$	14,780	$	—	$	(620,792)	$	(23,149)	$	488	$	(628,673)

*    Represents the effect of the September 27, 2019 stock dividend on the third quarter 2019 common-stock activity.

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

	Vector Group Ltd. Stockholders' Deficiency
				Additional Paid-In				Accumulated Other Comprehensive		Non-controlling
	Common Stock					Accumulated
	Shares	Amount		Capital		Deficit		Loss		Interest		Total
Balance as of January 1, 2020	148,084,900	$	14,808	$	—	$	(678,464)	$	(21,808)	$	448	$	(685,016)
Impact of adoption of new accounting standards	—	—		—		(2,263)		—		—		(2,263)
Net income	—	—		—		60,682		—		—		60,682
Total other comprehensive income	—	—		—		—		1,141		—		1,141
Distributions and dividends on common stock ($0.60 per share)	—	—		(56,868)		(36,816)		—		—		(93,684)
Restricted stock grant	425,000	43		(43)		—		—		—		—
Surrender of shares in connection with restricted stock vesting	(216,542)	(22)		(2,164)		—		—		—		(2,186)
Issuance of common stock, net of offering costs	5,000,000	500		52,063		—		—		—		52,563
Stock-based compensation	—	—		7,012		—		—		—		7,012
Distributions to non-controlling interest	—	—		—		—		—		(448)		(448)
Other	—	—		—		80		—		—		80
Balance as of September 30, 2020	153,293,358	$	15,329	$	—	$	(656,781)	$	(20,667)	$	—	$	(662,119)

	Vector Group Ltd. Stockholders' Deficiency
				Additional Paid-In				Accumulated Other Comprehensive		Non-controlling
	Common Stock					Accumulated
	Shares	Amount		Capital		Deficit		Loss		Interest		Total
Balance as of January 1, 2019	140,914,642	$	14,092	$	—	$	(542,169)	$	(19,982)	$	693	$	(547,366)
Impact of adoption of new accounting standards	—	—		—		3,147		(4,697)		—		(1,550)
Net income	—	—		—		90,268		—		80		90,348
Total other comprehensive income	—	—		—		—		1,530		—		1,530
Distributions and dividends on common stock ($1.14 per share)	—	—		(4,964)		(171,334)		—		—		(176,298)
Restricted stock grant	60,000	6		(6)		—		—		—		—
Surrender of shares in connection with restricted stock vesting	(221,668)	(22)		(2,152)		—		—		—		(2,174)
Effect of 2019 stock dividend*	7,037,649	704		—		(704)		—		—		—
Stock-based compensation	—	—		7,122		—		—		—		7,122
Distributions to non-controlling interest	—	—		—		—		—		(285)		(285)
Balance as of September 30, 2019	147,790,623	$	14,780	$	—	$	(620,792)	$	(23,149)	$	488	$	(628,673)

*    Represents the effect of the September 27, 2019 stock dividend on the third quarter 2019 common-stock activity.

The accompanying notes are an integral part of the condensed consolidated financial statements.

6

VECTOR GROUP LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands)

Unaudited

	Nine Months Ended		Nine Months Ended
	September 30, 2020		September 30, 2019
Net cash provided by operating activities	$	318,660	$	195,349
Cash flows from investing activities:
Sale of investment securities	20,773		16,186
Maturities of investment securities	43,405		45,798
Purchase of investment securities	(64,827)		(76,094)
Proceeds from sale or liquidation of long-term investments	30,255		—
Purchase of long-term investments	(9,238)		(1,000)
Investments in real estate ventures	(6,239)		(36,269)
Distributions from investments in real estate ventures	11,606		30,934
Increase in cash surrender value of life insurance policies	(723)		(773)
Decrease in restricted assets	384		661
Proceeds from sale of fixed assets	—		17
Capital expenditures	(8,824)		(10,158)
Purchase of subsidiaries	—		(323)
Paydowns of investment securities	627		828
Investments in real estate, net	(701)		(1,910)
Net cash provided by (used in) investing activities	16,498		(32,103)
Cash flows from financing activities:
Proceeds from issuance of debt	520		—
Deferred financing costs	—		(36)
Repayments of debt	(173,779)		(230,874)
Borrowings under revolver	130,686		204,506
Repayments on revolver	(165,639)		(221,373)
Dividends and distributions on common stock	(97,781)		(179,449)
Distributions to non-controlling interest	(448)		(285)
Proceeds from issuance of Vector stock	52,563		—
Other	—		(46)
Net cash used in financing activities	(253,878)		(427,557)
Net increase (decrease) in cash, cash equivalents and restricted cash	81,280		(264,311)
Cash, cash equivalents and restricted cash, beginning of period	379,476		591,729
Cash, cash equivalents and restricted cash, end of period	$	460,756	$	327,418

The accompanying notes are an integral part of the condensed consolidated financial statements.

7

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

1.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)Basis of Presentation:

The condensed consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.

Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Liggett Vector Brands coordinates Liggett and Vector Tobacco’s sales and marketing efforts. Certain references to “Liggett” refer to the Company’s tobacco operations, including the business of Liggett and Vector Tobacco, unless otherwise specified. New Valley is engaged in the real estate business.

The unaudited, interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair statement of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”). The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year.

Certain reclassifications have been made to the 2019 financial information to conform to the 2020 presentation.

(b)Distributions and Dividends on Common Stock:

The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital to the extent paid-in-capital is available and then to accumulated deficit. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all periods presented. On November 5, 2019, the Company announced that its board of directors decided that the Company will no longer pay an annual stock dividend.

(c)Earnings Per Share (“EPS”):

Net income for purposes of determining basic EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	84,216

8

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Net income for purposes of determining diluted EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributable to 7.5% Variable Interest Senior Convertible Notes	—		—		—		(1,246)
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	82,970

Basic and diluted EPS were calculated using the following common shares:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2020	2019	2020	2019
Weighted-average shares for basic EPS	152,216,118	146,703,766	149,541,642	146,562,252
Plus incremental shares related to convertible debt	—	—	—	961,191
Plus incremental shares related to stock options and non-vested restricted stock	8,470	32,374	32,007	13,782
Weighted-average shares for diluted EPS	152,224,588	146,736,140	149,573,649	147,537,225

The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three and nine months ended September 30, 2020 and 2019, but were not included in the computation of diluted EPS because the impact of the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods and the common shares issuable under the convertible debt were anti-dilutive to EPS.

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Weighted-average shares of non-vested restricted stock	612,538		1,012,285		555,918		1,274,549
Weighted-average expense per share	$	18.29	$	18.03	$	19.54	$	17.95
Weighted-average number of shares issuable upon conversion of debt	—		11,447,061		3,237,522		11,447,061
Weighted-average conversion price	$	—	$	20.27	$	20.27	$	20.27

(d)Restructuring:

In response to the current novel coronavirus pandemic (“COVID-19”), the Company's Real Estate segment, including Douglas Elliman, has commenced a restructuring by realigning its administrative support function and office locations as well as adjusting its business model to more efficiently serve its clients. This included a reduction of staff by approximately 25% at Douglas Elliman.

9

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The following table summarizes amounts expensed for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Cash Charges:
Employee severance and benefits	$	186	$	1,785
Other restructuring expenses	64		282
	250		2,067
Non-Cash:
Loss on fixed assets associated with consolidation of sales offices	70		1,214
	70		1,214
Total restructuring charges	$	320	$	3,281

All amounts expensed for the three and nine months ended September 30, 2020 are included as Restructuring charges in the Company’s condensed consolidated statements of operations and are all attributable to the Company’s Real Estate segment.

Severance and benefits expensed for the three and nine months ended September 30, 2020 relate entirely to a reduction in administrative positions.

The following table presents the activity under the Real Estate segment restructuring plan for the nine months ended September 30, 2020:

	Employee Severance and Benefits		Other		Non-Cash Loss on Fixed Assets		Total
Accrual balance as of January 1, 2020	$	—	$	—	$	—	$	—
Restructuring charges	1,785		282		1,214		3,281
Utilized	(1,735)		(282)		(1,214)		(3,231)
Accrual balance as of September 30, 2020	$	50	$	—	$	—	$	50

(e)Investments in Real Estate Ventures:

In accounting for its investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as (a) entities in which the equity investment at risk is not sufficient to finance its activities without additional subordinated financial support; (b) as a group, the equity investors at risk lack 1) the power to direct the activities of a legal entity that most significantly impact the entity’s economic performance, 2) the obligation to absorb the expected losses of the entity, or 3) the right to receive the expected residual returns of the entity; or (c) as a group, the equity investors have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.

The Company’s interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).

Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

10

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The Company’s maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the VIE, any unfunded capital commitments to the VIE, and, in some cases, guarantees in connection with debt on the specific project. The Company’s maximum exposure to loss in its investment in consolidated VIEs is limited to its investment, which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.

On a quarterly basis, the Company evaluates its investments in real estate ventures to determine if there are indicators of impairment. If so, the Company further investigates to determine if an impairment has occurred and whether such impairment is considered temporary or other than temporary. The Company believes that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven.

(f)Other, net:

Other, net consisted of:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Interest and dividend income	$	1,251	$	3,083	$	5,331	$	9,430
Net gains (losses) recognized on investment securities	2,516		(1,487)		(4,943)		5,601
Net periodic benefit cost other than the service costs	(452)		(576)		(1,361)		(1,692)
Credit loss expense	(8,576)		—		(9,008)		—
Other income	165		1,203		1,865		1,105
Other, net	$	(5,096)	$	2,223	$	(8,116)	$	14,444

(g)Other Assets:

Other assets consisted of:

	September 30, 2020		December 31, 2019
Restricted assets	$	4,008	$	5,241
Prepaid pension costs	32,467		31,686
Equity-method investments	16,240		15,942
Contract assets, net	26,083		18,443
Other assets	36,250		48,778
Total other assets	$	115,048	$	120,090

11

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

(h)Other Current Liabilities:

Other current liabilities consisted of:

	September 30, 2020		December 31, 2019
Accounts payable	$	11,962	$	10,222
Accrued promotional expenses	45,966		35,900
Accrued excise and payroll taxes payable, net	2,817		18,653
Accrued interest	33,159		35,756
Commissions payable	28,972		18,378
Accrued salary and benefits	19,059		29,464
Contract liabilities	9,725		9,358
Allowance for sales returns	7,857		7,785
Other current liabilities	34,511		23,801
Total other current liabilities	$	194,028	$	189,317

(i)    Reconciliation of Cash, Cash Equivalents and Restricted Cash:

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	September 30, 2020		December 31, 2019
Cash and cash equivalents	$	451,071	$	371,341
Restricted cash and cash equivalents included in other current assets	7,224		4,423
Restricted cash and cash equivalents included in other assets	2,461		3,712
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	460,756	$	379,476

Amounts included in current restricted assets and non-current restricted assets represent cash and cash equivalents required to be deposited into escrow for bonds required to appeal adverse product liability judgments, amounts required for letters of credit related to office leases, and certain deposit requirements for banking arrangements. The restrictions related to the appellate bonds will remain in place until the appeal process has been completed. The restrictions related to the letters of credit will remain in place for the duration of the respective lease. The restrictions related to the banking arrangements will remain in place for the duration of the arrangement.

(j)    New Accounting Pronouncements:

In March 2020, the Securities and Exchange Commission (“SEC”) adopted final rules that amend the financial disclosure requirement for guarantors of registered debt securities in Rule 3-10 of Regulation S-X. The new Rule 13-01 of Regulation S-X amends and streamlines the disclosures required by guarantors and issuers of guaranteed securities. Among other things, the new disclosures may be located outside the financial statements. The new rule is effective January 4, 2021, and early adoption is permitted. The Company elected to early adopt the new rule on September 30, 2020. Accordingly, the revised condensed consolidating financial information is presented in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations.

Accounting Standards Updates (“ASU”) adopted in 2020:

In October 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities. The guidance requires indirect interests

12

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

held through related parties under common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. The ASU eliminates disclosures such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The ASU also adds new disclosure requirements for Level 3 measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of ASU 2018-13 impacted financial statement disclosure and had no impact on operating results.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), sets forth a current expected credit loss model that changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This guidance is effective for fiscal years beginning after December 15, 2019.

The ASU introduces a new accounting model, the Current Expected Credit Losses model (CECL), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for notes and other receivables at the time the financial asset is originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaced the previous impairment models in U.S. GAAP, which generally required that a loss be incurred before it is recognized. The new standard applies to receivables arising from revenue transactions such as contract assets and accounts receivables. The adoption of this standard resulted in an increase in stockholders’ deficiency of $2,263, net of tax, attributed to commercial real estate term loans allowance for credit losses of $3,100 as of January 1, 2020.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. Under the amendments of the ASU, an entity should recognize an impairment charge for the amount by which the carrying amount of a reporting unit exceeds its fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendments in this update are effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. This guidance was adopted on January 1, 2020, on a prospective basis. The Company applied the new guidance to evaluate its goodwill during the first quarter of 2020. As a result, a goodwill impairment charge of $46,252 was recorded as the Company's estimated fair value of a reporting unit was less than its book value.

ASUs to be adopted in future periods:

In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans (“ASU 2018-14”). ASU 2018-14 eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. ASU 2018-14 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company will adopt for the period

13

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

ending December 31, 2020. The adoption of ASU 2018-14 will impact financial statement disclosure with no impact on operating results.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). This update simplifies various aspects related to accounting for income taxes, removes certain exceptions to the general principles in Accounting Standards Codification (“ASC”) 740, and clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In January 2020, the FASB issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted, including early adoption in an interim period. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This ASU is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance is effective for all entities for contract modifications beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The Company has not yet determined the extent to which it will utilize these expedients and exceptions should a modification occur. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements.

2.    REVENUE RECOGNITION

Disaggregation of Revenue

In the following table, revenue is disaggregated by major product line for the Tobacco segment:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Tobacco Segment Revenues:
Core Discount Brands - Eagle 20’s, Pyramid, Montego, Grand Prix, Liggett Select, and Eve	$	300,487	$	283,621	$	864,880	$	798,272
Other Brands	18,363		19,639		53,549		56,245
Total tobacco revenues	$	318,850	$	303,260	$	918,429	$	854,517

14

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

In the following table, revenue is disaggregated by major services line and primary geographical market for the Real Estate segment:

	Three months ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	43,039	$	58,909	$	43,883	$	42,000	$	187,831
Commission and other brokerage income - development marketing	4,571		—		5,564		534		10,669
Property management revenue	8,334		250		—		—		8,584
Title fees	358		554		—		—		912
Total Douglas Elliman revenue	56,302		59,713		49,447		42,534		207,996
Other real estate revenues	—		20,500		—		485		20,985
Total real estate revenues	$	56,302	$	80,213	$	49,447	$	43,019	$	228,981

	Three months ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	73,081	$	47,066	$	25,008	$	27,770	$	172,925
Commission and other brokerage income - development marketing	6,920		—		7,614		3,992		18,526
Property management revenue	8,484		184		—		—		8,668
Title fees	—		1,049		—		—		1,049
Total Douglas Elliman revenue	88,485		48,299		32,622		31,762		201,168
Other real estate revenues	—		—		—		362		362
Total real estate revenues	$	88,485	$	48,299	$	32,622	$	32,124	$	201,530

15

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

	Nine Months Ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	129,009	$	129,264	$	97,293	$	87,724	$	443,290
Commission and other brokerage income - development marketing	18,195		—		15,033		1,202		34,430
Property management revenue	25,513		682		—		—		26,195
Title fees	1,425		1,186		—		—		2,611
Total Douglas Elliman revenue	174,142		131,132		112,326		88,926		506,526
Other real estate revenues	—		20,500		—		2,624		23,124
Total real estate revenues	$	174,142	$	151,632	$	112,326	$	91,550	$	529,650

	Nine Months Ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	243,061	$	118,057	$	79,303	$	77,952	$	518,373
Commission and other brokerage income - development marketing	41,024		—		10,680		4,021		55,725
Property management revenue	26,699		538		—		—		27,237
Title fees	—		4,682		—		—		4,682
Total Douglas Elliman revenue	310,784		123,277		89,983		81,973		606,017
Other real estate revenues	—		—		—		3,612		3,612
Total real estate revenues	$	310,784	$	123,277	$	89,983	$	85,585	$	609,629

Contract Balances

The following table provides information about contract assets and contract liabilities from development marketing and commercial leasing contracts with customers:

	September 30, 2020		December 31, 2019
Receivables, which are included in accounts receivable - trade, net	$	2,194	$	2,129
Contract assets, net, which are included in other current assets	5,965		8,766
Payables, which are included in other current liabilities	1,544		1,663
Contract liabilities, which are included in other current liabilities	9,725		9,358
Contract assets, net, which are included in other assets	26,083		18,443
Contract liabilities, which are included in other liabilities	28,304		29,045

The Company recognized revenue of $1,451 and $8,109 for the three and nine months ended September 30, 2020, that were included in the contract liabilities balances at December 31, 2019. The Company recognized revenue of $4,722 and $9,753 for the three and nine months ended September 30, 2019, that were included in the contract liabilities balances at December 31, 2018.

16

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

3.    CURRENT EXPECTED CREDIT LOSSES

On January 1, 2020, the Company adopted ASU No. 2016-13, which sets forth a current expected credit loss model that changes how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income.

ASU 2016-13 introduces a new accounting model, the Current Expected Credit Losses model (“CECL”), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The Company adopted this guidance using the modified retrospective approach, as required, and has not adjusted prior period comparative information and will continue to disclose the prior period financial information in accordance with the previous guidance. The adoption of this standard resulted in an increase in stockholders’ deficiency of $2,263 net of tax, attributed to commercial real estate term loans allowance for credit losses of $3,100 as of January 1, 2020.

Tobacco receivables: Average collection terms for Tobacco sales range between three and twelve days from the time that the cigarettes are shipped to the customer. Based on Tobacco historical and ongoing cash collections from customers, an estimated credit loss in accordance with ASU 2016-13 was not required for these trade receivables as of January 1, 2020 and September 30, 2020.

Real estate broker agent receivables: Douglas Elliman Realty is exposed to credit losses for various amounts due from real estate agents, which are included in Other current assets on the condensed consolidated balance sheets, net of an allowance for credit losses. The Company historically estimated its allowance for credit losses on receivables from agents based on an evaluation of aging, agent sales in pipeline, any security, specific exposures, and historical experience of collections from the individual agents. Based on the Company’s historical credit losses on receivables from agents, current and expected future market trends (such as the current and expected impact of COVID-19 on the real estate market), it was determined that the requirements of Topic 326 did not result in a material impact on the Company’s allowance for credit losses as of January 1, 2020 of $6,132. The Company estimated that the credit losses for these receivables were $7,715 at September 30, 2020.

Term loan receivables: New Valley periodically provides term loans to commercial real estate developers, which are included in Other assets on the condensed consolidated balance sheets. New Valley had two loans with a total amortized cost basis of $15,928 and $15,276, including accrued interest receivable of $6,428 and $5,776 at September 30, 2020 and December 31, 2019, respectively, and have maturities in 2021 and beyond. The loans are secured by guarantees and given their risk profiles are evaluated individually. As New Valley does not have internal historical loss information by which to evaluate the risk of credit losses, external market data measuring default risks on high yield loans as of each measurement date was utilized to estimate reserves for credit losses on these loans. Pursuant to the requirements of Topic 326, New Valley’s expected credit loss estimate was $3,100 as of January 1, 2020 and $12,108 as of September 30, 2020, which reflects the significant current and expected decline in market conditions as of September 30, 2020 due to the impact of COVID-19 on the real estate market.

The adoption of this standard did not have a material impact on the debt securities available for sale portfolio.

The following is the rollforward of the allowance for credit losses for the nine months ended September 30, 2020:

	January 1, 2020		Current Period Provision			Write-offs		Recoveries		September 30, 2020
Allowance for credit losses:
Real estate broker agent receivables	$	6,132	$	1,724	(1)	$	141	$	—	7,715
New Valley term loan receivables	3,100		9,008		(2)	—		—		12,108

______________________

(1) The bad debt expense related to the real estate broker agent receivables is included in Operating, selling, administrative and general expenses on the condensed consolidated statements of operations.

(2) The credit losses related to the New Valley term loan receivables are included in Other, net on the condensed consolidated statements of operations.

17

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

4.    LEASES

Leases

The Company has operating and finance leases for corporate and sales offices, and certain vehicles and equipment. The components of lease expense were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Operating lease cost	$	9,475	$	9,707	$	28,255	$	28,212
Short-term lease cost	218		397		1,007		910
Variable lease cost	663		715		1,818		2,405
Finance lease cost:
Amortization	17		67		94		186
Interest on lease liabilities	4		5		11		12
Total lease cost	$	10,377	$	10,891	$	31,185	$	31,725

Supplemental cash flow information related to leases was as follows:

	Nine Months Ended
	September 30,
	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	19,376	$	28,023
Operating cash flows from finance leases	11		12
Financing cash flows from finance leases	86		182
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	13,711		32,511
Finance leases	60		159

18

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Supplemental balance sheet information related to leases was as follows:

	September 30,			December 31,
	2020			2019
Operating leases:
Operating lease right-of-use assets	$	147,959		$	149,578
Current operating lease liability	$	22,485		$	18,294
Non-current operating lease liability	159,200			156,963
Total operating lease liabilities	$	181,685		$	175,257
Finance leases:
Investments in real estate, net (1)	$	73		$	88
Property, plant and equipment, at cost	$	127		$	127
Accumulated amortization	(38)			(19)
Property and equipment, net	$	89		$	108
Current portion of notes payable and long-term debt	$	59		$	86
Notes payable, long-term debt and other obligations, less current portion	110			108
Total finance lease liabilities	$	169		$	194
Weighted average remaining lease term:
Operating leases	8.09			8.46
Finance leases	2.90			3.01
Weighted average discount rate:
Operating leases	9.28		%	10.75		%
Finance leases	7.75		%	8.61		%

(1)     Included in Investments in real estate, net on the condensed consolidated balance sheets are financing lease equipment, at cost of $748 and $762 and accumulated amortization of $675 and $674 as of September 30, 2020 and December 31, 2019, respectively.

As of September 30, 2020, maturities of lease liabilities were as follows:

	Operating Leases		Finance Leases
Period Ending December 31:
Remainder of 2020	$	6,496	$	19
2021	41,353		66
2022	36,892		61
2023	32,417		35
2024	26,749		8
2025	21,797		—
Thereafter	96,556		—
Total lease payments	262,260		189
Less imputed interest	(80,575)		(20)
Total	$	181,685	$	169

19

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

As of September 30, 2020, the Company had $23 in undiscounted lease payments relating to an additional operating lease for equipment that has not yet commenced. The operating lease will commence in the fourth quarter of 2020 with a lease term of 3 years.

Due to the business disruptions and challenges severely affecting the global economy caused by the COVID-19 pandemic, lessors may provide rent deferrals and other lease concessions to lessees. While the lease modification guidance in Topic 842 addresses routine changes to lease terms resulting from negotiations between the lessee and the lessor, this guidance does not contemplate concessions being so rapidly executed to address the sudden liquidity constraints of some lessees arising from the COVID-19 pandemic and restrictions intended to prevent its spread.

In April 2020, the FASB staff issued a question and answer document (the “Lease Modification Q&A”) focused on the application of lease accounting guidance to lease concessions provided as a result of the COVID-19 pandemic. Under existing lease guidance, the Company would have to determine, on a lease by lease basis, if a lease concession was the result of a new arrangement reached with the tenant (treated within the lease modification accounting framework) or if a lease concession was under the enforceable rights and obligations within the existing lease agreement (precluded from applying the lease modification accounting framework). The Lease Modification Q&A allows the Company, if certain criteria have been met, to bypass the lease by lease analysis, and instead elect to either apply the lease modification accounting framework or not, with such election applied consistently to leases with similar characteristics and similar circumstances.

As a result of the COVID-19 pandemic, the Company received lease concessions from landlords mostly in the form of rent deferrals and a few in the form of rent abatements during the nine months ended September 30, 2020. The Company elected to treat these deferrals and abatements as lease modifications and the existing lease liabilities were remeasured with a corresponding adjustment to the right-of-use asset on the effective date of the modification. The deferrals varied as to the timing of repayment but all agreements required repayment of the deferrals over the remaining lease terms.

5.    INVENTORIES

Inventories consisted of:

	September 30, 2020		December 31, 2019
Leaf tobacco	$	42,448	$	44,516
Other raw materials	5,733		4,669
Work-in-process	645		333
Finished goods	67,211		71,183
Inventories at current cost	116,037		120,701
LIFO adjustments	(21,489)		(21,939)
	$	94,548	$	98,762

All of the Company’s inventories at September 30, 2020 and December 31, 2019 are reported under the LIFO method. The $21,489 LIFO adjustment as of September 30, 2020 decreased the current cost of inventories by $14,761 for Leaf tobacco, $180 for Other raw materials, $24 for Work-in-process and $6,524 for Finished goods. The $21,939 LIFO adjustment as of December 31, 2019 decreased the current cost of inventories by $15,210 for Leaf tobacco, $182 for Other raw materials, $24 for Work-in-process and $6,523 for Finished goods.

The amount of capitalized MSA cost in “Finished goods” inventory was $20,969 and $20,472 at September 30, 2020 and December 31, 2019, respectively. Federal excise tax capitalized in inventory was $27,648 and $27,676 at September 30, 2020 and December 31, 2019, respectively.

At September 30, 2020, Liggett had tobacco purchase commitments of approximately $17,483. Liggett has a single-source supply agreement for reduced ignition propensity cigarette paper through 2022.

20

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

6.    INVESTMENT SECURITIES

Investment securities consisted of the following:

	September 30, 2020		December 31, 2019
Debt securities available for sale	$	89,239	$	83,445
Equity securities at fair value:
Marketable equity securities	11,897		23,819
Mutual funds invested in debt securities	22,956		22,377
Long-term investment securities at fair value (1)	31,619		45,781
Total equity securities at fair value	66,472		91,977
Total investment securities at fair value	155,711		175,422
Less:
Long-term investment securities at fair value	31,619		45,781
Current investment securities at fair value	124,092		129,641
Equity-method investments	$	16,240	$	15,942

(1) These assets are measured at net asset value (“NAV”) as a practical expedient under ASC 820.

Net gains (losses) recognized on investment securities were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Net gains (losses) recognized on debt securities available for sale	22		25		(25)		67
Impairment expense	(22)		(6)		(408)		(11)
Net gains (losses) recognized on investment securities	$	2,516	$	(1,487)	$	(4,943)	$	5,601

(a) Debt Securities Available for Sale:

The components of debt securities available for sale at September 30, 2020 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	88,336	$	903	$	—	$	89,239

21

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The table below summarizes the maturity dates of debt securities available for sale at September 30, 2020.

Investment Type:	Fair Value		Under 1 Year		1 Year up to 5 Years		More than 5 Years
U.S. Government securities	$	11,412	$	9,068	$	2,344	$	—
Corporate securities	58,481		28,863		29,618		—
U.S. mortgage-backed securities	5,759		114		5,645		—
Commercial paper	13,587		13,587		—		—
Total debt securities available for sale by maturity dates	$	89,239	$	51,632	$	37,607	$	—

The components of debt securities available for sale at December 31, 2019 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	82,714	$	731	$	—	$	83,445

There were no available-for-sale debt securities with continuous unrealized losses for less than 12 months and 12 months or greater at September 30, 2020 and December 31, 2019, respectively.

Gross realized gains and losses on debt securities available for sale were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Gross realized gains on sales	$	23	$	27	$	193	$	74
Gross realized losses on sales	(1)		(2)		(218)		(7)
Net gains (losses) recognized on debt securities available for sale	$	22	$	25	$	(25)	$	67
Impairment expense	$	(22)	$	(6)	$	(408)	$	(11)

Although management generally does not have the intent to sell any specific securities at the end of the period, in the ordinary course of managing the Company’s investment securities portfolio, management may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements.

(b) Equity Securities at Fair Value:

The following is a summary of unrealized and realized net gains and losses recognized in net income on equity securities at fair value during the three and nine months ended September 30, 2020 and 2019, respectively:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Less: Net (losses) gains recognized on equity securities sold	(2)		58		(19)		468
Net unrealized gains (losses) recognized on equity securities still held at the reporting date	$	2,518	$	(1,564)	$	(4,491)	$	5,077

22

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The Company’s marketable equity securities and mutual funds invested in debt securities are classified as Level 1 under the fair value hierarchy disclosed in Note 12. Their fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.

The Company received cash distributions of $30,358 and recognized a receivable of $2,438 of in-transit redemptions as of September 30, 2020 related to its long-term investment securities at fair value. The Company classified $30,255 of these distributions as investing cash inflows for the nine months ended September 30, 2020. The remaining distributions were classified as operating cash inflows.

(c) Equity-Method Investments:

Equity-method investments consisted of the following:

	September 30, 2020		December 31, 2019
Mutual fund and hedge funds	$	16,240	$	15,509
Ladenburg Thalmann Financial Services Inc. (“LTS”)	—		433
	$	16,240	$	15,942

At September 30, 2020, the Company’s ownership percentages in the mutual fund and hedge funds accounted for under the equity method ranged from 6.24% to 36.70%. The Company’s ownership percentage in these investments meets the threshold for equity-method accounting.

In November 2019, LTS entered into an Agreement and Plan of Merger with Advisor Group whereby each LTS common share would be converted into the right to receive $3.50 per common share. On February 14, 2020, the merger was completed and the Company received proceeds of $53,169 in exchange for the Company’s 15,191,205 common shares of LTS. The Company also tendered 240,000 shares of LTS 8% Series A Cumulative Redeemable Preferred Stock (Liquidation Preference $25.00 Per Share) for redemption and received an additional $6,009 in March 2020. At the closing of the transaction, the Company’s Executive Vice President resigned as Chairman, President and Chief Executive Officer of LTS, and the Company’s management agreement with LTS was terminated.

Equity in earnings (losses) from investments were:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Mutual fund and hedge funds	$	1,468	$	(632)	$	775	$	(20)
LTS	372		139		53,424		(846)
Other	—		25		—		75
Equity in earnings (losses) from investments	$	1,840	$	(468)	$	54,199	$	(791)

The Company received cash distributions of $53,528 (including the $53,169 received by the Company in exchange for the Company’s 15,191,205 common shares of LTS) and $1,495 from the Company’s equity-method investments for the nine months ended September 30, 2020 and 2019, respectively. The Company classified these cash distributions as operating activities on the condensed consolidated statements of cash flows for the nine months ended September 30, 2020 and September 30, 2019, respectively.

23

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

(d) Equity Securities Without Readily Determinable Fair Values That Do Not Qualify for the NAV Practical Expedient

Equity securities without readily determinable fair values that do not qualify for the NAV practical expedient consisted of investments in various limited liability companies at September 30, 2020 and December 31, 2019, respectively. The total carrying value of these investments was $5,200 as of September 30, 2020 and $6,200 as of December 31, 2019, and was included in “Other assets” on the condensed consolidated balance sheets. No impairment or other adjustments related to observable price changes in orderly transactions for identical or similar investments were identified for the three and nine months ended September 30, 2020 and 2019, respectively.

    7.    NEW VALLEY LLC

Investments in real estate ventures:

The components of “Investments in real estate ventures” were as follows:

	Range of Ownership (1)	September 30, 2020		December 31, 2019
Condominium and Mixed Use Development:
New York City Standard Metropolitan Statistical Area (“SMSA”)	3.1% - 49.5%	$	36,252	$	51,078
All other U.S. areas	15.0% - 77.8%	41,403		55,842
		77,655		106,920
Hotels:
New York City SMSA	1.0% - 18.4%	2,892		2,462
International	49.0%	1,767		2,161
		4,659		4,623
Commercial:
New York City SMSA	49.0%	2,271		1,852
All other U.S. areas	1.6%	6,987		7,634
		9,258		9,486
Other:	15.0% - 49.0%	10,886		10,527
Investments in real estate ventures		$	102,458	$	131,556

______________________

(1) The Range of Ownership reflects New Valley’s estimated current ownership percentage. New Valley’s actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.

24

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Contributions:

The components of New Valley’s contributions to its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,169	$	21,760
All other U.S. areas	4,176		14,000
	5,345		35,760
Apartment Buildings:
All other U.S. areas	76		—
	76		—
Hotels:
New York City SMSA	294		172
	294		172
Other:	524		337
Total contributions	$	6,239	$	36,269

For ventures where New Valley previously held an investment, New Valley contributed its proportionate share of additional capital along with contributions by the other investment partners during the nine months ended September 30, 2020 and September 30, 2019. New Valley’s direct investment percentage for these ventures did not significantly change. 

Distributions:

The components of distributions received by New Valley from its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,735	$	3,380
All other U.S. areas	11,060		1,279
	12,795		4,659
Apartment Buildings:
All other U.S. areas	—		79
	—		79
Hotels:
New York City SMSA	—		21,572
	—		21,572
Commercial:
New York City SMSA	591		13
All other U.S. areas	113		160
	704		173
Other	26		8,088
Total distributions	$	13,525	$	34,571

25

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Of the distributions received by New Valley from its investment in real estate ventures, $1,919 and $3,637 were from distributions of earnings for the nine months ended September 30, 2020 and 2019, respectively, and $11,606 and $30,934 were a return of capital for the nine months ended September 30, 2020 and 2019, respectively. Distributions from earnings are included in cash from operations in the condensed consolidating statements of cash flows, while distributions that are returns of capital are included in cash flows from investing activities in the condensed consolidating statements of cash flows.

Equity in (Losses) Earnings from Real Estate Ventures:

New Valley recognized equity in (losses) earnings from real estate ventures as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	(6,835)	$	2,099	$	(15,286)	$	(1,127)
All other U.S. areas (1)	(618)		4,600		(9,906)		2,234
	(7,453)		6,699		(25,192)		1,107
Apartment Buildings:
All other U.S. areas (1)	(208)		76		(284)		79
	(208)		76		(284)		79
Hotels:
New York City SMSA (1)	(1,119)		(102)		(1,768)		8,132
International	157		434		(394)		70
	(962)		332		(2,162)		8,202
Commercial:
New York City SMSA	783		(149)		1,010		114
All other U.S. areas	(519)		146		(534)		517
	264		(3)		476		631
Other:	(177)		946		(139)		1,983
Equity in (losses) earnings from real estate ventures	$	(8,536)	$	8,050	$	(27,301)	$	12,002

______________________

(1) The Company recognized a liability, classified in Other current liabilities, of $1,302 as a result of recording equity in losses in excess of the joint ventures' carrying value.

During the nine months ended September 30, 2019, New Valley’s Park Lane joint venture sold 80.0% of its interest in the Park Lane Hotel, a hotel located in the New York City SMSA. New Valley recognized equity in earnings of $10,328 from the sale and received distributions of $20,788 for the nine months ended September 30, 2019. The sale reduced New Valley’s direct ownership percentage of the Park Lane Hotel from 5.2% to 1.0%. New Valley continues to account for its investment in the joint venture under the equity method of accounting because its ownership percentage in its direct investment continues to meet the threshold for equity method accounting.

As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair value of three of its New York City SMSA Condominium and Mixed Use Development ventures were less than their carrying value as of September 30, 2020. The Company determined that the impairments were other than temporary. The Company recorded impairment charges as a component of equity in losses from real estate ventures of $6,617 and $10,401 for the three and nine months ended September 30, 2020.

26

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair values of three New York City SMSA and one All other U.S. areas Condominium and Mixed Use Development ventures were less than their carrying value as of September 30, 2019. The Company determined that the impairmentw were other than temporary. The Company recorded impairment charges as a component of equity in earnings from real estate ventures of $4,445 and $8,311 for the three and nine months ended September 30, 2019.

VIE Consideration:

The Company has determined that New Valley is the primary beneficiary of two real estate ventures because it controls the activities that most significantly impact economic performance of each of the two real estate ventures. Consequently, New Valley consolidates these variable interest entities (“VIEs”).

The carrying amount of the consolidated assets of the VIEs was $0 and $897 as of September 30, 2020 and December 31, 2019, respectively. Those assets are owned by the VIEs, not the Company. Neither of the two consolidated VIEs had recourse liabilities as of September 30, 2020 and December 31, 2019. A VIE’s assets can only be used to settle obligations of that VIE. The VIEs are not guarantors of the Company’s senior notes and other debts payable.

For the remaining investments in real estate ventures, New Valley determined that the entities were VIEs but New Valley was not the primary beneficiary. Therefore, New Valley’s investment in such real estate ventures has been accounted for under the equity method of accounting.

Maximum Exposure to Loss:

New Valley’s maximum exposure to loss from its investments in real estate ventures consisted of the net carrying value of the venture adjusted for any future capital commitments and/or guarantee arrangements. The maximum exposure to loss was as follows:

	September 30, 2020
Condominium and Mixed Use Development:
New York City SMSA	$	36,252
All other U.S. areas	41,403
	77,655
Hotels:
New York City SMSA	2,892
International	1,767
	4,659
Commercial:
New York City SMSA	2,271
All other U.S. areas	6,987
	9,258
Other	24,461
Total maximum exposure to loss	$	116,033

New Valley capitalized $932 and $3,188 of interest costs into the carrying value of its ventures whose projects were currently under development for the three and nine months ended September 30, 2020. New Valley capitalized $1,703 and $4,706 of interest costs into the carrying value of its ventures whose projects were currently under development for the three and nine months ended September 30, 2019.

Douglas Elliman is engaged by certain developers as a broker for several of the real estate ventures that New Valley invests in. Douglas Elliman earned gross commissions of approximately $8,829 and $15,394 from these projects for the nine months ended September 30, 2020 and 2019, respectively.

27

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Investments in Real Estate, net:

The components of “Investments in real estate, net” were as follows:

	September 30, 2020		December 31, 2019
Escena, net	$	9,786	$	9,972
Sagaponack	—		18,345
Investments in real estate, net	$	9,786	$	28,317

Escena.  The assets of “Escena, net” were as follows:

	September 30, 2020		December 31, 2019
Land and land improvements	$	8,911	$	8,910
Building and building improvements	1,926		1,926
Other	1,670		1,659
	12,507		12,495
Less accumulated depreciation	(2,721)		(2,523)
	$	9,786	$	9,972

New Valley recorded operating losses of $738 and $965 for the three months ended September 30, 2020 and 2019, respectively, from Escena. New Valley recorded operating losses of $1,010 and $633 for the nine months ended September 30, 2020 and 2019, respectively, from Escena. Escena is a master planned community, golf course, and club house in Palm Springs, California.

Investment in Sagaponack. In April 2015, New Valley invested $12,502 in a residential real estate project located in Sagaponack, NY. In August 2020, New Valley sold the project for $20,500 and recognized the revenue in accordance with the scope of ASC Topic 606 since New Valley has no continuing investment or involvement. The sales were presented as revenues and the cost of the investment as cost of goods sold on the condensed consolidated statements of operations.

28

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

8.    NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS

Notes payable, long-term debt and other obligations consisted of:

	September 30, 2020		December 31, 2019
Vector:
6.125% Senior Secured Notes due 2025	$	850,000	$	850,000
10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392	551,868		551,608
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $0 and $5,276*	—		164,334
Liggett:
Revolving credit facility	—		34,952
Equipment loans	94		347
Other	26,773		30,146
Notes payable, long-term debt and other obligations	1,428,735		1,631,387
Less:
Debt issuance costs	(22,087)		(24,902)
Total notes payable, long-term debt and other obligations	1,406,648		1,606,485
Less:
Current maturities	(10,684)		(209,269)
Amount due after one year	$	1,395,964	$	1,397,216

______________________

* The fair value of the derivatives embedded within the 5.5% Variable Interest Senior Convertible Debentures ($4,999 at December 31, 2019) is separately classified as a derivative liability in the condensed consolidated balance sheets.

6.125% Senior Secured Notes due 2025 — Vector:

As of September 30, 2020, the Company was in compliance with all debt covenants related to its 6.125% Senior Secured Notes due 2025.

10.5% Senior Notes due 2026 — Vector:

As of September 30, 2020, the Company was in compliance with all debt covenants related to its 10.5% Senior Notes due 2026.

5.5% Variable Interest Senior Convertible Debentures due 2020 — Vector:

In April 2020, the Company paid $169,610 of principal as full payment of its 5.5% Variable Interest Senior Convertible Debentures due 2020, which matured on April 15, 2020.

Revolving Credit Agreement — Liggett:

As of September 30, 2020, there was no outstanding balance due under the Third Amended and Restated Credit Agreement (the “Credit Agreement”), all of which was classified as current debt as of September 30, 2020. Availability, as determined under the Credit Agreement, was approximately $58,800 based on eligible collateral at September 30, 2020. As of September 30, 2020, the Company’s applicable subsidiaries were in compliance with all debt covenants under the Credit Agreement.

Other:

Other Notes Payable consist primarily of $26,300 of notes payable issued by New Valley. On December 31, 2018, New Valley acquired the remaining 29.41% interest in Douglas Elliman for a total purchase price of $40,000, which included $10,000 of cash paid and the remaining $30,000 of notes payable to the sellers. Interest on the outstanding principal balance of the notes accrued at the mid-term applicable federal rate (“AFR”) in effect as of December 31, 2018 until January 1, 2020 and thereafter is adjusted to the then-current AFR on each payment date. Principal and interest is payable in installments

29

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

through October 1, 2022. $3,750 of principal has been repaid through September 30, 2020 and the remaining principal is due to be repaid as follows: (1) $1,250 in the remainder of 2020; (2) $12,500 in 2021; and (3) $12,500 in 2022.

Non-Cash Interest Expense — Vector:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Amortization of debt discount, net	$	89	$	5,746	$	5,536	$	19,718
Amortization of debt issuance costs	847		1,089		2,894		3,327
	$	936	$	6,835	$	8,430	$	23,045

Fair Value of Notes Payable and Long-Term Debt:

	September 30, 2020				December 31, 2019
	Carrying		Fair		Carrying			Fair
	Value		Value		Value			Value
Senior Notes	$	1,401,868	$	1,419,309	$	1,401,608		$	1,409,920
Variable Interest Senior Convertible Debt	—		—		164,334			176,289
Liggett and other	26,867		26,878		65,445			65,456
Notes payable and long-term debt	$	1,428,735	$	1,446,187	$	1,631,387	(1)	$	1,651,665

______________________

(1) The carrying value does not include the carrying value of the embedded derivative. See Note 12.

Notes payable and long-term debt are carried on the condensed consolidated balance sheets at amortized cost. The fair value determinations disclosed above are classified as Level 2 under the fair value hierarchy disclosed in Note 12 if such liabilities were recorded on the condensed consolidated balance sheets at fair value. The estimated fair value of the Company’s notes payable and long-term debt has been determined by the Company using available market information and appropriate valuation methodologies including the evaluation of the Company’s credit risk as described in the Company’s Form 10-K. The Company used a derived price based upon quoted market prices and trade activity as of September 30, 2020 to determine the fair value of its publicly-traded notes and debentures. The carrying value of the revolving credit facility is equal to fair value. The fair value of the equipment loans and other obligations was determined by calculating the present value of the required future cash flows. However, considerable judgment is required to develop the estimates of fair value and, accordingly, the estimate presented herein is not necessarily indicative of the amount that could be realized in a current market exchange.

30

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

9.    CONTINGENCIES

Tobacco-Related Litigation:

Overview. Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. The cases have generally fallen into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (“Individual Actions”); (ii) lawsuits by individuals requesting the benefit of the Engle ruling (“Engle progeny cases”); (iii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging that use of the terms “lights” and/or “ultra lights” constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (“Class Actions”); and (iv) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (“Health Care Cost Recovery Actions”). The future financial impact of the risks and expenses of litigation are not quantifiable. For the nine months ended September 30, 2020 and 2019, Liggett incurred tobacco product liability legal expenses and costs totaling $4,684 and $5,627, respectively. The tobacco product liability legal expenses and costs are included in the operating, selling, administrative and general expenses and litigation settlement and judgment expense line items in the condensed consolidated statements of operations. Legal defense costs are expensed as incurred.

Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending cases. With the commencement of new cases, the defense costs and the risks relating to the unpredictability of litigation increase. Management reviews on a quarterly basis with counsel all pending litigation and evaluates the probability of a loss being incurred and whether an estimate can be made of the possible loss or range of loss that could result from an unfavorable outcome. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. Damages awarded in tobacco-related litigation can be significant.

Bonds. Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that a majority of states now limit the dollar amount of bonds or require no bond at all. As of September 30, 2020, to obtain a stay of the judgment pending the appeal of the Santoro case, Liggett secured a $535 supersedeas bond.

In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny cases in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. The maximum amount of any such bond for an appeal in the Florida state courts will be no greater than $5,000. In several cases, plaintiffs challenged the constitutionality of the bond cap statute, but to date the courts have upheld the constitutionality of the statute. It is possible that the Company’s consolidated financial position, results of operations, and cash flows could be materially adversely affected by an unfavorable outcome of such challenges.

Accounting Policy. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as discussed in this Note 9: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to reasonably estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.

Although Liggett has generally been successful in managing the litigation filed against it, litigation is subject to uncertainty and significant challenges remain, including with respect to the remaining Engle progeny cases. There can be no assurances that Liggett’s past litigation experience will be representative of future results. Judgments have been entered against Liggett in the past, in Individual Actions and Engle progeny cases, and several of those judgments were affirmed on appeal and satisfied by Liggett. It is possible that the consolidated financial position, results of operations and cash flows of the Company could be materially adversely affected by an unfavorable outcome or settlement of any of the remaining smoking-related litigation. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are and will continue to be vigorously defended. Liggett has

31

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

entered into settlement discussions in individual cases or groups of cases where Liggett has determined it was in its best interest to do so, and it may continue to do so in the future. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.

Individual Actions

As of September 30, 2020, there were 70 Individual Actions pending against Liggett, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. The following table lists the number of Individual Actions by state:

State	Number of Cases
Florida	39
Illinois	11
Nevada	7
New Mexico	5
Virgin Islands	5
Louisiana	2
Massachusetts	1

The plaintiffs’ allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity, violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”), state RICO statutes and antitrust statutes. In many of these cases, in addition to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.

Defenses raised in Individual Actions include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, statute of repose, equitable defenses such as “unclean hands” and lack of benefit, failure to state a claim and federal preemption.

Engle Progeny Cases

In May 1994, the Engle case was filed as a class action against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, “have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking.” A trial was held and the jury returned a verdict adverse to the defendants (approximately $145,000,000 in punitive damages, including $790,000 against Liggett). Following an appeal to the Third District Court of Appeal, the Florida Supreme Court in July 2006 decertified the class on a prospective basis and affirmed the appellate court’s reversal of the punitive damages award. Former class members had until January 2008 to file individual lawsuits. As a result, Liggett and the Company, and other cigarette manufacturers, were sued in thousands of Engle progeny cases in both federal and state courts in Florida. Although the Company was not named as a defendant in the Engle case, it was named as a defendant in substantially all of the Engle progeny cases where Liggett was named as a defendant.

Cautionary Statement About Engle Progeny Cases. Since 2009, judgments have been entered against Liggett and other cigarette manufacturers in Engle progeny cases. A number of the judgments were affirmed on appeal and satisfied by the defendants. Many were overturned on appeal. As of September 30, 2020, 25 Engle progeny cases where Liggett was a defendant at trial resulted in verdicts.

There have been 16 verdicts returned in favor of the plaintiffs and nine in favor of Liggett. In five of the cases, punitive damages were awarded against Liggett. Several of the adverse verdicts were overturned on appeal and new trials were ordered. In certain cases, the judgments were entered jointly and severally with other defendants and Liggett may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate

32

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

or jury-allocated share of a judgment. As a result, under certain circumstances, Liggett may have to pay more than its proportionate share of any bonding or judgment related amounts. Except as discussed in this Note 9, management is unable to estimate the possible loss or range of loss from the remaining Engle progeny cases as there are currently multiple defendants in each case and, in most cases, discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are in fact Engle class members, the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify the amount of their demand for damages. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.

Engle Progeny Settlements.

In October 2013, the Company and Liggett entered into a settlement with approximately 4,900 Engle progeny plaintiffs and their counsel. Pursuant to the terms of the settlement, Liggett agreed to pay a total of approximately $110,000, with $61,600 paid in an initial lump sum and the balance of $48,000 to be paid in installments over 14 years starting in February 2015. In exchange, the claims of these plaintiffs were dismissed with prejudice against the Company and Liggett. The Company’s future payments will be approximately $3,400 per annum through 2028, with a cost of living increase beginning in 2021.

Liggett subsequently entered into two separate agreements with a total of 152 Engle progeny plaintiffs where Liggett paid a total of $23,150 to settle their claims. On an individual basis, Liggett settled an additional 201 Engle progeny cases for approximately $8,100 in the aggregate.

Notwithstanding the comprehensive nature of the Engle Progeny Settlements, 42 plaintiffs’ claims remain pending in state court. Therefore, the Company and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.

Judgments Paid in Engle Progeny Cases.

As of September 30, 2020, Liggett had paid in the aggregate $39,773, including interest and attorneys’ fees, to satisfy the judgments in the following Engle progeny cases: Lukacs, Campbell, Douglas, Clay, Tullo, Ward, Rizzuto, Lambert and Buchanan. An adverse verdict against Liggett for $265 in Santoro is currently on appeal.

Maryland Cases

Liggett was a defendant in 16 multi-defendant personal injury cases in Maryland alleging claims arising from asbestos and tobacco exposure (“synergy cases”). In July 2016, the Court of Appeals (Maryland’s highest court) ruled that joinder of tobacco and asbestos cases may be possible in certain circumstances, but plaintiffs must demonstrate at the trial court level how such cases may be joined while providing appropriate safeguards to prevent embarrassment, delay, expense or prejudice to defendants and “the extent to which, if at all, the special procedures applicable to asbestos cases should extend to tobacco companies.” The Court of Appeals remanded these issues to be determined at the trial court level. In June 2017, the trial court issued an order dismissing all synergy cases against the tobacco defendants, including Liggett, without prejudice. Plaintiffs may seek appellate review or file new cases against the tobacco companies.

Liggett Only Cases  

There are currently two cases where Liggett is the sole defendant: Cowart, a Florida Individual Action, and Tumin, an Engle progeny case. It is possible that cases where Liggett is the only defendant could increase as a result of the remaining Engle progeny cases and newly filed Individual Actions.

Class Actions

As of September 30, 2020, two actions were pending for which either a class had been certified or plaintiffs were seeking class certification where Liggett is a named defendant. Other cigarette manufacturers are also named in these two cases.

Plaintiffs’ allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.

33

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption.

In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, allege they were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. A stay order entered on March 16, 2016 stays the case pending completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.

In February 1998, in Parsons v. AC & S Inc., a purported class action was commenced on behalf of all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy of three of the defendants.

Health Care Cost Recovery Actions

As of September 30, 2020, one Health Care Cost Recovery Action was pending against Liggett, Crow Creek Sioux Tribe v. American Tobacco Company, a South Dakota case filed in 1997, where the plaintiff seeks to recover damages from Liggett and other cigarette manufacturers based on various theories of recovery as a result of alleged sales of tobacco products to minors. The case is dormant.

The claims asserted in health care cost recovery actions vary, but can include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. Although no specific damage amounts are typically pleaded, it is possible that requested damages might be in the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was “unjustly enriched” by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.

Department of Justice Lawsuit

In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover, among other things, an unspecified amount of health care costs paid and to be paid by the federal government for smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants. In August 2006, the trial court entered a Final Judgment against each of the cigarette manufacturing defendants, except Liggett. The judgment was affirmed on appeal. As a result, the cigarette manufacturing defendants, other than Liggett, are now subject to the trial court’s Final Judgment which ordered, among other things, the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “lights” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to environmental tobacco smoke.

Upcoming Trials

As of September 30, 2020, there were three Individual Actions (Gordon, Baron and Feld) and one Engle progeny case (Blocker) scheduled for trial through September 30, 2021, where Liggett (and/or the Company) is a named defendant. Trial dates are subject to change and additional cases could be set for trial during this time.

MSA and Other State Settlement Agreements

In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors.

In November 1998, Philip Morris, R.J. Reynolds and two other companies (the “Original Participating Manufacturers” or “OPMs”) and Liggett and Vector Tobacco (together with any other tobacco product manufacturer that becomes a signatory, the “Subsequent Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are hereinafter referred to jointly as “PMs”)

34

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

entered into the Master Settlement Agreement (the “MSA”) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the “Settling States”) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State.

As a result of the MSA, the Settling States released Liggett and Vector Tobacco from:

•all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and

•all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business.

The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of PMs. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each PM to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits PMs from licensing third parties to advertise tobacco brand names in any manner prohibited under the MSA; and prohibits PMs from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities.

The MSA also requires PMs to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of PMs. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA.

Under the payment provisions of the MSA, PMs are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions including a “Non-Participating Manufacturers Adjustment” or “NPM Adjustment”). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each PM and are not the responsibility of any parent or affiliate of a PM.

Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. Liggett and Vector Tobacco’s domestic shipments accounted for approximately 4.0% of the total cigarettes sold in the United States in 2019. If Liggett’s or Vector Tobacco’s market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. On December 30, 2019, Liggett and Vector Tobacco pre-paid $140,000 of their approximate $169,000 2019 MSA obligation, the balance of which was paid in April 2020, subject to applicable disputes or adjustments.

Certain MSA Disputes

NPM Adjustment.  Liggett and Vector Tobacco contend that they are entitled to an NPM Adjustment for each year from 2003 - 2019. The NPM Adjustment is a potential adjustment to annual MSA payments, available when PMs suffer a market share loss to NPMs for a particular year and an economic consulting firm selected pursuant to the MSA determines (or the parties agree) that the MSA was a “significant factor contributing to” that loss. A Settling State that has “diligently enforced” its qualifying escrow statute in the year in question may be able to avoid its allocable share of the NPM Adjustment. For 2003 - 2019, Liggett and Vector Tobacco, as applicable, disputed that they owed the Settling States the NPM Adjustments as calculated by the independent auditor. As permitted by the MSA, Liggett and Vector Tobacco either paid subject to dispute, withheld payment, or paid into a disputed payment account, the amounts associated with these NPM Adjustments.

    In June 2010, after the PMs prevailed in 48 of 49 motions to compel arbitration, the parties commenced the arbitration for the 2003 NPM Adjustment. That arbitration concluded in September 2013. It was followed by various challenges filed in state courts by states that did not prevail in the arbitration. Those challenges resulted in reductions, but not elimination of, the amounts awarded.

35

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

    The PMs settled most of the disputed NPM Adjustment years with 37 states representing approximately 75% of the MSA share for 2003 - 2022. The 2004 NPM Adjustment arbitration commenced in 2016, with the final individual state hearings likely to occur in April 2021 and a second phase addressing the effect of the settlements to start thereafter. The parties have also selected an arbitration panel to address the NPM Adjustments for 2005-2007 and initial proceedings in that arbitration are likely to commence in 2021. A separate court proceeding regarding Montana remains pending.

As a result of the settlement charge and arbitration award described above, Liggett and Vector Tobacco reduced cost of sales for years 2013 - 2019 by $48,032 and by $3,899 for the three and nine months ended September 30, 2020. Liggett and Vector Tobacco may be entitled to further adjustments. As of September 30, 2020, Liggett and Vector Tobacco had accrued approximately $13,400 related to the disputed amounts withheld from the non-settling states for 2004 - 2010, which may be subject to payment, with interest, if Liggett and Vector Tobacco lose the disputes for those years. As of September 30, 2020, there remains approximately $41,500 in the disputed payments account relating to Liggett and Vector Tobacco’s 2011 - 2019 NPM Adjustment disputes with the non-settling states. If Liggett and Vector Tobacco lose the disputes for all or any of those years, pursuant to the MSA, no interest would be due on the amounts paid into the disputed payment account.

Other State Settlements.  The MSA replaced Liggett’s prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Except as described below, Liggett’s agreements with these states remain in full force and effect. These states’ settlement agreements with Liggett contained most favored nation provisions which could reduce Liggett’s payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on settlements or resolutions with United States Tobacco Company, Liggett’s payment obligations to those four states were eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each state’s respective settlement with the other major tobacco companies. Therefore, Liggett’s non-economic obligations to all states and territories are now defined by the MSA.

In 2003, as a result of a dispute with Minnesota regarding its settlement agreement, Liggett agreed to pay $100 a year in any year cigarettes manufactured by Liggett are sold in that state. Further, the Attorneys General for Florida, Mississippi and Texas advised Liggett that they believed Liggett had failed to make payments under the respective settlement agreements with those states. In 2010, Liggett settled with Florida and agreed to pay $1,200 and to make further annual payments of $250 for a period of 21 years, starting in March 2011, with the payments from year 12 forward being subject to an inflation adjustment.

In January 2016, the Attorney General for Mississippi filed a motion in Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement (the “1996 Agreement”) alleging that Liggett owes Mississippi at least $27,000 in compensatory damages and additional amounts for interest, punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the 1996 Agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded.  In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration as to two issues concerning damages and stayed the proceedings before the Special Master pending completion of the arbitration. In March 2019, the arbitration panel issued its final arbitration award on the two issues before it: (i) the panel ruled in favor of Liggett, finding that the $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income; and (ii) ruled in favor of Mississippi on the remaining issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement. Following confirmation of the arbitration award, Mississippi voluntarily dismissed with prejudice its claims for punitive damages and attorneys’ fees.

In July 2019, the parties stipulated that the unpaid principal (exclusive of interest) purportedly due from Liggett to Mississippi pursuant to the 1996 Agreement (from inception through 2019) is approximately $15,500, subject to Liggett’s right to litigate and/or appeal the enforceability of the 1996 Agreement (and all issues other than the calculation of such principal amount). In September 2019, the Special Master held a hearing regarding the state’s claim for approximately $17,500 in prejudgment interest as well as post-judgment interest in amounts to be determined. A decision is pending. Liggett continues to believe that the April 2017 Chancery Court order is in error because the most favored nations provision in the 1996 Agreement eliminated all of Liggett’s payment obligations to Mississippi, and it reserved all rights to appeal this and other issues at the conclusion of the case. In the event Liggett appeals an adverse judgment, the posting of a bond may be required.

Liggett may be required to make additional payments to Mississippi and Texas which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.

36

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

Cautionary Statement  

Management is not able to reasonably predict the outcome of the litigation pending or threatened against Liggett or the Company. Litigation is subject to many uncertainties. Liggett has been found liable in multiple Engle progeny cases and Individual Actions, several of which were affirmed on appeal and satisfied by Liggett. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may attempt to settle particular cases if it believes it is in its best interest to do so.

Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that Liggett may not be able to meet those requirements. An unfavorable outcome of a pending smoking-related case could encourage the commencement of additional litigation. Except as discussed in this Note 9, management is unable to estimate the loss or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its consolidated financial statements for unfavorable outcomes.

The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional litigation or legislation.

It is possible that the Company’s consolidated financial position, results of operations and cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation.

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2020 was as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2020	$	34,116	$	4,249	$	38,365	$	17,275	$	20,594	$	37,869
Expenses	139,393		28		139,421		—		—		—
Change in MSA obligations capitalized as inventory	32		—		32		—		—		—
Payments	(27,214)		(4,324)		(31,538)		—		—		—
Reclassification to/(from) non-current liabilities	(855)		3,252		2,397		855		(3,252)		(2,397)
Interest on withholding	—		330		330		—		1,422		1,422
Balance as of September 30, 2020	$	145,472	$	3,535	$	149,007	$	18,130	$	18,764	$	36,894

37

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2019 were as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2019	$	36,561	$	310	$	36,871	$	16,383	$	21,794	$	38,177
Expenses	125,911		895		126,806		—		—		—
Change in MSA obligations capitalized as inventory	2,756		—		2,756		—		—		—
Payments	(31,959)		(355)		(32,314)		—		—		—
Reclassification to/(from) non-current liabilities	(892)		3,338		2,446		892		(3,338)		(2,446)
Interest on withholding	—		187		187		—		1,600		1,600
Balance as of September 30, 2019	$	132,377	$	4,375	$	136,752	$	17,275	$	20,056	$	37,331

Other Matters:

Liggett’s and Vector Tobacco’s management are unaware of any material environmental conditions affecting their existing facilities. Liggett’s and Vector Tobacco’s management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material impact on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco.

Liggett and the Company have received three separate demands for indemnification from Altria Client Services, on behalf of Philip Morris, relating to lawsuits alleging smokers’ use of L&M cigarettes. The indemnification demands are purportedly issued in connection with Eve Holdings’ 1999 sale of certain brands to Philip Morris.

In addition to the foregoing, Douglas Elliman and certain of its subsidiaries are subject to numerous proceedings, lawsuits and claims in connection with their ordinary business activities. Many of these matters are covered by insurance or, in some cases, the Company is indemnified by third parties.

Management is of the opinion that the liabilities, if any, resulting from other proceedings, lawsuits and claims pending against the Company and its consolidated subsidiaries, unrelated to tobacco product liability, should not materially affect the Company’s consolidated financial position, results of operations or cash flows.

38

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

10.    GOODWILL AND OTHER INTANGIBLE ASSETS

The components of Goodwill and other intangible assets, net were as follows:

	December 31, 2019		Impairment Losses		Amortization		September 30, 2020
Goodwill	$	78,008	$	(46,252)	$	—	$	31,756
Indefinite life intangibles:
Intangible asset associated with benefit under the MSA	107,511		—		—		107,511
Trademark - Douglas Elliman	80,000		(12,000)		—		68,000
Intangibles with a finite life, net	474		—		(123)		351
Total goodwill and other intangible assets, net	$	265,993	$	(58,252)	$	(123)	$	207,618

Goodwill is evaluated for impairment annually or whenever the Company identifies certain triggering events or circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Events or circumstances that might indicate an interim evaluation is warranted include, among other things, unexpected adverse business conditions, macro and reporting unit specific economic factors (for example, interest rate and foreign exchange rate fluctuations, and loss of key personnel), supply costs, unanticipated competitive activities, and acts by governments and courts.

During the first quarter of 2020, the Company determined that a triggering event occurred related to the Douglas Elliman reporting unit due to a decline in sales and profitability projections for the reporting unit driven by the COVID-19 pandemic and related economic disruption. The Company utilized third-party valuation specialists to prepare a quantitative assessment of goodwill and trademark intangible asset related to Douglas Elliman.

For the goodwill testing, the Company utilized an income approach (a discounted cash flows “DCF” method) to estimate the fair value of the Douglas Elliman business. The estimated fair value of the trademark indefinite-life intangible asset related to the Douglas Elliman brand name was determined using an approach that values the Company’s cash savings from having a royalty-free license compared to the market rate it would pay for access to use the trade name.

The third-party quantitative assessments of the goodwill and trademark intangible asset reflected management’s assumptions regarding revenue growth rates, economic and market trends including current expectations of deterioration resulting from the COVID-19 pandemic, changes to cost structures and other expectations about the anticipated short-term and long-term operating results of Douglas Elliman. The quantitative assessments resulted in impairment charges to goodwill of $46,252 and to the trademark intangible asset of $12,000. If the Company fails to achieve the financial projections used in the quantitative assessments of fair value or the impacts of COVID-19 are more severe than expected, additional impairment charges could result in future periods, and such impairment charges could be material.

39

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

11.    INCOME TAXES

The Company’s effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets, and any tax planning opportunities available to the Company. For interim financial reporting, the Company estimates the annual effective income tax rate based on full year projections and applies the annual effective income tax rate against year-to-date pretax income to record income tax expense, adjusted for discrete items, if any. The Company refines annual estimates as new information becomes available. The Company’s tax rate does not bear a relationship to statutory tax rates due to permanent differences, which are primarily related to nondeductible compensation, and state taxes.

The Company’s income tax expense consisted of the following:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Income before provision for income taxes	$	55,962	$	49,744	$	88,443	$	128,292
Income tax expense using estimated annual effective income tax rate	16,784		14,844		26,497		38,378
Changes in effective tax rates	66		(785)		—		—
Impact of discrete items, net	973		(323)		1,264		(434)
Income tax expense	$	17,823	$	13,736	$	27,761	$	37,944

The discrete items for the three months ended September 30, 2020 relate to income tax expense related to changes in value of certain contingent consideration and stock-based compensation. The discrete items for the nine months ended September 30, 2020 relate to income tax expense related to the equity in earnings from investments associated with the one-time gain on sale of LTS partially offset by the goodwill and trademark impairment charges, changes in value of certain contingent consideration, and stock-based compensation. The discrete items for the three and nine months ended September 30, 2019 are related to the release of certain valuation allowances offset by income tax expense related to state tax audits and stock-based compensation.

On March 27, 2020, the President of the United States signed the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act into law. The Act includes several significant tax and payroll-related provisions for corporations, including the usage of net operating losses, bonus depreciation, interest expense, and certain payroll benefits. The Company continues to evaluate the impact this Act will have on its financial statements and required disclosures.

40

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

12.    INVESTMENTS AND FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities subject to fair value measurements were as follows:

	Fair Value Measurements as of September 30, 2020
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	373,030	$	373,030	$	—	$	—
Commercial paper (1)	39,884		—		39,884		—
Certificates of deposit (2)	2,108		—		2,108		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	11,897		11,897		—		—
Mutual funds invested in debt securities	22,956		22,956		—		—
Total equity securities at fair value	34,853		34,853		—		—
Debt securities available for sale
U.S. government securities	11,412		—		11,412		—
Corporate securities	58,481		—		58,481		—
U.S. government and federal agency	5,759		—		5,759		—
Commercial paper	13,587		—		13,587		—
Total debt securities available for sale	89,239		—		89,239		—
Total investment securities at fair value	124,092		34,853		89,239		—
Long-term investments
Long-term investment securities at fair value (3)	31,619		—		—		—
Total	$	571,268	$	408,418	$	131,231	$	—
Liabilities:
Fair value of contingent liability	$	1,064	$	—	$	—	$	1,064
Total	$	1,064	$	—	$	—	$	1,064

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $7,224 that is included in Other current assets and $1,907 that is included in Other assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

41

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

	Fair Value Measurements as of December 31, 2019
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	307,655	$	307,655	$	—	$	—
Commercial paper (1)	47,328		—		47,328		—
Certificates of deposit (2)	2,193		—		2,193		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	23,819		23,819		—		—
Mutual funds invested in debt securities	22,377		22,377		—		—
Total equity securities at fair value	46,196		46,196		—		—
Debt securities available for sale
U.S. government securities	14,660		—		14,660		—
Corporate securities	54,413		—		54,413		—
U.S. government and federal agency	6,816		—		6,816		—
Commercial mortgage-backed securities	382		—		382		—
Commercial paper	5,887		—		5,887		—
Index-linked U.S. bonds	779		—		779		—
Foreign fixed-income securities	508		—		508		—
Total debt securities available for sale	83,445		—		83,445		—
Total investment securities at fair value	129,641		46,196		83,445		—
Long-term investments
Long-term investment securities at fair value (3)	45,781		—		—		—
Total	$	533,133	$	354,386	$	132,966	$	—
Liabilities:
Fair value of contingent liability	$	3,147	$	—	$	—	$	3,147
Fair value of derivatives embedded within convertible debt	4,999		—		—		4,999
Total	$	8,146	$	—	$	—	$	8,146

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $4,423 that is included in current restricted assets and $3,160 that is included in non-current restricted assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

The fair value of the Level 2 certificates of deposit is based on the discounted value of contractual cash flows. The discount rate is the rate offered by the financial institution. The fair value of investment securities at fair value included in Level 1 is based on quoted market prices from various stock exchanges. The Level 2 investment securities at fair value are

42

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

based on quoted market prices of securities that are thinly traded, quoted prices for identical or similar assets in markets that are not active or inputs other than quoted prices such as interest rates and yield curves.

The long-term investments are based on NAV per share provided by the partnerships based on the indicated market value of the underlying assets or investment portfolio. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed above because they are measured at fair value using the NAV practical expedient.

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at September 30, 2020:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	September 30, 2020		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of contingent liability	$	1,064	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	169,000
				Risk-free rate for a 2.50 year term	0.14		%
				Leverage-adjusted equity volatility of peer firms	70.78		%

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at December 31, 2019:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2019		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of derivatives embedded within convertible debt	$	4,999	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed remaining cash dividends - Q4 2019 and Q1 2020	$0.40/$0.20
				Stock price	$	13.39
				Convertible trading price (as a percentage of par value)	103.94		%
				Volatility	36.94		%
				Risk-free rate	Term structure of US Treasury Securities
				Implied credit spread	1.0% - 3.0% (2.0%)
Fair value of contingent liability	$	3,147	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	271,500
				Risk-free rate for a 3-year term	1.61		%
				Leverage-adjusted equity volatility of peer firms	35.56		%

In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. The Company had no nonrecurring nonfinancial assets subject to fair value measurements as of September 30, 2020 and December 31, 2019, respectively, except for investments in real estate ventures that were impaired as of September 30, 2020 and December 31, 2019.

43

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

The Company’s investments in real estate ventures subject to nonrecurring fair value measurements are as follows:

			Fair Value Measurement Using:
	Three Months Ended September 30, 2020				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	6,617	$	6,901	$	—	$	—	$	6,901

The Company estimated the fair value of its investments in real estate ventures using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the investments in real estate ventures was attributed to the decline in the projected sales prices of the respective real estate venture. The $6,617 of impairment charges were included in equity in losses from real estate ventures for the three months September 30, 2020.

			Fair Value Measurement Using:
	Year Ended December 31, 2019				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	39,757	$	18,335	$	—	$	—	$	18,335

The Company estimated the fair value of its investments in real estate ventures using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the investments in real estate ventures was attributed to the decline in the projected sales prices and the duration of the estimated sell out of the respective real estate ventures. The $39,757 of impairment charges were included in equity in losses from real estate ventures for the year ended December 31, 2019.

44

VECTOR GROUP LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)

Unaudited

13.    SEGMENT INFORMATION

The Company’s business segments for the three and nine months ended September 30, 2020 and 2019 were Tobacco and Real Estate. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Financial information for the Company’s operations before taxes and non-controlling interests for the three and nine months ended September 30, 2020 and 2019 were as follows:

				Real			Corporate
	Tobacco			Estate			and Other		Total
Three months ended September 30, 2020
Revenues	$	318,850		$	228,981		$	—	$	547,831
Operating income (loss)	91,319		(1)	10,850		(2)	(6,252)		95,917
Equity in losses from real estate ventures	—			(8,536)			—		(8,536)
Depreciation and amortization	1,965			2,167			214		4,346
Three months ended September 30, 2019
Revenues	$	303,260		$	201,530		$	—	$	504,790
Operating income (loss)	72,799		(3)	628			(6,707)		66,720
Equity in earnings from real estate ventures	—			8,050			—		8,050
Depreciation and amortization	1,941			2,240			249		4,430
Nine months ended September 30, 2020
Revenues	$	918,429		$	529,650		$	—	$	1,448,079
Operating income (loss)	239,814		(4)	(63,500)		(5)	(18,504)		157,810
Equity in losses from real estate ventures	—			(27,301)			—		(27,301)
Depreciation and amortization	6,007			6,678			648		13,333
Capital expenditures	3,644			5,160			20		8,824
Nine months ended September 30, 2019
Revenues	$	854,517		$	609,629		$	—	$	1,464,146
Operating income (loss)	201,594		(6)	4,672			(20,712)		185,554
Equity in earnings from real estate ventures	—			12,002			—		12,002
Depreciation and amortization	5,848			6,765			749		13,362
Capital expenditures	3,425			6,733			—		10,158

(1) Operating income includes $286 of expense from MSA settlement.

(2) Operating income includes $320 of restructuring charges.

(3) Operating income includes $240 of litigation settlement and judgment expense.

(4) Operating income includes $286 of expense from MSA settlement and $53 of litigation settlement and judgment expense.

(5) Operating loss includes $58,252 of impairment charges related to the impairments of goodwill and intangible assets and $3,281 of restructuring charges.

(6) Operating income includes $895 of litigation settlement and judgment expense.

45

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

(Dollars in Thousands, Except Per Share Amounts)

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of Vector Group Ltd.’s financial statements with a narrative from our management’s perspective. Our MD&A is divided into the following sections:

•Overview

•Recent Developments

•Results of Operations

•Summary of Real Estate Investments

•Liquidity and Capital Resources

Please read this discussion along with our MD&A and audited financial statements as of and for the year ended December 31, 2019 and Notes thereto, included in our 2019 Annual Report on Form 10-K, and our Condensed Consolidated Financial Statements and related Notes as of and for the quarterly period and nine months ended September 30, 2020 and 2019.

Overview

We are a holding company and are engaged principally in two business segments:

•Tobacco: the manufacture and sale of cigarettes in the United States through our Liggett Group LLC (“Liggett”) and Vector Tobacco Inc. (“Vector Tobacco”) subsidiaries, and

•Real Estate: the real estate services, technology and investment business through our subsidiary New Valley LLC (“New Valley”), which (i) owns Douglas Elliman Realty, LLC (“Douglas Elliman”), (ii) has interests in numerous real estate projects across the United States and (iii) is seeking to acquire or invest in additional real estate services, technologies, properties or projects. Douglas Elliman operates the largest residential brokerage company in the New York metropolitan area and also conducts residential real estate brokerage operations in Florida, California, Connecticut, Massachusetts, Colorado, New Jersey and Texas.

Recent Developments

COVID-19 Pandemic. The recent outbreak of the novel coronavirus, COVID-19, which was declared a pandemic by the World Health Organization on March 11, 2020, has led to adverse impacts on the U.S. and global economies and created economic uncertainty. Although much uncertainty still surrounds the pandemic, including its duration and ultimate overall impact on our operations and real estate ventures, we are carefully evaluating potential outcomes and working to mitigate risks. As with many other companies, our operations have been affected by COVID-19. We have implemented remote working for many employees and adopted the social distancing protocols recommended by public health authorities. The following provides a summary of our actions in our two segments - Tobacco and Real Estate - since COVID-19 was declared a pandemic.

Impact of COVID-19 on Tobacco Segment.  To date, we have not experienced any material disruptions to our supply or distribution chains, and have not experienced any material adverse effects associated with governmental actions to restrict consumer movement or business operations. However, our suppliers and members of our distribution chain may be subject to government action requiring facility closures and remote working protocols. The majority of retail stores in which our tobacco products are sold, including convenience stores, have been deemed to be essential businesses by authorities and have remained open. We continue to monitor the risk that a supplier, a distributor or any other entity within our supply and distribution chain closes temporarily or permanently.

Although our tobacco segment has not been negatively impacted to date by COVID-19, there remains uncertainty as to how the pandemic may ultimately impact the market. We continue to monitor the macro-economic risks of COVID-19 and the effect on tobacco consumers, including purchasing behavior changes and changes in sales volumes and mix within the discount category. Our Eagle 20’s and Montego brands are priced in the deep discount category and our other brands are primarily priced in the traditional discount category.

46

Impact of COVID-19 on Real Estate Segment.  Douglas Elliman is the largest residential real estate broker in the New York City market and approximately 46% of its revenues were derived from this region in 2018 and 2019. In addition, New Valley has investments in multiple real estate ventures and properties in the New York metropolitan area, which had a carrying value of $41,415 at September 30, 2020. Published reports and data indicate that the New York metropolitan area was initially impacted more than any other area in the United States. Consequently, various governmental agencies in the New York metropolitan area and in other markets where Douglas Elliman operates, instituted quarantines, “pause” orders, “shelter-in-place” rules, restrictions on travel and restrictions on the types of businesses that could operate. These restrictions adversely impacted Douglas Elliman’s ability to conduct business during the nine months ended September 30, 2020. For example, Douglas Elliman’s agents were restricted from performing in-person showings of properties or conducting open houses in most of Douglas Elliman’s markets from March 2020 to September 2020. Douglas Elliman experienced a severe decline in closed sales volume in New York City beginning in March 2020, which has continued. We anticipate that sales volume declines in New York City may continue during this pandemic.

Beginning in April 2020, we made significant operating adjustments at Douglas Elliman, including a reduction of personnel of approximately 25% and reductions of other administrative expenses, as well as a reduction, deferral or elimination of certain office lease expenses. While we continue to evaluate other expense reduction measures, as Douglas Elliman’s business began to improve in the third quarter, we began to relinquish, as appropriate, some of the second quarter expense reductions, including advertising and personnel expenses. We will continue to evaluate these expense reduction measures.

The COVID-19 pandemic could continue to have a material impact on our Real Estate segment; the likelihood and magnitude of a material impact increases with the amount of time the virus affects activity levels in locations in which Douglas Elliman operates. Therefore, we are unable to predict the ultimate impact of the COVID-19 pandemic on the future financial condition, results of operations and cash flows from our Real Estate segment.

Ladenburg Thalmann Financial Services Inc. (“LTS”). On November 11, 2019, LTS entered into an Agreement and Plan of Merger with Advisor Group. On February 14, 2020, the merger was completed, and each share of LTS common stock was converted into a cash payment of $3.50 per share. We received proceeds of $53,169 from our 15,191,205 common shares of LTS, and we recorded a pre-tax gain of $53,424 from the transaction. We also tendered 240,000 shares of LTS’s 8% Series A Cumulative Redeemable Preferred Stock for redemption and received an additional $6,009 in March 2020. At the closing of the transaction, our Executive Vice President resigned as Chairman, President and Chief Executive Officer of LTS, and our management agreement with LTS was terminated.

Maturity of 5.5% Variable Interest Senior Convertible Debentures due 2020. In April 2020, our 5.5% Variable Interest Senior Convertible Debentures due 2020 matured and we retired them with a cash payment for the principal balance of $169,610.

Issuance of Common Stock. On May 14, 2020, we announced the pricing of our underwritten public offering (the “Offering”) of 5,000,000 shares of our common stock. We received approximately $53,000 in proceeds from the offering.

Montego. In August 2020, Liggett expanded the distribution of its Montego deep discount brand by 10 states, primarily located in the southeast. Prior to August 2020, Montego was sold in select targeted markets in four states. Montego’s volume represented 5.6% of Liggett’s unit volume for the nine months ended September 30, 2020 compared to 3.6% for the nine months ended September 30, 2019.

Recent Developments in Litigation

The cigarette industry continues to be challenged on numerous fronts. New cases continue to be commenced against Liggett and other cigarette manufacturers. Liggett could be subjected to substantial liabilities and bonding requirements from litigation relating to cigarette products. Adverse litigation outcomes could have a negative impact on our ability to operate due to their impact on cash flows. It is possible that there could be adverse developments in pending cases including the certification of additional class actions. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. In addition, an unfavorable outcome in any tobacco-related litigation could have a material adverse effect on our consolidated financial position, results of operations or cash flows. Liggett could face difficulties in obtaining a bond to stay execution of a judgment pending appeal.

See “Legislation and Regulation” in Item 2 of the MD&A for further information on litigation.

47

Critical Accounting Policies

There are no material changes except for the items listed below from the critical accounting policies set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K, for the year ended December 31, 2019. Please refer to that section and the information below for disclosures regarding the critical accounting policies related to our business.

Current Expected Credit Losses. On January 1, 2020, we adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, therefore, our measurement of credit losses for most financial assets and certain other instruments has been modified as discussed in Note 3 to our condensed consolidated financial statements.

Goodwill and Indefinite Life Assets. Goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment on an annual basis, or whenever events or changes in business circumstances indicate the carrying value of the assets may not be recoverable. As discussed in Note 10 to our condensed consolidated financial statements, during the first quarter of 2020, we performed quantitative assessments of the goodwill associated with the Douglas Elliman reporting unit and its trademark intangible asset in conjunction with our quarterly review for indicators of impairment. Based on the results of these assessments, we recognized a $58,252 non-cash impairment charge related to the valuation of Douglas Elliman’s goodwill and its trademarks for the nine months ended September 30, 2020. If Douglas Elliman fails to meet the financial projections used in the quantitative assessments or the impacts of COVID-19 are more severe than expected, we may record additional impairment charges related to the Company’s goodwill and trademark intangible assets. To date, Douglas Elliman has met the financial projections used in the quantitative assessments.

Results of Operations

The following discussion provides an assessment of our results of operations, capital resources and liquidity and should be read in conjunction with our condensed consolidated financial statements included elsewhere in this report. The condensed consolidated financial statements include the accounts of Liggett, Vector Tobacco, Liggett Vector Brands, New Valley and other less significant subsidiaries.

For purposes of this discussion and other consolidated financial reporting, our business segments for the three and nine months ended September 30, 2020 and 2019 were Tobacco and Real Estate. The Tobacco segment consisted of the manufacture and sale of cigarettes. The Real Estate segment included our investment in New Valley, which includes ownership of Douglas Elliman, investments in real estate and investments in real estate ventures.

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2020			2019			2020			2019
Revenues:
Tobacco	$	318,850		$	303,260		$	918,429		$	854,517
Real estate	228,981			201,530			529,650			609,629
Total revenues	$	547,831		$	504,790		$	1,448,079		$	1,464,146
Operating income (loss):
Tobacco	$	91,319	(1)	$	72,799	(3)	$	239,814	(4)	$	201,594	(6)
Real estate	10,850		(2)	628			(63,500)		(5)	4,672
Corporate and Other	(6,252)			(6,707)			(18,504)			(20,712)
Total operating income	$	95,917		$	66,720		$	157,810		$	185,554

(1) Operating income includes $286 of expense from MSA settlement.

(2) Operating income includes $320 of restructuring charges.

(3) Operating income includes $240 of litigation settlement and judgment expense.

(4) Operating income includes $286 of expense from MSA settlement and $53 of litigation settlement and judgment expense.

(5) Operating loss includes $58,252 of impairment charges related to the impairments of goodwill and intangible assets and $3,281 of restructuring charges.

(6) Operating income includes $895 of litigation settlement and judgment expense.

48

Three Months Ended September 30, 2020 Compared to Three Months Ended September 30, 2019

Revenues. Total revenues were $547,831 for the three months ended September 30, 2020 compared to $504,790 for the three months ended September 30, 2019. The $43,041 (8.5%) increase in revenues was primarily due to a $15,590 increase in Tobacco revenues and a $27,451 increase in Real Estate revenues, which was primarily related to the sale of the Sagaponack property.

Cost of sales. Total cost of sales was $374,575 for the three months ended September 30, 2020 compared to $345,456 for the three months ended September 30, 2019. The $29,119 (8.4%) increase in cost of sales was primarily due to a $34,210 increase in Real Estate cost of sales, which was primarily related to the sale of Sagaponack property. This was offset by a $5,091 decline in Tobacco cost of sales.

Expenses. Operating expenses were $77,339 for the three months ended September 30, 2020 compared to $92,614 for the same period last year. The $15,275 (16.5%) decline in operating expenses was due to a $16,981 decline in Real Estate expenses, primarily at Douglas Elliman, including restructuring charges of $320 for the three months ended September 30, 2020 and a $455 decline in Corporate and Other expenses. This was offset by a $2,161 increase in Tobacco expenses.

Operating income. Operating income was $95,917 for the three months ended September 30, 2020 compared to $66,720 for the same period last year. The $29,197 (43.8%) increase in operating income was due to a $18,520 increase in Tobacco operating income, a $10,222 increase in Real Estate operating income, primarily related to Douglas Elliman, and a decline of $455 in Corporate and Other operating loss.

Other expenses. Other expenses were $39,955 and $16,976 for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020, other expenses primarily consisted of interest expense of $28,163, equity in losses from real estate ventures of $8,536 and other expense of $5,096. This was offset by equity in earnings from investments of $1,840. For the three months ended September 30, 2019, other expenses primarily consisted of interest expense of $32,963 and equity in losses from investments of $468. This was offset by income of $6,182 from changes in fair value of derivatives embedded within convertible debt, equity in earnings from real estate ventures of $8,050, and other income of $2,223.

Income before provision for income taxes. Income before income taxes was $55,962 and $49,744 for the three months ended September 30, 2020 and 2019, respectively.

Income tax expense. Income tax expense was $17,823 and $13,736 for the three months ended September 30, 2020 and 2019, respectively. Our provision for income taxes in interim periods is based on expected income, statutory rates, permanent differences, valuation allowances against deferred tax assets, and any tax planning opportunities available to us. For interim financial reporting, we estimate the annual effective income tax rate based on full year projections and apply the annual effective income tax rate against year-to-date pretax income to record income tax expense, adjusted for discrete items, if any. We refine annual estimates as new information becomes available. For the three months ended September 30, 2020, the annual effective tax rate applied to year-to-date income resulted in tax expense which was reduced by discrete items. The discrete items of $973 primarily relates to changes in value of certain contingent consideration and stock-based compensation.

Tobacco.

Tobacco revenues. Liggett increased the list price of Eagle 20’s by $0.13 per pack on November 2, 2020, $0.11 per pack on June 22, 2020, $0.08 per pack in February 2020, and $0.08 per pack in October 2019. Liggett also increased the list price of Pyramid, Liggett, Eve and Grand Prix by $0.13 per pack on November 2, 2020, $0.11 per pack on June 22, 2020, $0.08 per pack in February 2020, $0.08 per pack in October 2019, and $0.06 per pack in June 2019.

All of our Tobacco sales were in the discount category in 2020 and 2019. For the three months ended September 30, 2020, Tobacco revenues were $318,850 compared to $303,260 for the three months ended September 30, 2019. Revenues increased by $15,590 (5.1%) due primarily to an increase in the average selling price of our brands for the three months ended September 30, 2020 offset by a 2.1% (52.0 million units) decline in sales volume.

49

Tobacco cost of sales. The major components of our Tobacco cost of sales were as follows:

	Three Months Ended
	September 30,
	2020			2019
Manufacturing overhead, raw materials and labor	$	32,644		$	32,863
Customer shipping and handling	1,590			1,446
Federal Excise Taxes, net	120,320			122,951
FDA expense	6,369			6,149
MSA expense, net of market share exemption	43,178		(1)	45,783
Total cost of sales	$	204,101		$	209,192

(1) Includes $286 of expense from MSA settlements.

The Tobacco segment’s MSA expense is included in cost of sales. Under the terms of the MSA, we have no payment obligations except to the extent that our tobacco subsidiaries’ market share of the U.S. Cigarette market exceeds 1.92%. The calculation of our benefit from the MSA is an estimate based on U.S. domestic taxable cigarette shipments. As of September 30, 2020, we estimate taxable shipments in the U.S. will decline by 1.5% in 2020. As a result of the relatively strong U.S. cigarette industry in 2020, the value of Liggett’s market share exemption increased compared to the three months ended September 30, 2019 and resulted in a decrease in cost of sales of $959.

Tobacco gross profit was $114,749 for the three months ended September 30, 2020 compared to $94,068 for the three months ended September 30, 2019. The increase in gross profit for the three months ended September 30, 2020 is primarily attributable to increased pricing associated with the Eagle 20’s and Pyramid brands. For the three months ended September 30, 2020, Eagle 20’s remains Liggett’s primary low-cost cigarette brand and its percentage of Liggett’s total unit volume sales has increased from 60% in the three months ended September 30, 2019 to 62% for the three months ended September 30, 2020. Pyramid, Liggett’s second-largest brand, declined from 26% of total unit volume sales in the three months ended September 30, 2019 to 23% for the three months ended September 30, 2020. As a percentage of revenue (excluding Federal Excise Taxes), Tobacco gross profit increased from 52.2% in the 2019 period to 57.8% in the 2020 period primarily as a result of price increases and lower MSA expense, partially offset by a continued shift in sales volume to the lower-priced Eagle 20’s brand.

Tobacco expenses. Tobacco operating, selling, general and administrative expenses, excluding settlements and judgments, were $23,430 and $21,029 for the three months ended September 30, 2020 and 2019, respectively. The increase of $2,401 is primarily due to higher professional fees. Total tobacco product liability legal expenses, including settlements and judgments, were $1,493 and $1,890 for the three months ended September 30, 2020 and 2019, respectively.

Tobacco operating income. Tobacco operating income was $91,319 for the three months ended September 30, 2020 compared to $72,799 for the same period last year. The increase in operating income for the three months ended September 30, 2020 of $18,520 is primarily attributable to higher gross profit, as discussed above, partially offset by increased operating, selling, general and administrative expenses.

Real Estate.

Real Estate revenues. Real Estate revenues were $228,981 and $201,530 for the three months ended September 30, 2020 and 2019, respectively. Real Estate revenues increased by $27,451 (13.6%), primarily related to the $20,500 sale of an investment in real estate located in Sagaponack, NY, and an increase of $7,049 in Douglas Elliman’s commission and other brokerage income. Douglas Elliman’s commission and other brokerage income increased as a result of increased revenues in the Southeast region of $18,875, Northeast region, which does not include New York City, of $11,843 and California region of $14,230 and was offset by a $30,042 decline in the New York City region and a $7,857 decline in Development Marketing.

The COVID-19 pandemic has had a significant effect on the economy and, especially, in the New York City market, where approximately 46% of Douglas Elliman’s commissions and other brokerage revenues were derived in 2018 and 2019. In response to the pandemic, various governmental agencies in the markets where Douglas Elliman operates instituted restrictions on individuals and on the types of businesses that were permitted to operate from March 2020 to June 2020, which adversely impacted Douglas Elliman’s business.

50

Real Estate revenues and cost of sales for the three months ended September 30, 2020 and 2019 were as follows:

	Three Months Ended
	September 30,
	2020		2019
Real Estate Revenues:
Commission and other brokerage income	$	198,500	$	191,451
Property management revenue	8,584		8,668
Title fees	912		1,049
Revenues from investments in real estate	20,500		—
Sales on facilities primarily from Escena	485		362
Total real estate revenues	$	228,981	$	201,530
Real Estate Cost of Sales:
Real estate commissions	$	149,010	$	135,241
Cost of sales from investments in real estate	20,488		—
Cost of sales on facilities primarily from Escena	840		868
Title fees	136		155
Total real estate cost of sales	$	170,474	$	136,264

___________________________________

Real Estate cost of sales. Real Estate cost of sales were $170,474 and $136,264 for the three months ended September 30, 2020 and 2019, respectively. Real Estate cost of sales increased by $34,210, primarily related to $20,488 from the sale of an investment in real estate located in Sagaponack, NY, and a $13,769 increase in Douglas Elliman’s commissions. Douglas Elliman real estate commissions increased by $13,769 for the three months ended September 30, 2020 as a result of an increase in sales volume.

Douglas Elliman’s gross margin on real estate brokerage income declined from 29.4% for the three months ended September 30, 2019 to 24.9% for the three months ended September 30, 2020. This was primarily due to the decline in the percentage of revenues from the New York City region, which traditionally earns higher gross margin percentages than the Southeast (Florida) and Western (primarily California) regions.

Real Estate expenses. Real Estate expenses, which are primarily expenses at Douglas Elliman, were $47,657 and $64,638 for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020, Real Estate expenses included restructuring charges of $320. The restructuring charges were the result of Douglas Elliman realigning its administrative support functions, and office locations as well as adjusting its business model to more efficiently serve its clients. In response to the COVID-19 pandemic, we have implemented significant expense reductions at Douglas Elliman, including a reduction of personnel by approximately 25% as well as reduction, deferral or elimination of leases across the country. As a result of the expense reductions, in addition to personnel expenses, Douglas Elliman’s professional services, advertising, travel and other occupancy expenses were reduced during the three months ended September 30, 2020. While we continue to evaluate other expense reduction measures, to the extent Douglas Elliman’s business improves in the fourth quarter, we will begin to relinquish, as appropriate, some of the second quarter expense reductions, including advertising and personnel expenses.

Real Estate operating income. The Real Estate segment had operating income of $10,850 and $628 for the three months ended September 30, 2020 and 2019, respectively. The increase in operating income of $10,222 was primarily related to increased operating income at Douglas Elliman, which was primarily related to expense reductions offset by lower gross margin percentages.

Corporate and Other.

Corporate and Other operating loss. The operating loss at the Corporate and Other segment was $6,252 for the three months ended September 30, 2020 compared to $6,707 for the same period in 2019 and the difference was due primarily to decreased administrative costs related to professional fees and travel expenses.

51

Nine Months Ended September 30, 2020 Compared to Nine Months Ended September 30, 2019

Revenues. Total revenues were $1,448,079 for the nine months ended September 30, 2020 compared to $1,464,146 for the nine months ended September 30, 2019. The $16,067 (1.1%) decline in revenues was primarily due to a $79,979 decline in Real Estate revenues, which was primarily related to a decrease in Douglas Elliman’s brokerage revenues. This was offset by a $63,912 increase in Tobacco revenues related to an increase in both unit volume and net pricing.

Cost of sales. Total cost of sales was $990,083 for the nine months ended September 30, 2020 compared to $999,650 for the nine months ended September 30, 2019. The $9,567 (1.0%) decline in cost of sales was primarily due to a $34,069 decline in Real Estate cost of sales, which was primarily related to increases Douglas Elliman’s commissions. This was offset by a $24,502 increase in Tobacco cost of sales primarily related to increased sales volume and higher MSA expense.

Expenses. Operating expenses were $300,186 for the nine months ended September 30, 2020 compared to $278,942 for the same period last year. The $21,244 (7.6%) increase was due to a $22,262 increase in Real Estate expenses, including impairment of goodwill and intangible asset charge at Douglas Elliman of $58,252 and restructuring charges of $3,281, and a $1,190 increase in Tobacco expenses for the nine months ended September 30, 2020. This was offset by a $2,208 decline in Corporate and Other expense.

See Critical Accounting Policies - Goodwill and Indefinite Life Assets for detail of the Douglas Elliman impairment charge.

Operating income. Operating income was $157,810 for the nine months ended September 30, 2020 compared to $185,554 for the same period last year, a decline of $27,744 (15.0%). Real Estate operating income declined $68,172 primarily related to the impairments of goodwill and intangible assets of $58,252 at Douglas Elliman and restructuring charges of $3,281. This was offset by an increase in Tobacco operating income of $38,220 and the Corporate and Other operating loss declined $2,208.

Other expenses. Other expenses were $69,367 for the nine months ended September 30, 2020 compared to $57,262 for the nine months ended September 30, 2019. For the nine months ended September 30, 2020, other expenses primarily consisted of interest expense of $93,148, equity in losses from real estate ventures of $27,301 and other losses of $8,116. This was offset by equity in earnings from investments of $54,199, and income of $4,999 from changes in fair value of derivatives embedded within convertible debt. For the nine months ended September 30, 2019, other expenses primarily consisted of interest expense of $103,236 and equity in losses from investments of $791. This was offset by income of $20,319 from changes in fair value of derivatives embedded within convertible debt, other income of $14,444 and equity in earnings from real estate ventures of $12,002.

Income before provision for income taxes. Income before income taxes was $88,443 for the nine months ended September 30, 2020 compared to $128,292 for the nine months ended September 30, 2019.

Income tax expense. Income tax expense was $27,761 for the nine months ended September 30, 2020 compared to $37,944 for the nine months ended September 30, 2019. Our provision for income taxes in interim periods is based on expected income, statutory rates, permanent differences, valuation allowances against deferred tax assets, and any tax planning opportunities available to us. For interim financial reporting, we estimate the annual effective income tax rate based on full year projections and apply the annual effective income tax rate against year-to-date pretax income to record income tax expense, adjusted for discrete items, if any. We refine annual estimates as new information becomes available. Our income tax expense for the nine months ended September 30, 2020 was increased by discrete items related to income tax benefits on the goodwill and trademark impairment charges, changes in value of certain contingent consideration, stock-based compensation, and state tax audits partially offset by the income tax expense related to the equity in earnings from investments associated with the one-time gain on sale of LTS. Our income tax expense for the nine months ended September 30, 2019 was decreased by discrete items related to an income tax benefit for stock-based compensation.

Tobacco.

Tobacco revenues. Liggett increased the list price of Eagle 20’s by $0.13 per pack on November 2, 2020, $0.11 per pack on June 22, 2020, $0.08 per pack in February 2020, $0.08 per pack in October 2019, and $0.11 per pack in February 2019. Liggett also increased the list price of Pyramid, Liggett Select, Eve and Grand Prix by $0.13 per pack on November 2, 2020, $0.11 per pack on June 22, 2020, $0.08 per pack in February 2020, $0.08 per pack in October 2019, $0.06 per pack in June 2019, and $0.11 per pack in February 2019.

All of our Tobacco sales were in the discount category in 2020 and 2019. For the nine months ended September 30, 2020, Tobacco revenues were $918,429 compared to $854,517 for the nine months ended September 30, 2019. Revenues increased by $63,912 (7.5%) due primarily to an increase in the average selling price of our brands for the nine months ended September 30, 2020 along with a 2.1% (144 million units) increase in unit sales volume.

52

Tobacco cost of sales. The major components of our Tobacco cost of sales were as follows:

	Nine Months Ended
	September 30,
	2020			2019
Manufacturing overhead, raw materials and labor	$	98,178		$	94,535
Customer shipping and handling	4,423			4,441
Federal Excise Taxes, net	354,629			347,527
FDA expense	18,835			18,542
MSA expense, net of market share exemption	139,393		(1)	125,911
Total cost of sales	$	615,458		$	590,956

(1) Includes $286 of expense from MSA settlements.

The Tobacco segment’s MSA expense is included in cost of sales. Under the terms of the MSA, we have no payment obligations except to the extent that our tobacco subsidiaries’ market share of the U.S. Cigarette market exceeds 1.92%. The calculation of our benefit from the MSA is an estimate based on U.S. domestic taxable cigarette shipments. As of September 30, 2020, we estimate taxable shipments in the U.S. will decline by 1.5% in 2020. As a result of the relatively strong U.S. cigarette industry in 2020, the value of Liggett’s market share exemption increased compared to the nine months ended September 30, 2019 and resulted in a decrease in cost of sales of $2,771.

Tobacco gross profit was $302,971 for the nine months ended September 30, 2020 compared to $263,561 for the nine months ended September 30, 2019, an increase of $39,410. The increase in gross profit for the nine months ended September 30, 2020 was primarily attributable to increased pricing on the Eagle 20’s and Pyramid brands and increased Eagle 20’s volume. For the nine months ended September 30, 2020, Eagle 20’s remains Liggett’s primary low-cost cigarette brand and its percentage of Liggett’s total unit volume sales has increased from approximately 60% in the nine months ended September 30, 2019 to approximately 62% for the nine months ended September 30, 2020. Pyramid, Liggett’s second largest brand, declined from approximately 27% of total unit volume sales in the nine months ended September 30, 2019 to approximately 23% for the nine months ended September 30, 2020. As a percentage of revenue (excluding Federal Excise Taxes), Tobacco gross profit increased from 52.0% in the 2019 period to 53.7% in the 2020 period primarily as a result of price and volume increases partially offset by a continued shift in sales volume to the lower-priced Eagle 20’s brand.

Tobacco expenses. Tobacco operating, selling, general and administrative expenses, excluding settlements and judgments, were $63,104 for the nine months ended September 30, 2020 compared to $61,072 for the nine months ended September 30, 2019. The increase of $2,032 was mainly due to higher professional fees offset by lower travel related expenses. Tobacco product liability legal expenses, including settlements and judgments, were $4,684 and $5,627 for the nine months ended September 30, 2020 and 2019, respectively.

Tobacco operating income. Tobacco operating income was $239,814 for the nine months ended September 30, 2020 compared to $201,594 for the same period last year, an increase of $38,220. The increase in operating income was primarily attributable to higher gross profit, as discussed above, partially offset by increased operating, selling, general and administrative expenses.

Real Estate.

Real Estate revenues. Real Estate revenues were $529,650 and $609,629 for the nine months ended September 30, 2020 and 2019, respectively. Real Estate revenues declined by $79,979 (13.1%), which was primarily related to a decline of $96,378 in Douglas Elliman’s Commission and other brokerage income, which we believe was primarily due to the impact of the COVID-19 pandemic, which is discussed in Results of Operations - Three Months ended September 30, 2020 compared to Three Months ended September 30, 2019. Douglas Elliman’s commission and other brokerage income declined as a result of a $114,052 decline in revenues from the New York City region and a $21,295 decline in revenues from Development Marketing, offset by increased revenues in the Southeast region of $17,990, Northeast region, which does not include New York City, of $11,207 and California region of $ 9,772. This was partially offset by $20,500 from the sale of the investment in real estate located in Sagaponack, NY.

.

53

Real Estate revenues and cost of sales for the nine months ended September 30, 2020 and 2019, respectively, were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Real Estate Revenues:
Commission and other brokerage income	$	477,720	$	574,098
Property management revenue	26,195		27,237
Title fees	2,611		4,682
Revenues from investments in real estate	20,500		—
Sales on facilities primarily from Escena	2,624		3,612
Total real estate revenues	$	529,650	$	609,629
Real Estate Cost of Sales:
Real estate commissions	$	351,325	$	404,783
Cost of sales from investments in real estate	20,488		—
Cost of sales on facilities primarily from Escena	2,399		2,826
Title fees	413		1,085
Total real estate cost of sales	$	374,625	$	408,694

Real Estate cost of sales. Real Estate cost of sales were $374,625 and $408,694 for the nine months ended September 30, 2020 and 2019, respectively. Real Estate cost of sales declined by $34,069, primarily related to $53,458 decline in Douglas Elliman’s commissions offset by $20,488 from the sale of an investment in real estate located in Sagaponack, NY. Douglas Elliman real estate commissions declined by $53,458 as a result of lower commission and other brokerage income.

Douglas Elliman’s gross margin on real estate brokerage income declined from 29.5% for the nine months ended September 30, 2019 to 26.5% for the nine months ended September 30, 2020. This was primarily due to the decline in the percentage of revenues from the New York City region, which traditionally earns higher gross margin percentages than the Southeast (Florida) and Western (primarily California) regions.

See Results of Operations - Three Months ended September 30, 2020 compared to Three Months ended September 30, 2019 for a discussion of the impact of the COVID-19 pandemic on the Real Estate segment.

Real Estate expenses. Real Estate expenses were $218,525 and $196,263 for the nine months ended September 30, 2020 and 2019. These expenses included the non-cash impairment of goodwill and intangible assets of $58,252 and restructuring charges of $3,281 at Douglas Elliman for the nine months ended September 30, 2020. The non-cash impairment related to the evaluation of potential impacts of the COVID-19 pandemic, including the possibility of an economic recession, on Douglas Elliman’s business. The restructuring charges were the result of Douglas Elliman realigning its administrative support functions, and office locations as well as adjusting its business model to more efficiently serve its clients. In response to the current COVID-19 pandemic, we have implemented significant expense reductions at Douglas Elliman, including a reduction of personnel by approximately 25%, as well as reduction, deferral or elimination of leases across the country. As a result of the expense reductions, in additional to personnel expenses, Douglas Elliman’s professional services, advertising, travel and other occupancy expenses were reduced during the nine months ended September 30, 2020. While we continue to evaluate other expense reduction measures, to the extent Douglas Elliman’s business improves in the fourth quarter, we will begin to relinquish, as appropriate, some of the second quarter expense reductions, including advertising and personnel expenses.

Real Estate operating (loss) income. The Real Estate segment had operating loss of $63,500 and operating income of $4,672 for the nine months ended September 30, 2020 and 2019, respectively. The Real Estate segment’s operating loss was primarily caused by the impairment of goodwill and intangible assets of $58,252 at Douglas Elliman, the decreased gross margin percentages discussed above, and restructuring charges of $3,281 at Douglas Elliman; it was offset by the impact of expense-reduction initiatives at Douglas Elliman in 2020.

Corporate and Other.

Corporate and Other loss. The operating loss at the Corporate and Other segment was $18,504 for the nine months ended September 30, 2020 compared to $20,712 for the same period in 2019 and the difference was due primarily to decreased administrative costs related to professional fees and travel expenses.

54

Summary of Real Estate Investments

We own and seek to acquire investment interests in various domestic and international real estate projects through debt and equity investments. Our real estate investments primarily include the following projects as of September 30, 2020:

	(Dollars in Thousands. Area and Unit Information in Ones)
	Location	Date of Initial Investment	Percentage Owned (1)		Net Cash Invested (Returned)		Cumulative Earnings (Losses)		Carrying Value as of September 30, 2020		Future Capital Commit- ments from New Valley (2)		Projected Residential and/or Hotel Area		Projected Commercial Space		Projected Number of Residential Lots, Units and/or Hotel Rooms		Actual/Projected Construction Start Date	Projected Construction End Date
Escena, net	Master planned community, golf course, and club house in Palm Springs, CA	March 2008	100	%	2,182		7,604		9,786		—		450	Acres	—		667 450	R Lots H	N/A	N/A
Investments in real estate, net					$	2,182	$	7,604	$	9,786	$	—
Investments in real estate ventures:
10 Madison Square West (1107 Broadway)	Flatiron District/NoMad neighborhood, Manhattan, NY	October 2011	5.0	%	$	(43,671)	$	43,671	$	—	$	—	260,000	SF	20,000	SF	124	R	August 2012	Completed
11 Beach Street	TriBeCa, Manhattan, NY	June 2012	49.5	%	4,090		2,811		6,901		—		97,000	SF	—		27	R	May 2014	Completed
20 Times Square (701 Seventh Avenue)	Times Square, Manhattan, NY	August 2012	7.9	%	(7,827)		7,827		—		—		252,000	SF	80,000	SF	452	H	September 2013	Completed
111 Murray Street	TriBeCa, Manhattan, NY	May 2013	9.5	%	6,393		(4,413)		1,980		—		330,000	SF	1,700	SF	157	R	September 2014	Completed
160 Leroy Street	West Greenwich Village, Manhattan, NY	March 2013	3.1	%	(1,075)		1,075		—		—		130,000	SF	—		57	R	Fall 2015	Completed
The Dutch (25-19 43rd Avenue)	Long Island City, NY	May 2014	9.9	%	(1,247)		1,385		138				65,000	SF	—		86	R	September 2014	Completed
87 Park (8701 Collins Avenue)	Miami Beach, FL	December 2013	15.0	%	7,292		2,914		10,206		—		160,000	SF	TBD		70	R	October 2015	Completed
125 Greenwich Street	Financial District, Manhattan, NY	August 2014	13.4	%	7,992		(7,992)		—		—		306,000	SF	16,000	SF	273	R	March 2015	TBD
West Hollywood Edition (9040 Sunset Boulevard) (4)	West Hollywood, CA	October 2014	48.5	%	5,963		(6,153)		(190)		—		210,000	SF	—		20 190	R H	May 2015	Completed
The XI (76 Eleventh Avenue)	West Chelsea, Manhattan, NY	May 2015	5.1	%	17,000		(17,000)		—		—		630,000	SF	85,000	SF	236 137	R H	September 2016	June 2021
Monad Terrace	Miami Beach, FL	May 2015	19.6	%	7,635		(4,644)		2,991		—		160,000	SF	—		59	R	May 2016	January 2021
Takanasee (805 Ocean Ave)	Long Branch, NJ	December 2015	22.8	%	6,144		(6,144)		—		—		63,000	SF	—		13	R	June 2017	TBD
Brookland (15 East 19th St)	Brooklyn, NY	April 2017	9.8	%	402		44		446		—		24,000	SF	—		33	R	August 2017	Completed
Dime (209 Havemeyer St)	Brooklyn, NY	November 2017	16.5	%	9,145		2,308		11,453		—		100,000	SF	150,000	SF	177	R	May 2017	November 2020
352 6th Avenue	Brooklyn, NY	February 2019	37.0	%	500		71		571		—		5,200	SF	—		4	R	September 2019	December 2020
Meatpacking Plaza	Meatpacking District, NY	April 2019	16.9	%	10,692		(1,573)		9,119		—		TBD	—	TBD	—	TBD	—	TBD	TBD
The Park on Fifth	Miami Beach, FL	September 2019	38.9	%	14,132		762		14,894		—		482,000	SF	15,000	SF	330	R	April 2020	August 2023
9 DeKalb	Brooklyn, NY	April 2019	4.2	%	5,000		644		5,644		—		450,000	SF	120,000	SF	540	R	March 2019	June 2022
West Hialeah	Miami, FL	December 2019	77.8	%	12,522		790		13,312		—		1,400,000	SF	—		1,369	R	December 2019	February 2024
Condominium and Mixed Use Development					$	61,082	$	16,383	$	77,465	$	—
Maryland Portfolio	Primarily Baltimore County, MD	July 2012	7.6	%	774		(982)		(208)		—		N/A		N/A		5,517	R	N/A	N/A
Apartment Buildings					$	774	$	(982)	$	(208)	$	—
Park Lane Hotel (36 Central Park South)	Central Park South, Manhattan, NY	November 2013	1.0	%	$	8,682	$	(6,699)	$	1,983	$	—	446,000	SF	—		628	H	N/A	N/A
215 Chrystie Street (4)	Lower East Side, Manhattan, NY	December 2012	18.4	%	(4,257)		3,353		(904)		—		246,000	SF	—		367	H	June 2014	Completed
Coral Beach and Tennis Club	Coral Beach, Bermuda	December 2013	49.0	%	6,048		(4,281)		1,767		—		52	Acres	—		101	H	N/A	N/A
Parker New York	Central Park South, Manhattan, NY	July 2019	1.0	%	1,000		(91)		909		—		TBD		—		589 99	H R	May 2020	February 2022
Hotels					$	11,473	$	(7,718)	$	3,755	$	—
The Plaza at Harmon Meadow	Secaucus, NJ	March 2015	49.0	%	$	4,209	$	(1,938)	$	2,271	$	—	—	—	219,000	SF	—	—	N/A	N /A
Wynn Las Vegas Retail	Las Vegas, NV	December 2016	1.6	%	4,737		2,250		6,987		—		—	—	160,000	SF	—	—	N/A	N/A
Commercial					$	8,946	$	312	$	9,258	$	—
Witkoff GP Partners (3)	Multiple	March 2017	15.0	%	$	11,154	$	(1,228)	$	9,926	$	4,840	N/A		N/A		N/A		N/A	N/A
1 QPS Tower (23-10 Queens Plaza South)	Long Island City, NY	December 2012	45.4	%	(14,406)		14,406		—		—		N/A		N/A		N/A		March 2014	Completed
Witkoff EB-5 Capital Partners	Multiple	September 2018	49.0	%	516		444		960		8,735		N/A		N/A		N/A		N/A	N/A
Diverse Real Estate Portfolio					$	(2,736)	$	13,622	$	10,886	$	13,575
Investments in real estate ventures					$	79,539	$	21,617	$	101,156	$	13,575
Total Carrying Value					$	81,721	$	29,221	$	110,942
(1) The Percentage Owned reflects our estimated current ownership percentage. Our actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.
(2) This column only represents capital commitments required under the various joint venture agreements. However, many of the operating agreements provide for the operating partner to call capital. If a joint venture partner, such as New Valley, declines to fund the capital call, then the partner’s ownership percentage could either be diluted or, in some situations, the character of a funding member’s contribution would be converted from a capital contribution to a member loan.
(3) The Witkoff GP Partners venture includes a $2,495 investment in 500 Broadway and a $7,431 investment in Fontainebleau Las Vegas.
(4) Equity in losses in excess of the joint ventures' carrying value were $ 1,302 as of September 30, 2020, and are classified in Other current liabilities.
N/A - Not applicable	SF - Square feet	H - Hotel rooms					TBD -To be determined				R - Residential Units			R Lots - Residential lots

55

New Valley capitalizes net interest expense into the carrying value of its ventures whose projects were under development. Net capitalized interest costs included in Carrying Value as of September 30, 2020 were $7,582. This amount is included in the “Cumulative Earnings (Losses)” column in the table above. During the nine months ended September 30, 2020, New Valley capitalized $3,188 of interest costs and utilized (reversed) $6,203 of previously capitalized interest in connection with the recognition of equity in (losses) earnings, gains and liquidations from various ventures.

56

Liquidity and Capital Resources

Cash, cash equivalents and restricted cash increased by $81,280 for the nine months ended September 30, 2020 and decreased by $264,311 for the nine months ended September 30, 2019.

Cash provided from operations was $318,660 and $195,349 for the nine months ended September 30, 2020 and 2019, respectively. The increase primarily related to proceeds received from the sale of LTS, changes in operating income, after adjusting for the non-cash impairment charges in the 2020 period and increases in working capital, particularly in increased income tax payables and MSA liability.

Cash provided by investing activities was $16,498 for the nine months ended September 30, 2020 and cash used in investing activities was $32,103 for the nine months ended September 30, 2019. In the first nine months of 2020, cash provided by investing activities was from the sale of investment securities of $20,773, paydowns of investment securities of $627, maturities of investment securities of $43,405, distributions from investments in real estate ventures of $11,606, a decrease in restricted assets of $384, and proceeds from the sale or liquidation of long-term investments of $30,255. This was offset by the purchase of investment securities of $64,827, investments in real estate ventures of $6,239, capital expenditures of $8,824, investments in real estate, net of $701, an increase in cash surrender value of life insurance policies of $723, and purchase of long-term investments of $9,238. In the first nine months of 2019, cash used in investing activities was for the purchase of investment securities of $76,094, investments in real estate ventures of $36,269, capital expenditures of $10,158, investments in real estate, net of $1,910, an increase in cash surrender value of life insurance policies of $773, purchase of long-term investments of $1,000, and purchase of subsidiaries of $323. This was offset by the sale of investment securities of $16,186, paydowns of investment securities of $828, maturities of investment securities of $45,798, and distributions from investments in real estate ventures of $30,934, a decrease in restricted assets of $661, and proceeds from the sale of fixed assets of $17.

Cash used in financing activities was $253,878 and $427,557 for the nine months ended September 30, 2020 and 2019, respectively. In the first nine months of 2020, cash was used for the dividends and distributions on common stock of $97,781, repayments of debt of $173,779, net repayments of debt under the revolver of $34,953, and distributions to non-controlling interest of $448. This was offset by proceeds from issuance of common stock of $52,563 and proceeds from debt issuance of $520. In the first nine months of 2019, cash was used for the dividends and distributions on common stock of $179,449, repayments of debt of $230,874, distributions to non-controlling interest of $285, deferred financing costs of $36, net repayments of debt under the revolver of $16,867, and other of $46.

The terms of our 10.5% Senior Notes due 2026 contain covenants that place significant limitations on our ability to pay dividends and distributions in the future. See “10.5% Senior Notes due 2026” below. For the next twelve months beginning September 30, 2020, we have significant liquidity commitments at the corporate level (not including our tobacco and real estate operations) that require the use of existing cash resources. These include cash interest expense of approximately $110,300 on our other debt and other corporate expenses and taxes. In addition, the board continues to evaluate our dividend policy on a quarterly basis. Based on the $0.20 per share quarterly dividend rate in 2020, payment of our quarterly dividend would require cash payments of approximately $128,900 over the next twelve months.

In order to meet these liquidity requirements as well as other liquidity needs in the normal course of business, we have in the past used cash flows from operations as well as existing cash and cash equivalents, which have, in the past, been generated from operations, monetization of investments and proceeds from debt and equity issuances. Should these resources be insufficient to meet upcoming liquidity needs, we may also liquidate investment securities and other long-term investments, or, if available, draw on Liggett’s credit facility. While there are actions we can take to reduce our liquidity needs, there can be no assurance that such measures will be successful. As of September 30, 2020, we had cash and cash equivalents of $451,071 (including $75,683 of cash at Douglas Elliman and $147,617 of cash at Liggett), investment securities, which were carried at $124,092 (see Note 6 to condensed consolidated financial statements), and long-term investments, which were carried at $31,619 (including in-transit redemptions of $2,438 at September 30, 2020, with a fair value of $34,057). As discussed elsewhere, we used $169,610 of cash to retire the convertible notes due in April 2020. As of September 30, 2020, our investments in real estate ventures were carried at $102,458 and our investment in real estate, net of accumulated depreciation, was carried at $9,786.

Limitation of interest expense deductible for income taxes. Since 2018, our interest expense that is deductible in the computation of our income tax liability has been limited to a percentage of adjusted taxable income, as defined, with certain exceptions. In 2019 and 2020, the amount is limited to 50% of taxable income before interest, depreciation and amortization and, in 2021, the amount is limited to 30% of taxable income before interest, depreciation and amortization. Beginning in 2022, the amount is limited to 30% of taxable income before interest thereafter for non-excepted trade or businesses. One such excepted trade or business is any electing real property trade or business, which portions of our real estate business may qualify. Interest expense allocable to an excepted trade or business is not subject to limitation. If any interest expense is disallowed, we are permitted to carry forward the disallowed interest expense indefinitely. Nonetheless, due to our high degree of leverage, a

57

portion of our interest expense in future years may not be deductible, which could increase the after-tax cost of any new debt financings as well as the refinancing of our existing debt.

Tobacco Litigation. Adverse verdicts have been entered in 16 Engle progeny cases against Liggett. Liggett has paid $39,773, including interest and attorney’s fees, to satisfy the final judgments entered against it. It is possible that additional cases could be decided unfavorably.

Notwithstanding the comprehensive nature of the Engle progeny settlements, 42 Engle progeny cases remain pending. In addition, 70 individual actions are pending in state court. Therefore, we and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on our consolidated financial position, results of operations and cash flows.

Management cannot predict the cash requirements related to any future settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. Management is unable to make a reasonable estimate of the amount or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases. It is possible that our consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any such tobacco-related litigation.

Vector.

6.125% Senior Secured Notes due 2025. In January 2017, we issued $850,000 of our 6.125% Senior Secured Notes due 2025 (“6.125% Senior Secured Notes”) in a private offering, exempt from the registration requirements of the Securities Act, to qualified institutional buyers in accordance with Rule 144A of the Securities Act and to persons outside of the United States in accordance with Regulation S under the Securities Act. The 6.125% Senior Secured Notes are guaranteed by all of our wholly owned domestic subsidiaries that are engaged in the conduct of our cigarette business. The indenture governing our 6.125% Senior Secured Notes (the “2025 Indenture”) contains covenants that restrict the payment of dividends if our consolidated earnings before interest, taxes, depreciation and amortization (“Consolidated EBITDA”), as defined in the 2025 Indenture, for the most recently ended four full quarters is less than $75,000. The 2025 Indenture also restricts the incurrence of debt if our Leverage Ratio and our Secured Leverage Ratio, as defined in the 2025 Indenture, exceed 3.0 and 1.5, respectively. Our Leverage Ratio is defined in the 2025 Indenture as the ratio of our guaranteeing subsidiaries’ total debt less the fair market value of our cash, investment securities and long-term investments to Consolidated EBITDA, as defined in the 2025 Indenture. Our Secured Leverage Ratio is defined in the 2025 Indenture in the same manner as the Leverage Ratio, except that secured indebtedness is substituted for indebtedness. The following table summarizes the requirements of these financial covenants and the results of the calculation, as defined in the 2025 Indenture.

	Indenture	September 30, 2020
Covenant	Requirement
Consolidated EBITDA, as defined	$75,000	$412,070
Leverage ratio, as defined	<3.0 to 1	2.02 to 1
Secured leverage ratio, as defined	<1.5 to 1	0.71 to 1

As of September 30, 2020 and December 31, 2019, we were in compliance with all debt covenants related to the 2025 Indenture.

10.5% Senior Notes due 2026. On November 2, 2018 and November 18, 2019, respectively, we sold $325,000 and $230,000 of our 10.5% Senior Notes due 2026 in private offerings exempt from the registration requirements of the Securities Act to qualified institutional buyers in accordance with Rule 144A of the Securities Act and to persons outside of the United States in accordance with Regulation S under the Securities Act. The 10.5% Senior Secured Notes due 2026 are guaranteed by all of our wholly owned domestic subsidiaries that are engaged in the conduct of our cigarette business and DER Holdings LLC.

The indenture governing our 10.5% Senior Notes due 2026 (the “2026 Indenture”) restricts our ability to pay dividends and make certain other distributions subject to certain exceptions, including exceptions for (1) dividends and other distributions in an amount up to 50% of our consolidated net income, plus certain specified proceeds received us, if no event of default has occurred, and we are in compliance with a Fixed Charge Coverage Ratio (as defined in the 2026 Indenture) of at least 2.0x, and (2) dividends and other distributions in an unlimited amount, if no event of default has occurred and we are in compliance with a Net Leverage Ratio (as defined in the 2026 Indenture) no greater than 4.0x. As a result, absent an event of default, we can pay dividends if the Net Leverage ratio is below 4.0x, regardless of the value of the Fixed Charge Coverage Ratio at the time. The 2026 Indenture also restricts our ability to incur debt if our Fixed Charge Coverage Ratio is less than 2.0x, and restricts our ability to secure debt other than secured debt incurred pursuant to a Secured Leverage Ratio no greater than 3.75x, unless the 10.5% Senior Notes are secured on an equal and ratable basis. In addition, the 2026 Indenture restricts our ability to spin-off or

58

transfer New Valley and its subsidiaries as a whole, or DER Holdings LLC and its subsidiaries (including Douglas Elliman) as a whole, unless (1) such spin-off or transfer complies with the covenants restricting mergers and asset sales, or (2) our Net Leverage Ratio is no greater than 4.0x. Our Fixed Charge Coverage Ratio is defined in the 2026 Indenture as the ratio of our Consolidated EBITDA to our Fixed Charges (each as defined in the 2026 Indenture). Our Net Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total debt less our cash, cash equivalents, and the fair market value of our investment securities, long-term investments, investments in real estate, net, and investments in real estate ventures, to Consolidated EBITDA, as defined in the 2026 Indenture. Our Secured Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total secured debt, to Consolidated EBITDA, as defined in the 2026 Indenture.

Covenant	Indenture Requirement	September 30, 2020
Consolidated EBITDA, as defined	N/A	$300,064
Fixed charge coverage ratio, as defined	>2.0 to 1	2.9 to 1
Net leverage ratio, as defined	<4.0 to 1	2.23 to 1
Secured leverage ratio, as defined	<3.75 to 1	2.89 to 1

As of September 30, 2020 and December 31, 2019, we were in compliance with all of the debt covenants related to the 2026 Indenture.

Guarantor Summarized Financial Information. Vector Group Ltd. (the “Issuer”) and its wholly-owned domestic subsidiaries that are engaged in the conduct of our cigarette business (the “Subsidiary Guarantors”) have filed a shelf registration statement for the offering of debt and equity securities on a delayed or continuous basis and we are including this condensed consolidating financial information in connection therewith. Any such debt securities may be issued by us and guaranteed by our Subsidiary Guarantors with the exception of New Valley or any of its subsidiaries, other than DER Holdings LLC (the “Nonguarantor Subsidiaries”). Both the Subsidiary Guarantors and Nonguarantor Subsidiaries are wholly-owned by the Issuer. The Condensed Consolidating Balance Sheet as of September 30, 2020 and the related Condensed Consolidating Statement of Operations for the nine months ended September 30, 2020 of the Issuer, Subsidiary Guarantors and Nonguarantor Subsidiaries are set forth in Exhibit 99.2.

Presented herein are the Summarized Combined Balance Sheets as of September 30, 2020 and December 31, 2019 and the related Summarized Combined Statement of Operations for the nine months ended September 30, 2020 for the Issuer and the Subsidiary Guarantors (collectively, the “Obligor Group”). The summarized combined financial information is presented after the elimination of: (i) intercompany transactions and balances among the Obligor Group, and (ii) equity in earnings from and investments in the Nonguarantor Subsidiaries.

Summarized Combined Balance Sheets:

	September 30, 2020	December 31, 2019
Assets:
Current assets	625,615	561,689
Noncurrent assets	261,845	276,886
Intercompany receivables from Nonguarantor Subsidiaries	47,450	44,043
Liabilities:
Current liabilities	305,102	387,261
Noncurrent liabilities	1,511,906	1,525,531
Intercompany payable to Nonguarantor Subsidiaries	24,245	—

59

Summarized Combined Statements of Operations:

	Nine Months Ended
	September 30,
	2020
Revenues	918,787
Cost of sales	615,458
Operating income	221,459
Net income	131,584

Liggett Credit Facility and Liggett Term Loan Under Credit Facility. As of September 30, 2020, there was no outstanding balance under the Credit Agreement, which was primarily the result of the 90-day postponement of U.S. excise taxes due between March 1, 2020 and June 30, 2020. Availability as determined under the Credit Agreement was $58,823 based on eligible collateral at September 30, 2020. At September 30, 2020, Liggett was in compliance with all covenants under the Credit Agreement; Liggett’s EBITDA, as defined, were $245,155 for the last twelve months ended September 30, 2020.

Anticipated Liquidity Obligations. We and our subsidiaries have significant indebtedness and debt service obligations. As of September 30, 2020, we and our subsidiaries had total outstanding indebtedness of approximately $1,431,900. Of this amount, $850,000 comprised of the outstanding amount under our 6.125% Senior Secured Notes due 2025, and $555,000 comprised of the outstanding amount under our 10.5% Senior Notes due 2026. There is a risk that we will not be able to generate sufficient funds to repay our debt. If we cannot service our fixed charges, it would have a material adverse effect on our business and results of operations.

We currently believe that our tobacco segment will be a positive cash-flow-generating unit and will continue to be able to sustain its operations in 2020 without any significant liquidity concerns. Our real estate segment has historically been a positive cash-flow generating segment, but it may not generate positive cash-flow in 2020, primarily due to the COVID-19 pandemic and related economic disruption.

In order to meet the above liquidity requirements as well as other anticipated liquidity needs in the normal course of business, we had cash and cash equivalents of approximately $451,100, investment securities at fair value of approximately $124,100, long-term investments with an estimated value of approximately $34,100, and availability under Liggett’s credit facility of approximately $58,800 at September 30, 2020. Management currently anticipates that these amounts, as well as expected cash flows from our operations, proceeds from public and/or private debt and equity financing to the extent available, management fees and other payments from subsidiaries should be sufficient to meet our liquidity needs over the next 12 months. 

We continue to evaluate our capital structure and current market conditions related to our capital structure. Depending on market conditions, we may utilize our cash, investment securities and long-term investments to repurchase our 6.125% Senior Secured Notes due 2025 and 10.5% Senior Notes due 2026 in open-market purchases or privately negotiated transactions.

Furthermore, we may access the capital markets to refinance our 6.125% Senior Secured Notes due 2025. We are presently able to redeem such bonds at price of 103.063% and the redemption price declines to 101.531% on February 1, 2021 and 100% on February 1, 2022. There can be no assurance that we would be able to continue to issue debt at a lower interest rate than our historical borrowing levels in the future and, in the event we pursue any capital markets activities, our ability to complete any debt or equity offering would be subject to market conditions.

 We may acquire or seek to acquire additional operating businesses through merger, purchase of assets, stock acquisition or other means, or to make other investments, which may limit our liquidity otherwise available.

Market Risk

We are exposed to market risks principally from fluctuations in interest rates, foreign currency exchange rates and equity prices. We seek to minimize these risks through our regular operating and financing activities and our long-term investment strategy. Our market risk management procedures cover all market risk sensitive financial instruments.

As of September 30, 2020, approximately $26,300 of our outstanding debt at face value had variable interest rates determined by various interest rate indices, which increases the risk of fluctuating interest rates. Our exposure to market risk includes interest rate fluctuations in connection with our variable rate borrowings, which could adversely affect our cash flows. As of September 30, 2020, there was no outstanding balance on the Liggett Credit Facility which also has variable interest

60

rates. As of September 30, 2020, we had no interest rate caps or swaps. Based on a hypothetical 100 basis point increase or decrease in interest rates (1%), our annual interest expense could increase or decrease by approximately $300.

We held debt securities available for sale totaling $89,239 as of September 30, 2020. See Note 6 to our condensed consolidated financial statements. Adverse market conditions could have a significant impact on the value of these investments.

On a quarterly basis, we evaluate our debt securities available for sale and equity securities without readily determinable fair values that do not qualify for the NAV practical expedient to determine whether an impairment has occurred. If so, we also make a determination if such impairment is considered temporary or other-than-temporary. We believe that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven. The impairment indicators that are taken into consideration as part of our analysis include (a) a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee, (b) a significant adverse change in the regulatory, economic, or technological environment of the investee, (c) a significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates, and (d) factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants.

Equity Security Price Risk

As of September 30, 2020, we held various investments in equity securities with a total fair value of $66,472, of which $34,853 represents equity securities at fair value and $31,619 represents long-term investment securities at fair value. The latter securities represent long-term investments in various investment partnerships. These investments are illiquid and their ultimate realization is subject to the performance of the underlying entities. See Note 6 to our condensed consolidated financial statements, respectively, for more details on equity securities at fair value and long-term investment securities at fair value. The impact to our condensed consolidated statement of operations related to equity securities fluctuates based on changes in their fair value.

We record changes in the fair value of equity securities in net income. To the extent that we continue to hold equity securities, our operating results may fluctuate significantly. Based on our equity securities held as of September 30, 2020, a hypothetical decrease of 10% in the price of these equity securities would reduce the fair value of the investments and, accordingly, our net income by approximately $6,647.

New Accounting Pronouncements

Refer to Note 1, Summary of Significant Accounting Policies, to our financial statements for further information on New Accounting Pronouncements.

Legislation and Regulation

    There are no material changes from the Legislation and Regulation section set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2019, except as follows. The following paragraph of “Item. 1. Business--Legislation and Regulation-Advertising and Warnings on Packaging” from our Annual Report on Form 10-K, which is referenced therein, is amended and restated in its entirety:  

    Advertising and Warnings on Packaging

On March 18, 2020, FDA issued a final rule to require new health warnings on cigarette packages and in cigarette advertisements. This rule requires each cigarette package and advertisement to bear one of eleven textual warning statements accompanied by a corresponding graphic image covering 50% of the area of the front and rear panels of cigarette packages and at least 20% of the area at the top of cigarette advertisements. The rule establishes marketing requirements that include the random and equal display and distribution of the required warnings for cigarette packages and quarterly rotation of the required warnings for cigarette advertisements. The final rule provided for an effective date of June 18, 2021, 15 months after issuance of the final rule. The inclusion of new warnings and rotation requirements pursuant to the final rule would likely increase Liggett’s production costs. On April 3, 2020, Liggett, along with other tobacco companies, commenced an action against the FDA in the United States District Court, District of Texas (Tyler Division) challenging the legality of the graphic warning final rule. On May 8, 2020, the court issued an updated scheduling order and granted a joint motion to postpone the effective date of the final rule by 120 days to October 16, 2021.

We cannot predict whether the court will delay the effective date and/or determine that some or all of the proposed textual and/or graphic warnings, or proposed prominence of the warnings, violate the First Amendment, Administrative Procedure Act,

61

or other legal requirements, or what the impact of such a court ruling would have on the compliance timeline or requirements imposed on industry. 

Certain States may Attempt to Pass Minimum Price Legislation.

The State of Colorado placed a referendum, called Proposition EE, for taxes on cigarettes, tobacco and nicotine products on the November 3, 2020 ballot. Proposition EE was approved by the voters. In addition to raising the Colorado state excise tax on cigarettes, Proposition EE includes a provision that fixes the minimum retail price of cigarettes in Colorado at $7.00 per pack beginning January 1, 2021, thus reducing the competitive advantage of our Company’s discount priced cigarettes in the Colorado marketplace. We commenced litigation against Colorado challenging the legality of the minimum price provision contained in Proposition EE, the outcome of which cannot be predicted. Although no other state has adopted a fixed minimum retail price law for cigarettes, other states may attempt to do so if the minimum price provision in Proposition EE is determined by the courts to be legal. In the event that litigation challenging the minimum price legislation is not successful or other states pass similar legislation that withstands judicial scrutiny, the result could have a material adverse effect on our future financial condition, results of operations and cash flows.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

In addition to historical information, this report contains “forward-looking statements” within the meaning of the federal securities law. Forward-looking statements include information relating to our intent, belief or current expectations, primarily with respect to, but not limited to:

•economic outlook,

•capital expenditures,

•cost reduction,

•legislation and regulations,

•cash flows,

•operating performance,

•litigation, and

•related industry developments (including trends affecting our business, financial condition and results of operations).

We identify forward-looking statements in this report by using words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may be,” “objective,” “plan,” “seek,” “predict,” “project” and “will be” and similar words or phrases or their negatives.

The forward-looking information involves important risks and uncertainties that could cause our actual results, performance or achievements to differ materially from our anticipated results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, without limitation, the following:

•general economic and market conditions and any changes therein, due to acts of war and terrorism or otherwise,

•governmental regulations and policies,

•adverse changes in global, national, regional and local economic and market conditions, including those related to pandemics and health crises, such as the recent outbreak of COVID-19,

•significant changes in the price, availability or quality of tobacco, other raw materials or component parts, including as a result of the COVID-19 pandemic,

•potential dilution to our holders of or common stock as a result of issuances of additional shares of common stock to fund our financial obligations and other financing activities,

•the impacts of the Tax Cuts and Jobs Act of 2017, including the deductibility of interest expense and the impact of the markets on our Real Estate segment,

•effects of industry competition,

•impact of business combinations, including acquisitions and divestitures, both internally for us and externally in the tobacco industry,

62

•impact of legislation on our results of operations and product costs, i.e. the impact of federal legislation providing for regulation of tobacco products by FDA,

•impact of substantial increases in federal, state and local excise taxes,

•uncertainty related to product liability and other tobacco-related litigations including the Engle progeny cases pending in Florida and other individual and class action cases where certain plaintiffs have alleged compensatory and punitive damage amounts ranging into the hundreds of million and even billions of dollars; and,

•potential additional payment obligations for us under the MSA and other settlement agreements with the states.

Further information on the risks and uncertainties to our business include the risk factors discussed above in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and under Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission.

Although we believe the expectations reflected in these forward-looking statements are based on reasonable assumptions, there is a risk that these expectations will not be attained and that any deviations will be material. The forward-looking statements speak only as of the date they are made.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Market Risk” is incorporated herein by reference.

ITEM 4.    CONTROLS AND PROCEDURES

    Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, and, based on their evaluation, our principal executive officer and principal financial officer have concluded that these controls and procedures are effective.

    There have not been any changes in our internal control over financial reporting that occurred during the third quarter of 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

63

PART II

OTHER INFORMATION

Item 1.     Legal Proceedings

Reference is made to Note 9, incorporated herein by reference, to our condensed consolidated financial statements included elsewhere in this report which contains a general description of certain legal proceedings to which our company, or its subsidiaries are a party and certain related matters. Reference is also made to Exhibit 99.1 for additional information regarding the pending smoking-related legal proceedings to which Liggett or us is a party. A copy of Exhibit 99.1 will be furnished without charge upon written request to us at our principal executive offices, 4400 Biscayne Boulevard, 10th Floor, Miami, Florida 33137, Attn. Investor Relations.

Item 1A. Risk Factors

There are no material changes from the risk factors set forth in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the year ended December 31, 2019 and Part II, Item 1A, “Risk Factors,” of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, except as set forth below:

Certain States may attempt to pass minimum price legislation.

The state of Colorado placed a referendum, called Proposition EE, for taxes on cigarettes, tobacco and nicotine products on the November 3, 2020 ballot. Proposition EE was approved by the voters. In addition to raising the Colorado state excise tax on cigarettes, Proposition EE includes a provision that fixes the minimum retail price of cigarettes in Colorado at $7.00 per pack beginning January 1, 2021, thus reducing the competitive advantage of our Company’s discount priced cigarettes in the Colorado marketplace. We commenced litigation against Colorado challenging the legality of the minimum price provision contained in Proposition EE, the outcome of which cannot be predicted. Although no other state has adopted a fixed minimum retail price law, other states may attempt to do so if the minimum price provision in Proposition EE is determined by the courts to be legal. In the event that litigation challenging the minimum price legislation is not successful or other states pass similar legislation that withstands judicial scrutiny, the result could have a material adverse effect on our future financial condition, results of operations and cash flows.

New Valley is heavily dependent on the performance of the real estate market in the New York metropolitan area, which has been adversely impacted by COVID-19.

New Valley’s business primarily depends on the performance of the real estate market in the New York metropolitan area. Our real estate brokerage businesses and our investments in real estate developments are largely located in New York City and elsewhere in the surrounding New York metropolitan area.

Douglas Elliman’s business primarily depends on sales transactions for residential property in the New York City market and it derived approximately 46% of its revenues in 2019 and 2018 from this region. Published reports and data indicate that the New York metropolitan area was impacted more than any other area in the United States by the COVID-19 pandemic. Consequently, various governmental agencies in the New York metropolitan area, and other markets where Douglas Elliman operates and where our real estate investments are located, instituted quarantines, “pause” orders, “shelter-in-place” rules, restrictions on travel and restrictions on the types of businesses that can operate. For example, Douglas Elliman’s agents were restricted from performing personal showings of properties or conducting open houses in most of Douglas Elliman’s markets from March 2020 to June 2020. These measures may occur again as we head into colder weather. As a result of such measures, volumes of residential property sales transactions in the New York metropolitan area, and specifically, New York City, have declined significantly, and the aggregate sales commissions earned by Douglas Elliman on sales transactions in the New York City area have correspondingly declined. Although there has been improvement in the suburban New York markets, and, in particular, the Hamptons, and, recently, the New York City market, this has had, and may continue to have, a material adverse effect on Douglas Elliman’s financial condition and results of operations, notwithstanding the mitigating actions we have initiated (including employee-related and other expense-reduction measures) and expect to continue during this pandemic.

In addition, property development and investment activities have been significantly lower than past levels and improvement in the markets where New Valley operates is uncertain. This may have a material adverse effect on New Valley’s real estate investments. As of September 30, 2020, we had investments in or were developing 14 projects in New York City. In addition, during the second quarter of 2020, construction was halted at many of the real estate projects where New Valley is invested. The construction that was halted as a result of the COVID-19 pandemic has since resumed, although the delays may

64

adversely impact those investments. Adverse developments in national and local economic conditions as a result of the COVID-19 pandemic, as measured by such factors as GDP growth, employment levels, job growth, consumer confidence, interest rates and population growth in the New York metropolitan area and the United States generally have impacted our investments through reduced demand and depressed prices and we anticipate that this will have a material adverse effect on our Real Estate segment, and its financial condition and results of operations.

We have made significant operating adjustments in Douglas Elliman’s real estate brokerage business, including staff reductions, which could negatively impact the financial success of Douglas Elliman’s brokerage business in the future.

Douglas Elliman’s real estate brokerage offices generate revenue in the form of commissions and service fees. Accordingly, its financial results depend upon the operational and financial success of its brokerage offices and its agents. As a result of the impact of the COVID-19 pandemic on Douglas Elliman’s brokerage business, in April 2020, we made significant operating adjustments at Douglas Elliman, including a reduction of personnel by approximately 25%, which resulted in a reduction in salaries and administrative expenses, as well as a reduction, deferral or elimination of leases across the country. As a result of the expense reductions, in addition to personnel expenses, Douglas Elliman’s professional services, advertising, travel and other occupancy expenses were reduced during the second and third quarters of 2020. While such expense-reduction measures were necessary in order to mitigate the on-going financial impacts of the COVID-19 pandemic on Douglas Elliman’s business, there can be no assurance that we will be able to re-hire those employees in the event that economic conditions improve, and as a result, the staff reductions that we have made could negatively impact the financial success of Douglas Elliman’s brokerage business in the future. Further, while we continue to evaluate other expense reduction measures, as Douglas Elliman’s business began to improve in the third quarter, we began to relinquish, as appropriate, some of the second quarter expense reductions, including advertising and personnel expenses and to the extent Douglas Elliman’s business continues to improve in the fourth quarter, we will continue to do so.

The COVID-19 pandemic could continue to have a material impact on our Real Estate segment; the likelihood and magnitude of a material impact increases with the amount of time the virus impacts activity levels in locations in which Douglas Elliman operates. Therefore, we are unable to predict the ultimate impact of the COVID-19 pandemic on the future financial condition, results of operations and cash flows from our Real Estate segment.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

No equity securities of ours which were not registered under the Securities Act have been issued or sold by us during the three months ended September 30, 2020.

Issuer Purchase of Equity Securities

Our purchase of our common stock during the three months ended September 30, 2020 were as follows:

Period	Total Number of Shares Purchased	Average Price Paid per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
July 1 to July 31, 2020	211,119	$	10.06	(1)	—	—
August 1 to August 31, 2020	—	—			—	—
September 1 to September 30, 2020	—	—			—	—
Total	211,119	$	10.06		—	—

(1) Delivery of shares to us in payment of tax withholding in connection with an employee’s vesting in restricted stock. The shares were immediately canceled.

65

Item 6.    Exhibits:

22	List of Subsidiary Guarantors
31.1	Certification of Chief Executive Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1	Material Legal Proceedings.
99.2	Condensed Consolidating Financial Statements of Vector Group Ltd.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase
104	Cover Page Interactive Data File (the cover page tabs are embedded within the Inline XBRL document).

* Incorporated by reference

66

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

		VECTOR GROUP LTD.
		(Registrant)
		By: /s/ J. Bryant Kirkland III
		J. Bryant Kirkland III
		Senior Vice President, Treasurer and
		Chief Financial Officer
Date:	November 6, 2020

67

EX-22

EXHIBIT 22

Vector Group Ltd. List of Guarantor Subsidiaries

Vector Group Ltd. (“Vector Group”), a Delaware corporation, and the following 100% owned subsidiaries of Vector Group have filed a shelf registration statement for the offering of debt securities on a delayed or continuous basis. Any such debt securities may be issued by Vector Group and guaranteed on a full and unconditional basis by the following subsidiaries:

Entity	Jurisdiction of Incorporation or Organization
VGR Holding LLC	Delaware
Liggett Group LLC	Delaware
Liggett Vector Brands LLC	Delaware
Vector Research LLC	Delaware
Vector Tobacco Inc.	Virginia
Liggett & Myers Holdings Inc.	Canada
100 Maple LLC	Delaware
V.T. Aviation LLC	Delaware
VGR Aviation LLC	Delaware
Eve Holdings LLC	Delaware
Zoom E-Cigs LLC	Delaware
DER Holdings LLC	Delaware

EX-31.1

EXHIBIT 31.1

RULE 13a-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Howard M. Lorber, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Vector Group Ltd.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2020

/s/ Howard M. Lorber

Howard M. Lorber

President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

RULE 13a-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, J. Bryant Kirkland III, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Vector Group Ltd.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2020

/s/ J. Bryant Kirkland III

J. Bryant Kirkland III

Senior Vice President, Treasurer and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER

    In connection with the Quarterly Report of Vector Group Ltd. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Howard M. Lorber, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 6, 2020

/s/ Howard M. Lorber

Howard M. Lorber

President and Chief Executive Officer

EX-32.2

EXHIBIT 32.2

SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER

    In connection with the Quarterly Report of Vector Group Ltd. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, J. Bryant Kirkland III, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 6, 2020

/s/ J. Bryant Kirkland III

J. Bryant Kirkland III

Senior Vice President, Treasurer and Chief Financial Officer

EX-99.1

Exhibit 99.1

I. INDIVIDUAL CASES

A. Engle Progeny Cases.

Pursuant to the Florida Supreme Court’s ruling in Engle v. Liggett Group Inc., which decertified the Engle class on a prospective basis, former class members had until January 2008 to file individual lawsuits. Lawsuits by individuals requesting the benefit of the Engle ruling are referred to as the “Engle progeny” cases. Liggett has resolved the claims of all but 42 Engle progeny plaintiffs. For more information on the Engle case and on the settlement, see “Note 9. Contingencies.”

(i)Engle Progeny Cases with trial dates through September 30, 2021.

Blocker v. R.J. Reynolds Tobacco Company, et al., Case No. 2008-32507 CICI, Circuit Court of the 7th Judicial Circuit, Volusia County (case filed 7/18/08). One individual suing as personal representative of the estate and survivors of a deceased smoker. The case is the second back-up case set for trial starting 08/02/21.

(ii)Post-Trial Engle Progeny Cases.

Santoro v. R.J. Reynolds Tobacco Company, et al., Case No. 08-025807, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 06/05/08). This wrongful death action proceeded to jury trial in March 2017. On March 29, 2017, the jury returned a verdict in favor of the plaintiff and awarded compensatory damages in the amount of $1,605,000. The jury apportioned fault as follows: Decedent - 36%, Philip Morris - 28%, R.J. Reynolds - 26% and Liggett - 10% ($160,500). In April 2017, a joint and several judgment was entered against defendants for $1,027,200 in compensatory damages as well as $15,000 in punitive damages against Liggett. Defendants filed post-trial motions seeking dismissal of all claims. In December 2017, the court granted the motion to set aside the verdict as to all claims other than conspiracy. Defendants moved for rehearing with respect to the conspiracy claim and plaintiff moved for entry of an amended final judgment to increase plaintiff’s recovery by the percentage of decedent’s fault. The court denied defendants’ remaining post-trial motions and the motion for rehearing and granted, in part, plaintiff’s motion to amend the final judgment. In light of the judge’s ruling on defendants’ motion for directed verdict, the parties agreed that the plaintiff was not entitled to punitive damages. A joint and several amended final judgment in the amount of $1,605,000 was entered in May 2018. Defendants appealed and Plaintiff cross-appealed. In May 2020, the Fourth District Court of Appeal affirmed the trial court on Defendants’ appellate issues. On Plaintiff’s cross-appeal, the appellate court reversed the trial court’s order granting directed verdict on the strict liability and negligence claims and reinstated the jury’s verdict, including the punitive damages award. Defendants filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court. Jurisdictional briefing is ongoing.

B. Other Individual Cases.

Florida

Barnes, et al. v. Philip Morris USA Inc., et al., Case No. 20-CA-000870, Circuit Court of the 8th Judicial Circuit, Alachua County (case filed 03/24/2020). Two individuals suing.

Baron, et al. v. Philip Morris USA Inc., et al., Case No. 17-CA-023133, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/21/17). Two individuals suing. The case is set for trial during the trial period starting 07/06/21.

Bennett, et al. v. Philip Morris USA Inc., et al., Case No. 17-CA-023046, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/20/17). Three individuals suing on behalf of the estate and survivors of a deceased smoker. The case is set for trial in 04/22.

1

Bennett v. R.J. Reynolds Tobacco Company, et al., Case No. 20-30196, Circuit Court of the 7th Judicial Circuit, Volusia County (case filed 02/27/2020). One individual suing on behalf of the estate and survivors of a deceased smoker. Vector Group was sued, but Liggett was not named as a defendant.

Broughton v. Philip Morris USA Inc., et al., Case No. 18-CA-007187, Circuit Court of the 13th Judicial Circuit, Hillsborough County (case filed 07/25/18). One individual suing.

Bullock v. R.J. Reynolds Tobacco Company, et al., Case No. 19-028814, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 09/30/19). One individual suing.

Cellini v. Philip Morris USA, Inc., et al., Case No. CACE20011084, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 07/08/2020). One individual suing.

Cole v. R.J. Reynolds Tobacco Company, et al., Case No. 19-000265, Circuit Court of the 6th Judicial Circuit, Pinellas County (case filed 01/11/19). One individual suing.

Cowart v. Liggett Group Inc., et al., Case No. 98-01483-CA, Circuit Court of the 4th Judicial Circuit, Duval County (case filed 03/16/98). One individual suing. Liggett is the only defendant in this case. The case is dormant.

Cravens v. Philip Morris USA Inc., et al., Case No. 19-CA-002944, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 12/30/19). One individual suing.

Cunningham v. R.J. Reynolds Tobacco Company, et al., Case No. 17-CA-000293, Circuit Court of the 19th Judicial Circuit, St. Lucie County (case filed 02/20/17). One individual suing on behalf of the estate and survivors of a deceased smoker.

Cupp v. Philip Morris USA Inc., et al., Case No. 17-CA-020257, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/06/17). One individual suing. The case is set for trial in 03/22.

DaSilva, et al. v. Philip Morris USA Inc., et al., Case No. 17-CA-022955, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/19/17). Two individuals suing.

Davis v. R.J. Reynolds Tobacco Company, et al., Case No. 19-CA-001182, Circuit Court of the 12th Judicial Circuit, Manatee County (case filed 03/19/19). One individual suing.

Davis, M. v. Philip Morris USA Inc., et al., Case No. 2020CA001655, Circuit Court of the 8th Judicial Circuit, Alachua County (case filed 06/19/2020). One individual suing on behalf of the estate and survivors of a deceased smoker. Vector Group was sued, but Liggett was not named as a defendant.

Feld v. Philip Morris USA Inc., et al., Case No. 17-CA-020119, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/03/17). One individual suing. The case is set for trial during the trial period starting 08/09/21.

Gonzalez v. Philip Morris USA Inc., et al., Case No. 18-36558, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 11/03/17). One individual suing.

Gordon v. R.J. Reynolds Tobacco Company, et al., Case No. 19-1074, Circuit Court for the 2nd Judicial Circuit, Gadsden County (case filed 10/23/19).  One individual suing.  The case is set for trial starting 05/17/21.

2

Griffin v. R.J. Reynolds Tobacco Company, et al., Case No. 19-015066,Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 05/17/19). One individual suing.

Harcourt v. Philip Morris USA Inc., et al., Case No. 17-CA-0202979, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/07/17). One individual suing.

Koedam v. Philip Morris USA Inc., et al., Case No. 19-CA-002970, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 01/03/2020). One individual suing.

Johnson v. R.J. Reynolds Tobacco Company, et al., Case No. 112376604, Circuit Court of the 2nd Judicial Circuit, Gadsden County (case filed 08/25/2020). One individual suing on behalf of the estate and survivors of a deceased smoker.

Lane, et al. v. Philip Morris USA Inc., et al., Case No. 17-011591, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 06/16/17). Two individuals suing. The case is scheduled for the trial period starting 10/25/21 - 11/12/21.

McMakin, et al. v. R.J. Reynolds Tobacco Company, et al., Case No. 20-30329, Circuit Court of the 7th Judicial Circuit, Volusia County, (case filed 03/30/2020). One individual suing on behalf of the estate and survivors of two deceased smokers. Vector Group was sued, but Liggett was not named as a defendant.

Mendez v. Philip Morris USA Inc., et al., Case No. 18-042377-CA-23, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 12/21/18).  One individual suing on behalf of the estate and survivors of a deceased smoker. The case is scheduled for trial in 11/21.

Moon v. Philip Morris USA Inc., et al., Case No. 19-CA-002941, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 12/30/19). One individual suing.

Nicholson, et al. v. R.J. Reynolds Tobacco Company, et al., Case No. 2020-014354-CA-01, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 07/08/2020). Two individuals suing.

Perez-Gell v. Philip Morris USA Inc., et al., Case No. 19-016287, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 05/30/19).  One individual suing.

Roney v. Philip Morris USA Inc., et al., Case No. 19-CA-002943, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 12/30/19). One individual suing.

Royal v. Philip Morris USA Inc., et al., Case No. 17-CA-020204, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 10/16/17). One individual suing.

Santana v. Philip Morris USA Inc., et al., Case No. 19-37329, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 01/03/20). One individual suing.

Schnitzer v. Philip Morris USA Inc., et al., Case No. 18-026537, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 08/06/18). One individual suing on behalf of the estate and survivors of deceased smoker.

Siders v. Philip Morris USA Inc., et al., Case No. 19-CA-002942, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 12/30/19). One individual suing.

Smith v. Philip Morris USA Inc., et al., Case No. 20-008481, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 04/16/20).  One individual suing as the personal representative of the estate and survivors of a deceased smoker.

3

Sweet v. Philip Morris USA Inc., et al., Case No. 19-001243, Circuit Court of the 2nd Judicial Circuit, Leon County (case filed 12/23/19). One individual suing.

Taylor v. Philip Morris USA Inc., et al., Case No. 19-CA-255, Circuit Court of the 2nd Judicial Circuit, Wakulla County (case file 12/18/19). One individual suing.

Voglio v. R.J. Reynolds Tobacco Company, et al., Case No. 18-CA-000640, Circuit Court of the 19th Judicial Circuit, Martin County (case filed 08/29/18). One individual suing on behalf of the estate and survivors of a deceased smoker.

Watson v. R.J. Reynolds Tobacco Company, et al., Case No. 2020-CA-009690-O, Circuit Court of the 9th Judicial Circuit, Orange County (case filed 09/25/2020). One individual suing.

Whitehurst v. Philip Morris USA Inc., et al., Case No. 19-016282, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 05/30/19). One individual suing.

Illinois

Akers, et al. v. Philip Morris USA Inc., et al., Case No. 2019-L-011779, Circuit Court of Cook County, Illinois (case filed 10/24/19). Two individuals suing.

Andersen v. Philip Morris USA Inc., et al., Case No. 2019-L-007984, Circuit Court of Cook County, Illinois (case filed 07/19/19).  One individual suing.

Bukowski, et al. v. Philip Morris USA, Inc., et al, Case No. 2019-L-010529, Circuit Court of Cook County, Illinois (case filed 09/24/19). Two individuals suing.

Clay v. Philip Morris USA Inc., et al., Case No. 1:18-cv-03549, United States District Court, Northern District of Illinois (case filed 04/16/18).  One individual suing.

Dispenza, et al. v. Philip Morris USA Inc., et al., Case No. 1:20-cv-05190, United States District Court, Northern District of Illinois (case filed 08/12/2020). Two individuals suing.

Jones v. Philip Morris USA Inc., et al., Case No. 1:20-cv-03349, United States District Court, Northern District of Illinois (case filed 05/04/20).  One individual suing.

Mitchell v. Philip Morris USA Inc., et al., Case No. 2018-L-011336, Circuit Court of Cook County, Illinois (case filed 10/22/18). One individual suing.

Prescott v. Philip Morris USA Inc., et al., Case No. 2018-L-003905, Circuit Court of Cook County, Illinois (case filed 04/17/18).  One individual suing on behalf of the estate and survivors of a deceased smoker.

Smith v. Philip Morris USA Inc., et al., Case No. 2018-L-008907, Circuit Court of Cook County, Illinois (case filed 08/16/18).  One individual suing.  

Stoklosa v. Philip Morris USA Inc., et al., Case No. 2019-L012409, Circuit Court of Cook County, Illinois (case filed 11/15/19). One individual suing.

Stone v. Philip Morris USA Inc., et al., Case No. 2020-L-008635, Circuit Court of Cook County, Illinois (case filed 08/17/20). One individual suing on behalf of the estate and survivors of a deceased smoker.

4

Louisiana

Oser v. The American Tobacco Co., et al., Case No. 97-9293, Circuit Court of the Civil District Court, Parish of Orleans (case filed 05/27/97). One individual suing. There has been no recent activity in this case.

Reese, et al. v. R. J. Reynolds, et al., Case No. 2003-12761, Circuit Court of the 22nd Judicial District Court, St. Tammany Parish (case filed 06/10/03). Five individuals suing. There has been no recent activity in this case.

Massachusetts

Moschella v. R J Reynolds Tobacco Company, et al., Case No. 2084CV01080, Superior Court, Suffolk County, Massachusetts (case filed 05/22/2020). One individual suing. Both Liggett and Liggett Vector Brands are named defendants.

Nevada

Camacho, et al. v. Philip Morris USA Inc., et al., Case No. A-19-807650C, District Court, Clark County, Nevada, (case filed 12/30/19). Two individuals suing.

Clark v. Philip Morris USA Inc., et al., Case No. A-19-802987C, District Court, Clark County, Nevada, (case filed 10/04/19). One individual suing on behalf of the estate and survivors of a deceased smoker.

Geist, et al. v. Philip Morris USA Inc., et al., Case No. A-19-807653C, District Court, Clark County, Nevada, (case filed 12/30/19). One individual suing on behalf of the estate and survivors of a deceased smoker.

Kelly, et al. v. Philip Morris USA Inc., et al., Case No. A-20-820112-C, District Court, Clark County, Nevada (case filed 08/25/20). Two individuals suing.

Speed v. Philip Morris USA Inc., et al., Case No. A-20-819040-C, District Court, Clark County, Nevada, (case filed 08/04/2020). One individual suing on behalf of the estate and survivors of a deceased smoker.

Thompson v. Philip Morris USA Inc., et al., Case No. A-20-811091C, District Court, Clark County, Nevada, (case filed 02/27/20). One individual suing on behalf of the estate and survivors of a deceased smoker.

Tully, et al. v. Philip Morris USA Inc., et al., Case No. A-19-807657C, District Court, Clark County, Nevada, (case filed 12/30/19). Two individuals suing.

New Mexico

Duran v. RJ Reynolds Tobacco Company, et al., Case No. D-0101-CV-2020-01683, 1st Judicial District, Santa Fe County, New Mexico (case filed 08/04/2020). One individual suing.

Lopez, H. v. RJ Reynolds Tobacco Company, et al., Case No. D-0101-CV-2020-01686, 1st Judicial District, Santa Fe County, New Mexico (case filed 08/04/2020). One individual suing on behalf of the estate and survivors of a deceased smoker.

Lopez, T. v. RJ Reynolds Tobacco Company, et al., Case No. D-0101-CV-2020-01688, 1st Judicial District, Santa Fe County, New Mexico (case filed 08/05/2020). One individual suing on behalf of the estate and survivors of a deceased smoker.

5

Grace v. RJ Reynolds Tobacco Company, et al., Case No. D-0101-CV-2020-01689, 1st Judicial District, Santa Fe County, New Mexico (case filed 08/05/2020). One individual suing on behalf of the estate and survivors of a deceased smoker.

Martinez v. RJ Reynolds Tobacco Company, et al., Case No. D-0101-CV-2020-01691, 1st Judicial District, Santa Fe County, New Mexico (case filed 08/05/2020). Two individuals suing.

Virgin Islands

Barry v. Philip Morris USA, Inc., et al., Case No. 722/2020, Superior Court of Virgin Islands Division of St. Croix, Virgin Islands (case filed 09/16/2020). One individual suing.

Bruney v. Philip Morris USA, Inc., et al., Case No. 376/2020, Superior Court of Virgin Islands Division of St. Thomas & St. John, Virgin Islands (case filed 09/18/2020). One individual suing.

Georges v. Philip Morris USA, Inc., et al., Case No. 720/2020, Superior Court of Virgin Islands Division of St. Croix, Virgin Islands (case filed 09/16/2020). One individual suing.

Schuster v. Philip Morris USA, Inc., et al., Case No. 721/2020, Superior Court of Virgin Islands Division of St. Croix, Virgin Islands (case filed 09/21/2020). One individual suing.

Soto v. Philip Morris USA, Inc., et al., Case No. 719/2020, Superior Court of Virgin Islands Division of St. Croix, Virgin Islands (case filed 09/21/2020). One individual suing.

II.CLASS ACTION CASES

Parsons, et al. v. A C & S Inc., et al., Case No. 00-C-7000, First Judicial Circuit, West Virginia, Ohio County (case filed 02/09/98). This purported class action is brought on behalf of plaintiff and all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy petitions filed by three defendants (Nitral Liquidators, Inc., Desseaux Corporation of North America and Armstrong World Industries).

Young, et al. v. American Brands Inc., et al., Case No. 97-19984cv, Civil District Court, Louisiana, Orleans Parish (case filed 11/12/97). This purported personal injury class action is brought on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. In March 2016, the court entered an order staying the case, including all discovery, pending the completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.

III.HEALTH CARE COST RECOVERY ACTIONS

Crow Creek Sioux Tribe v. The American Tobacco Company, et al., Case No. cv-97-09-082, Tribal Court of the Crow Creek Sioux Tribe, South Dakota (case filed 09/26/97). The plaintiff seeks to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program and disgorgement of unjust profits from alleged sales to minors. The case is dormant.

6

EX-99.2

EXHIBIT 99.2

Vector Group Ltd.

Condensed Consolidating Financial Statements

September 30, 2020

(in thousands of dollars)

Presented herein are Condensed Consolidating Balance Sheet as of September 30, 2020 and the related Condensed Consolidating Statements of Operations for the nine months ended September 30, 2020 of Vector Group Ltd. (Parent/Issuer), the guarantor subsidiaries (Subsidiary Guarantors) and the subsidiaries that are not guarantors (Subsidiary Non-Guarantors).

CONDENSED CONSOLIDATING BALANCE SHEETS

			September 30, 2020
					Subsidiary				Consolidated
	Parent/		Subsidiary		Non-		Consolidating		Vector Group
	Issuer		Guarantors		Guarantors		Adjustments		Ltd.
ASSETS:
Current assets:
Cash and cash equivalents	$	227,195	$	147,725	$	76,151	$	—	$	451,071
Investment securities at fair value	124,092		—		—		—		124,092
Accounts receivable - trade, net	—		19,776		24,223		—		43,999
Intercompany receivables	47,450		—		—		(47,450)		—
Inventories	—		94,548		—		—		94,548
Income taxes receivable, net	—		—		24,520		(24,520)		—
Other current assets	3,487		8,792		26,909		(475)		38,713
Total current assets	402,224		270,841		151,803		(72,445)		752,423
Property, plant and equipment, net	400		30,668		44,999		—		76,067
Investments in real estate, net	—		—		9,786		—		9,786
Long-term investment securities at fair value	31,619		—		—		—		31,619
Investments in real estate ventures	—		—		102,458		—		102,458
Operating lease right-of-use assets	6,235		6,346		135,378		—		147,959
Investments in consolidated subsidiaries	346,734		175,796		—		(522,530)		—
Goodwill and other intangible assets, net	—		107,511		100,107		—		207,618
Other assets	31,593		47,473		35,982		—		115,048
Total assets	$	818,805	$	638,635	$	580,513	$	(594,975)	$	1,442,978
LIABILITIES AND STOCKHOLDERS' DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	—	$	10,649	$	10,660	$	(10,625)	$	10,684
Intercompany payables	—		313		47,137		(47,450)		—
Income taxes payable, net	13,781		29,852		—		(24,520)		19,113
Current payments due under the Master Settlement Agreement	—		145,472		—		—		145,472
Current operating lease liability	1,242		1,878		19,365		—		22,485
Other current liabilities	44,279		81,881		68,069		(201)		194,028
Total current liabilities	59,302		270,045		145,231		(82,796)		391,782
Notes payable, long-term debt and other obligations, less current portion	1,379,781		15,695		16,113		(15,625)		1,395,964
Non-current employee benefits	51,996		9,345		—		—		61,341
Deferred income taxes, net	(16,931)		22,260		23,180		—		28,509
Non-current operating lease liability	6,383		5,022		147,795		—		159,200
Other liabilities, including litigation accruals and payments due under the Master Settlement Agreement	393		37,962		31,010		(1,064)		68,301
Total liabilities	1,480,924		360,329		363,329		(99,485)		2,105,097
Commitments and contingencies
Stockholders' (deficiency) equity attributed to Vector Group Ltd.	(662,119)		278,306		217,184		(495,490)		(662,119)
Non-controlling interest	—		—		—		—		—
Total stockholders' (deficiency) equity	(662,119)		278,306		217,184		(495,490)		(662,119)
Total liabilities and stockholders' deficiency	$	818,805	$	638,635	$	580,513	$	(594,975)	$	1,442,978

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

			Nine Months Ended September 30, 2020
					Subsidiary				Consolidated
	Parent/		Subsidiary		Non-		Consolidating		Vector Group
	Issuer		Guarantors		Guarantors		Adjustments		Ltd.
Revenues	$	—	$	918,787	$	529,650	$	(358)	$	1,448,079
Expenses:
Cost of sales	—		615,458		374,625		—		990,083
Operating, selling, administrative and general expenses	26,682		55,135		157,141		(358)		238,600
Litigation settlement and judgment expense	—		53		—		—		53
Impairments of goodwill and intangible assets	—		—		58,252		—		58,252
Management fee expense	—		9,342		—		(9,342)		—
Restructuring charges	—		—		3,281		—		3,281
Operating (loss) income	(26,682)		238,799		(63,649)		9,342		157,810
Other income (expenses):
Interest expense	(90,967)		(2,176)		(239)		234		(93,148)
Change in fair value of derivatives embedded within convertible debt	4,999		—		—		—		4,999
Equity in losses from real estate ventures	—		—		(27,301)		—		(27,301)
Equity in earnings from investments	54,199		—		—		—		54,199
Equity in earnings in consolidated subsidiaries	106,140		(62,244)		—		(43,896)		—
Management fee income	9,342		—		—		(9,342)		—
Other, net	(2,977)		2,629		(5,685)		(2,083)		(8,116)
Income (loss) before provision for income taxes	54,054		177,008		(96,874)		(45,745)		88,443
Income tax benefit (expense)	6,628		(60,361)		25,972		—		(27,761)
Net income (loss)	60,682		116,647		(70,902)		(45,745)		60,682
Net income (loss) attributed to Vector Group Ltd.	$	60,682	$	116,647	$	(70,902)	$	(45,745)	$	60,682
Comprehensive income (loss) attributed to Vector Group Ltd.	$	61,823	$	117,096	$	(70,902)	$	(46,194)	$	61,823

XML

Cover - shares	9 Months Ended
	Sep. 30, 2020	Nov. 02, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity Registrant Name	VECTOR GROUP LTD
Entity Central Index Key	0000059440
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity File Number	1-5759
Entity Tax Identification Number	65-0949535
Entity Address, Address Line One	4400 Biscayne Boulevard
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33137
City Area Code	305
Local Phone Number	579-8000
Title of 12(b) Security	Common stock, par value $0.10 per share
Trading Symbol	VGR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		153,293,358

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 451,071	$ 371,341
Investment securities at fair value	124,092	129,641
Accounts receivable - trade, net	43,999	36,959
Inventories	94,548	98,762
Other current assets	38,713	44,911
Total current assets	752,423	681,614
Property, plant and equipment, net	76,067	82,160
Investments in real estate, net	9,786	28,317
Long-term investment securities at fair value	31,619	45,781
Investments in real estate ventures	102,458	131,556
Operating lease right-of-use assets	147,959	149,578
Goodwill and other intangible assets, net	207,618	265,993
Other assets	115,048	120,090
Total assets	1,442,978	1,505,089
Current liabilities:
Current portion of notes payable and long-term debt	10,684	209,269
Current portion of fair value of derivatives embedded within convertible debt	0	4,999
Current payments due under the Master Settlement Agreement	145,472	34,116
Income taxes payable, net	19,113	5,138
Current operating lease liability	22,485	18,294
Other current liabilities	194,028	189,317
Total current liabilities	391,782	461,133
Notes payable, long-term debt and other obligations, less current portion	1,395,964	1,397,216
Non-current employee benefits	61,341	67,853
Deferred income taxes, net	28,509	33,695
Non-current operating lease liability	159,200	156,963
Payments due under the Master Settlement Agreement	18,130	17,275
Other liabilities	50,171	55,970
Total liabilities	2,105,097	2,190,105
Commitments and contingencies (Note 9)
Stockholders' deficiency:
Preferred stock, par value $1 per share, 10,000,000 shares authorized	0	0
Common stock, par value $0.1 per share, 250,000,000 shares authorized, 153,293,358 and 148,084,900 shares issued and outstanding	15,329	14,808
Accumulated deficit	(656,781)	(678,464)
Accumulated other comprehensive loss	(20,667)	(21,808)
Total Vector Group Ltd. stockholders' deficiency	(662,119)	(685,464)
Non-controlling interest	0	448
Total stockholders' deficiency	(662,119)	(685,016)
Total liabilities and stockholders' deficiency	$ 1,442,978	$ 1,505,089

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Stockholders' deficiency:
Preferred stock, par value (in dollars per share)	$ 1
Preferred stock, shares authorized (in shares)	10,000,000
Common stock, par value (in dollars per share)	$ 0.1
Common stock, shares authorized (in shares)	250,000,000
Common stock, shares issued (in shares)	153,293,358	148,084,900
Common stock, shares outstanding (in shares)	153,293,358	148,084,900

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues:
Total revenues		$ 547,831	$ 504,790	$ 1,448,079	$ 1,464,146
Cost of sales:
Total cost of sales		374,575	345,456	990,083	999,650
Operating, selling, administrative and general expenses		77,019	92,374	238,600	278,047
Litigation settlement and judgment expense		0	240	53	895
Impairments of goodwill and intangible assets		0	0	58,252	0
Restructuring charges		320	0	3,281	0
Operating income		95,917	66,720	157,810	185,554
Other income (expenses):
Interest expense		(28,163)	(32,963)	(93,148)	(103,236)
Change in fair value of derivatives embedded within convertible debt		0	6,182	4,999	20,319
Equity in earnings (losses) from investments		1,840	(468)	54,199	(791)
Equity in (losses) earnings from real estate ventures		(8,536)	8,050	(27,301)	12,002
Other, net		(5,096)	2,223	(8,116)	14,444
Income before provision for income taxes		55,962	49,744	88,443	128,292
Income tax expense		17,823	13,736	27,761	37,944
Net income		38,139	36,008	60,682	90,348
Net income attributed to non-controlling interest		0	0	0	(80)
Net income attributed to Vector Group Ltd.		$ 38,139	$ 36,008	$ 60,682	$ 90,268
Per basic common share:
Net income applicable to common shares attributed to Vector Group Ltd. (in dollars per share)		$ 0.25	$ 0.23	$ 0.39	$ 0.57
Per diluted common share:
Net income applicable to common shares attributed to Vector Group Ltd. (in dollars per share)		$ 0.25	$ 0.23	$ 0.39	$ 0.56
Tobacco
Revenues:
Tobacco	[1]	$ 318,850	$ 303,260	$ 918,429	$ 854,517
Total revenues		318,850		918,429
Cost of sales:
Total cost of sales	[1]	204,101	209,192	615,458	590,956
Real estate
Revenues:
Real estate		228,981	201,530	529,650	609,629
Cost of sales:
Total cost of sales		$ 170,474	$ 136,264	$ 374,625	$ 408,694

[1] Revenues and cost of sales include federal excise taxes of $120,320, $122,951, $354,629, and $347,527, respectively.

XML

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Tax portion of revenues and cost of goods sold	$ 120,320	$ 122,951	$ 354,629	$ 347,527

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 38,139	$ 36,008	$ 60,682	$ 90,348
Net unrealized (losses) gains on investment securities available for sale:
Change in net unrealized (losses) gains	(242)	2	(262)	725
Net unrealized losses (gains) reclassified into net income	1	(19)	434	(56)
Net unrealized (losses) gains on investment securities available for sale	(241)	(17)	172	669
Net change in pension-related amounts
Amortization of loss	463	491	1,390	1,439
Net change in pension-related amounts	463	491	1,390	1,439
Other comprehensive income	222	474	1,562	2,108
Income tax effect on:
Change in net unrealized (losses) gains on investment securities	65	(1)	71	(199)
Net unrealized losses (gains) reclassified into net income on investment securities	0	5	(117)	15
Pension-related amounts	(125)	(134)	(375)	(394)
Income tax provision on other comprehensive income	(60)	(130)	(421)	(578)
Other comprehensive income, net of tax	162	344	1,141	1,530
Comprehensive income	38,301	36,352	61,823	91,878
Comprehensive income attributed to non-controlling interest	0	0	0	(80)
Comprehensive income attributed to Vector Group Ltd.	$ 38,301	$ 36,352	$ 61,823	$ 91,798

XML

Condensed Consolidated Statements of Stockholders' Deficiency - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019		Sep. 30, 2020	Sep. 30, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)				148,084,900
Beginning Balance	$ (669,204)	$ (606,696)		$ (685,016)	$ (547,366)
Net income	38,139	36,008		60,682	90,348
Total other comprehensive income	162	344		1,141	1,530
Distributions and dividends on common stock	(31,563)	(58,724)		(93,684)	(176,298)
Restricted stock grant	0	0		0	0
Issuance of common stock, net of offering costs				52,563
Surrender of shares in connection with restricted stock vesting	(2,124)	(1,953)		(2,186)	(2,174)
Stock-based compensation	$ 2,471	2,348		7,012	7,122
Distributions to non-controlling interest				(448)	(285)
Other				$ 80
Ending Balance (in shares)	153,293,358			153,293,358
Ending Balance	$ (662,119)	$ (628,673)		$ (662,119)	$ (628,673)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	153,484,477	140,953,900		148,084,900	140,914,642
Beginning Balance	$ 15,348	$ 14,095		$ 14,808	$ 14,092
Restricted stock grant (in shares)	20,000			425,000	60,000
Restricted stock grant	$ 2			$ 43	$ 6
Issuance of common stock (in shares)				5,000,000
Issuance of common stock, net of offering costs				$ 500
Surrender of shares in connection with restricted stock vesting (in shares)	(211,119)	(200,926)		(216,542)	(221,668)
Surrender of shares in connection with restricted stock vesting	$ (21)	$ (19)		$ (22)	$ (22)
Ending Balance (in shares)	153,293,358	147,790,623		153,293,358	147,790,623
Ending Balance	$ 15,329	$ 14,780		$ 15,329	$ 14,780
Additional Paid-In
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	0	0		0	0
Distributions and dividends on common stock	(366)	(414)		(56,868)	(4,964)
Restricted stock grant	(2)			(43)	(6)
Issuance of common stock, net of offering costs				52,063
Surrender of shares in connection with restricted stock vesting	(2,103)	(1,934)		(2,164)	(2,152)
Stock-based compensation	2,471	2,348		7,012	7,122
Ending Balance	0	0		0	0
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(663,723)	(597,786)		(678,464)	(542,169)
Net income	38,139	36,008		60,682	90,268
Distributions and dividends on common stock	(31,197)	(58,310)		(36,816)	(171,334)
Other				80
Ending Balance	(656,781)	(620,792)		(656,781)	(620,792)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(20,829)	(23,493)		(21,808)	(19,982)
Total other comprehensive income	162	344		1,141	1,530
Ending Balance	(20,667)	(23,149)		(20,667)	(23,149)
Non-controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	0	488		448	693
Net income					80
Distributions to non-controlling interest				(448)	(285)
Ending Balance	$ 0	488		0	488
Impact of adoption of new accounting standards
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance				(2,263)	(1,550)
Impact of adoption of new accounting standards | Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance				$ (2,263)	3,147
Impact of adoption of new accounting standards | Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance					(4,697)
2019 Stock Dividend
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Effect of stock dividend		$ 0	[1]		$ 0	[2]
2019 Stock Dividend | Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Effect of stock dividend (in shares)		7,037,649	[1]		7,037,649	[2]
Effect of stock dividend		$ 704	[1]		$ 704	[2]
2019 Stock Dividend | Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Effect of stock dividend		$ (704)	[1]		$ (704)	[2]

[1] Represents the effect of the September 27, 2019 stock dividend on the third quarter 2019 common-stock activity.

[2] Represents the effect of the September 27, 2019 stock dividend on the third quarter 2019 common-stock activity.

XML

Condensed Consolidated Statements of Stockholders' Deficiency (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Stockholders' Equity [Abstract]
Distributions and dividends on common stock (in dollars per share)	$ 0.20	$ 0.38	$ 0.60	$ 1.14

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Statement of Cash Flows [Abstract]
Net cash provided by operating activities	$ 318,660	$ 195,349
Cash flows from investing activities:
Sale of investment securities	20,773	16,186
Maturities of investment securities	43,405	45,798
Purchase of investment securities	(64,827)	(76,094)
Proceeds from sale or liquidation of long-term investments	30,255	0
Purchase of long-term investments	(9,238)	(1,000)
Investments in real estate ventures	(6,239)	(36,269)
Distributions from investments in real estate ventures	11,606	30,934
Increase in cash surrender value of life insurance policies	(723)	(773)
Decrease in restricted assets	384	661
Proceeds from sale of fixed assets	0	17
Capital expenditures	(8,824)	(10,158)
Purchase of subsidiaries	0	(323)
Paydowns of investment securities	627	828
Investments in real estate, net	(701)	(1,910)
Net cash provided by (used in) investing activities	16,498	(32,103)
Cash flows from financing activities:
Proceeds from issuance of debt	520	0
Deferred financing costs	0	(36)
Repayments of debt	(173,779)	(230,874)
Borrowings under revolver	130,686	204,506
Repayments on revolver	(165,639)	(221,373)
Dividends and distributions on common stock	(97,781)	(179,449)
Distributions to non-controlling interest	(448)	(285)
Proceeds from issuance of Vector stock	52,563	0
Other	0	(46)
Net cash used in financing activities	(253,878)	(427,557)
Net increase (decrease) in cash, cash equivalents and restricted cash	81,280	(264,311)
Cash, cash equivalents and restricted cash, beginning of period	379,476	591,729
Cash, cash equivalents and restricted cash, end of period	$ 460,756	$ 327,418

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)Basis of Presentation:

The condensed consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.

Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Liggett Vector Brands coordinates Liggett and Vector Tobacco’s sales and marketing efforts. Certain references to “Liggett” refer to the Company’s tobacco operations, including the business of Liggett and Vector Tobacco, unless otherwise specified. New Valley is engaged in the real estate business.

The unaudited, interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair statement of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”). The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year.

Certain reclassifications have been made to the 2019 financial information to conform to the 2020 presentation.

(b)Distributions and Dividends on Common Stock:

The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital to the extent paid-in-capital is available and then to accumulated deficit. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all periods presented. On November 5, 2019, the Company announced that its board of directors decided that the Company will no longer pay an annual stock dividend.

(c)Earnings Per Share (“EPS”):

Net income for purposes of determining basic EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	84,216

Net income for purposes of determining diluted EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributable to 7.5% Variable Interest Senior Convertible Notes	—		—		—		(1,246)
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	82,970

Basic and diluted EPS were calculated using the following common shares:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2020	2019	2020	2019
Weighted-average shares for basic EPS	152,216,118	146,703,766	149,541,642	146,562,252
Plus incremental shares related to convertible debt	—	—	—	961,191
Plus incremental shares related to stock options and non-vested restricted stock	8,470	32,374	32,007	13,782
Weighted-average shares for diluted EPS	152,224,588	146,736,140	149,573,649	147,537,225

The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three and nine months ended September 30, 2020 and 2019, but were not included in the computation of diluted EPS because the impact of the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods and the common shares issuable under the convertible debt were anti-dilutive to EPS.

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Weighted-average shares of non-vested restricted stock	612,538		1,012,285		555,918		1,274,549
Weighted-average expense per share	$	18.29	$	18.03	$	19.54	$	17.95
Weighted-average number of shares issuable upon conversion of debt	—		11,447,061		3,237,522		11,447,061
Weighted-average conversion price	$	—	$	20.27	$	20.27	$	20.27

(d)Restructuring:

In response to the current novel coronavirus pandemic (“COVID-19”), the Company's Real Estate segment, including Douglas Elliman, has commenced a restructuring by realigning its administrative support function and office locations as well as adjusting its business model to more efficiently serve its clients. This included a reduction of staff by approximately 25% at Douglas Elliman.

The following table summarizes amounts expensed for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Cash Charges:
Employee severance and benefits	$	186	$	1,785
Other restructuring expenses	64		282
	250		2,067
Non-Cash:
Loss on fixed assets associated with consolidation of sales offices	70		1,214
	70		1,214
Total restructuring charges	$	320	$	3,281

All amounts expensed for the three and nine months ended September 30, 2020 are included as Restructuring charges in the Company’s condensed consolidated statements of operations and are all attributable to the Company’s Real Estate segment.

Severance and benefits expensed for the three and nine months ended September 30, 2020 relate entirely to a reduction in administrative positions.

The following table presents the activity under the Real Estate segment restructuring plan for the nine months ended September 30, 2020:

	Employee Severance and Benefits		Other		Non-Cash Loss on Fixed Assets		Total
Accrual balance as of January 1, 2020	$	—	$	—	$	—	$	—
Restructuring charges	1,785		282		1,214		3,281
Utilized	(1,735)		(282)		(1,214)		(3,231)
Accrual balance as of September 30, 2020	$	50	$	—	$	—	$	50

(e)Investments in Real Estate Ventures:

In accounting for its investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as (a) entities in which the equity investment at risk is not sufficient to finance its activities without additional subordinated financial support; (b) as a group, the equity investors at risk lack 1) the power to direct the activities of a legal entity that most significantly impact the entity’s economic performance, 2) the obligation to absorb the expected losses of the entity, or 3) the right to receive the expected residual returns of the entity; or (c) as a group, the equity investors have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.

The Company’s interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).

Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company’s maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the VIE, any unfunded capital commitments to the VIE, and, in some cases, guarantees in connection with debt on the specific project. The Company’s maximum exposure to loss in its investment in consolidated VIEs is limited to its investment, which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.

On a quarterly basis, the Company evaluates its investments in real estate ventures to determine if there are indicators of impairment. If so, the Company further investigates to determine if an impairment has occurred and whether such impairment is considered temporary or other than temporary. The Company believes that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven.

(f)Other, net:

Other, net consisted of:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Interest and dividend income	$	1,251	$	3,083	$	5,331	$	9,430
Net gains (losses) recognized on investment securities	2,516		(1,487)		(4,943)		5,601
Net periodic benefit cost other than the service costs	(452)		(576)		(1,361)		(1,692)
Credit loss expense	(8,576)		—		(9,008)		—
Other income	165		1,203		1,865		1,105
Other, net	$	(5,096)	$	2,223	$	(8,116)	$	14,444

(g)Other Assets:

Other assets consisted of:

	September 30, 2020		December 31, 2019
Restricted assets	$	4,008	$	5,241
Prepaid pension costs	32,467		31,686
Equity-method investments	16,240		15,942
Contract assets, net	26,083		18,443
Other assets	36,250		48,778
Total other assets	$	115,048	$	120,090

(h)Other Current Liabilities:

Other current liabilities consisted of:

	September 30, 2020		December 31, 2019
Accounts payable	$	11,962	$	10,222
Accrued promotional expenses	45,966		35,900
Accrued excise and payroll taxes payable, net	2,817		18,653
Accrued interest	33,159		35,756
Commissions payable	28,972		18,378
Accrued salary and benefits	19,059		29,464
Contract liabilities	9,725		9,358
Allowance for sales returns	7,857		7,785
Other current liabilities	34,511		23,801
Total other current liabilities	$	194,028	$	189,317

(i)    Reconciliation of Cash, Cash Equivalents and Restricted Cash:

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	September 30, 2020		December 31, 2019
Cash and cash equivalents	$	451,071	$	371,341
Restricted cash and cash equivalents included in other current assets	7,224		4,423
Restricted cash and cash equivalents included in other assets	2,461		3,712
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	460,756	$	379,476

Amounts included in current restricted assets and non-current restricted assets represent cash and cash equivalents required to be deposited into escrow for bonds required to appeal adverse product liability judgments, amounts required for letters of credit related to office leases, and certain deposit requirements for banking arrangements. The restrictions related to the appellate bonds will remain in place until the appeal process has been completed. The restrictions related to the letters of credit will remain in place for the duration of the respective lease. The restrictions related to the banking arrangements will remain in place for the duration of the arrangement.

(j)    New Accounting Pronouncements:

In March 2020, the Securities and Exchange Commission (“SEC”) adopted final rules that amend the financial disclosure requirement for guarantors of registered debt securities in Rule 3-10 of Regulation S-X. The new Rule 13-01 of Regulation S-X amends and streamlines the disclosures required by guarantors and issuers of guaranteed securities. Among other things, the new disclosures may be located outside the financial statements. The new rule is effective January 4, 2021, and early adoption is permitted. The Company elected to early adopt the new rule on September 30, 2020. Accordingly, the revised condensed consolidating financial information is presented in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations.

Accounting Standards Updates (“ASU”) adopted in 2020:

In October 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities. The guidance requires indirect interests

held through related parties under common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. The ASU eliminates disclosures such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The ASU also adds new disclosure requirements for Level 3 measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of ASU 2018-13 impacted financial statement disclosure and had no impact on operating results.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), sets forth a current expected credit loss model that changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This guidance is effective for fiscal years beginning after December 15, 2019.

The ASU introduces a new accounting model, the Current Expected Credit Losses model (CECL), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for notes and other receivables at the time the financial asset is originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaced the previous impairment models in U.S. GAAP, which generally required that a loss be incurred before it is recognized. The new standard applies to receivables arising from revenue transactions such as contract assets and accounts receivables. The adoption of this standard resulted in an increase in stockholders’ deficiency of $2,263, net of tax, attributed to commercial real estate term loans allowance for credit losses of $3,100 as of January 1, 2020.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. Under the amendments of the ASU, an entity should recognize an impairment charge for the amount by which the carrying amount of a reporting unit exceeds its fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendments in this update are effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. This guidance was adopted on January 1, 2020, on a prospective basis. The Company applied the new guidance to evaluate its goodwill during the first quarter of 2020. As a result, a goodwill impairment charge of $46,252 was recorded as the Company's estimated fair value of a reporting unit was less than its book value.

ASUs to be adopted in future periods:

In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans (“ASU 2018-14”). ASU 2018-14 eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. ASU 2018-14 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company will adopt for the period

ending December 31, 2020. The adoption of ASU 2018-14 will impact financial statement disclosure with no impact on operating results.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). This update simplifies various aspects related to accounting for income taxes, removes certain exceptions to the general principles in Accounting Standards Codification (“ASC”) 740, and clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In January 2020, the FASB issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted, including early adoption in an interim period. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This ASU is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance is effective for all entities for contract modifications beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The Company has not yet determined the extent to which it will utilize these expedients and exceptions should a modification occur. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements.

XML

Revenue Recognition

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue Recognition

REVENUE RECOGNITION

Disaggregation of Revenue

In the following table, revenue is disaggregated by major product line for the Tobacco segment:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Tobacco Segment Revenues:
Core Discount Brands - Eagle 20’s, Pyramid, Montego, Grand Prix, Liggett Select, and Eve	$	300,487	$	283,621	$	864,880	$	798,272
Other Brands	18,363		19,639		53,549		56,245
Total tobacco revenues	$	318,850	$	303,260	$	918,429	$	854,517

In the following table, revenue is disaggregated by major services line and primary geographical market for the Real Estate segment:

	Three months ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	43,039	$	58,909	$	43,883	$	42,000	$	187,831
Commission and other brokerage income - development marketing	4,571		—		5,564		534		10,669
Property management revenue	8,334		250		—		—		8,584
Title fees	358		554		—		—		912
Total Douglas Elliman revenue	56,302		59,713		49,447		42,534		207,996
Other real estate revenues	—		20,500		—		485		20,985
Total real estate revenues	$	56,302	$	80,213	$	49,447	$	43,019	$	228,981

	Three months ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	73,081	$	47,066	$	25,008	$	27,770	$	172,925
Commission and other brokerage income - development marketing	6,920		—		7,614		3,992		18,526
Property management revenue	8,484		184		—		—		8,668
Title fees	—		1,049		—		—		1,049
Total Douglas Elliman revenue	88,485		48,299		32,622		31,762		201,168
Other real estate revenues	—		—		—		362		362
Total real estate revenues	$	88,485	$	48,299	$	32,622	$	32,124	$	201,530

	Nine Months Ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	129,009	$	129,264	$	97,293	$	87,724	$	443,290
Commission and other brokerage income - development marketing	18,195		—		15,033		1,202		34,430
Property management revenue	25,513		682		—		—		26,195
Title fees	1,425		1,186		—		—		2,611
Total Douglas Elliman revenue	174,142		131,132		112,326		88,926		506,526
Other real estate revenues	—		20,500		—		2,624		23,124
Total real estate revenues	$	174,142	$	151,632	$	112,326	$	91,550	$	529,650

	Nine Months Ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	243,061	$	118,057	$	79,303	$	77,952	$	518,373
Commission and other brokerage income - development marketing	41,024		—		10,680		4,021		55,725
Property management revenue	26,699		538		—		—		27,237
Title fees	—		4,682		—		—		4,682
Total Douglas Elliman revenue	310,784		123,277		89,983		81,973		606,017
Other real estate revenues	—		—		—		3,612		3,612
Total real estate revenues	$	310,784	$	123,277	$	89,983	$	85,585	$	609,629

Contract Balances

The following table provides information about contract assets and contract liabilities from development marketing and commercial leasing contracts with customers:

	September 30, 2020		December 31, 2019
Receivables, which are included in accounts receivable - trade, net	$	2,194	$	2,129
Contract assets, net, which are included in other current assets	5,965		8,766
Payables, which are included in other current liabilities	1,544		1,663
Contract liabilities, which are included in other current liabilities	9,725		9,358
Contract assets, net, which are included in other assets	26,083		18,443
Contract liabilities, which are included in other liabilities	28,304		29,045

The Company recognized revenue of $1,451 and $8,109 for the three and nine months ended September 30, 2020, that were included in the contract liabilities balances at December 31, 2019. The Company recognized revenue of $4,722 and $9,753 for the three and nine months ended September 30, 2019, that were included in the contract liabilities balances at December 31, 2018.

XML

Current Expected Credit Losses

9 Months Ended

Sep. 30, 2020

Credit Loss [Abstract]

Current Expected Credit Losses

CURRENT EXPECTED CREDIT LOSSES

On January 1, 2020, the Company adopted ASU No. 2016-13, which sets forth a current expected credit loss model that changes how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income.

ASU 2016-13 introduces a new accounting model, the Current Expected Credit Losses model (“CECL”), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The Company adopted this guidance using the modified retrospective approach, as required, and has not adjusted prior period comparative information and will continue to disclose the prior period financial information in accordance with the previous guidance. The adoption of this standard resulted in an increase in stockholders’ deficiency of $2,263 net of tax, attributed to commercial real estate term loans allowance for credit losses of $3,100 as of January 1, 2020.

Tobacco receivables: Average collection terms for Tobacco sales range between three and twelve days from the time that the cigarettes are shipped to the customer. Based on Tobacco historical and ongoing cash collections from customers, an estimated credit loss in accordance with ASU 2016-13 was not required for these trade receivables as of January 1, 2020 and September 30, 2020.

Real estate broker agent receivables: Douglas Elliman Realty is exposed to credit losses for various amounts due from real estate agents, which are included in Other current assets on the condensed consolidated balance sheets, net of an allowance for credit losses. The Company historically estimated its allowance for credit losses on receivables from agents based on an evaluation of aging, agent sales in pipeline, any security, specific exposures, and historical experience of collections from the individual agents. Based on the Company’s historical credit losses on receivables from agents, current and expected future market trends (such as the current and expected impact of COVID-19 on the real estate market), it was determined that the requirements of Topic 326 did not result in a material impact on the Company’s allowance for credit losses as of January 1, 2020 of $6,132. The Company estimated that the credit losses for these receivables were $7,715 at September 30, 2020.

Term loan receivables: New Valley periodically provides term loans to commercial real estate developers, which are included in Other assets on the condensed consolidated balance sheets. New Valley had two loans with a total amortized cost basis of $15,928 and $15,276, including accrued interest receivable of $6,428 and $5,776 at September 30, 2020 and December 31, 2019, respectively, and have maturities in 2021 and beyond. The loans are secured by guarantees and given their risk profiles are evaluated individually. As New Valley does not have internal historical loss information by which to evaluate the risk of credit losses, external market data measuring default risks on high yield loans as of each measurement date was utilized to estimate reserves for credit losses on these loans. Pursuant to the requirements of Topic 326, New Valley’s expected credit loss estimate was $3,100 as of January 1, 2020 and $12,108 as of September 30, 2020, which reflects the significant current and expected decline in market conditions as of September 30, 2020 due to the impact of COVID-19 on the real estate market.

The adoption of this standard did not have a material impact on the debt securities available for sale portfolio.

The following is the rollforward of the allowance for credit losses for the nine months ended September 30, 2020:

	January 1, 2020		Current Period Provision			Write-offs		Recoveries		September 30, 2020
Allowance for credit losses:
Real estate broker agent receivables	$	6,132	$	1,724	(1)	$	141	$	—	7,715
New Valley term loan receivables	3,100		9,008		(2)	—		—		12,108

______________________

(1) The bad debt expense related to the real estate broker agent receivables is included in Operating, selling, administrative and general expenses on the condensed consolidated statements of operations.

(2) The credit losses related to the New Valley term loan receivables are included in Other, net on the condensed consolidated statements of operations.

XML

Leases

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Leases

LEASES

Leases

The Company has operating and finance leases for corporate and sales offices, and certain vehicles and equipment. The components of lease expense were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Operating lease cost	$	9,475	$	9,707	$	28,255	$	28,212
Short-term lease cost	218		397		1,007		910
Variable lease cost	663		715		1,818		2,405
Finance lease cost:
Amortization	17		67		94		186
Interest on lease liabilities	4		5		11		12
Total lease cost	$	10,377	$	10,891	$	31,185	$	31,725

Supplemental cash flow information related to leases was as follows:

	Nine Months Ended
	September 30,
	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	19,376	$	28,023
Operating cash flows from finance leases	11		12
Financing cash flows from finance leases	86		182
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	13,711		32,511
Finance leases	60		159

Supplemental balance sheet information related to leases was as follows:

	September 30,			December 31,
	2020			2019
Operating leases:
Operating lease right-of-use assets	$	147,959		$	149,578
Current operating lease liability	$	22,485		$	18,294
Non-current operating lease liability	159,200			156,963
Total operating lease liabilities	$	181,685		$	175,257
Finance leases:
Investments in real estate, net (1)	$	73		$	88
Property, plant and equipment, at cost	$	127		$	127
Accumulated amortization	(38)			(19)
Property and equipment, net	$	89		$	108
Current portion of notes payable and long-term debt	$	59		$	86
Notes payable, long-term debt and other obligations, less current portion	110			108
Total finance lease liabilities	$	169		$	194
Weighted average remaining lease term:
Operating leases	8.09			8.46
Finance leases	2.90			3.01
Weighted average discount rate:
Operating leases	9.28		%	10.75		%
Finance leases	7.75		%	8.61		%

(1)     Included in Investments in real estate, net on the condensed consolidated balance sheets are financing lease equipment, at cost of $748 and $762 and accumulated amortization of $675 and $674 as of September 30, 2020 and December 31, 2019, respectively.

As of September 30, 2020, maturities of lease liabilities were as follows:

	Operating Leases		Finance Leases
Period Ending December 31:
Remainder of 2020	$	6,496	$	19
2021	41,353		66
2022	36,892		61
2023	32,417		35
2024	26,749		8
2025	21,797		—
Thereafter	96,556		—
Total lease payments	262,260		189
Less imputed interest	(80,575)		(20)
Total	$	181,685	$	169

As of September 30, 2020, the Company had $23 in undiscounted lease payments relating to an additional operating lease for equipment that has not yet commenced. The operating lease will commence in the fourth quarter of 2020 with a lease term of 3 years.

Due to the business disruptions and challenges severely affecting the global economy caused by the COVID-19 pandemic, lessors may provide rent deferrals and other lease concessions to lessees. While the lease modification guidance in Topic 842 addresses routine changes to lease terms resulting from negotiations between the lessee and the lessor, this guidance does not contemplate concessions being so rapidly executed to address the sudden liquidity constraints of some lessees arising from the COVID-19 pandemic and restrictions intended to prevent its spread.

In April 2020, the FASB staff issued a question and answer document (the “Lease Modification Q&A”) focused on the application of lease accounting guidance to lease concessions provided as a result of the COVID-19 pandemic. Under existing lease guidance, the Company would have to determine, on a lease by lease basis, if a lease concession was the result of a new arrangement reached with the tenant (treated within the lease modification accounting framework) or if a lease concession was under the enforceable rights and obligations within the existing lease agreement (precluded from applying the lease modification accounting framework). The Lease Modification Q&A allows the Company, if certain criteria have been met, to bypass the lease by lease analysis, and instead elect to either apply the lease modification accounting framework or not, with such election applied consistently to leases with similar characteristics and similar circumstances.

As a result of the COVID-19 pandemic, the Company received lease concessions from landlords mostly in the form of rent deferrals and a few in the form of rent abatements during the nine months ended September 30, 2020. The Company elected to treat these deferrals and abatements as lease modifications and the existing lease liabilities were remeasured with a corresponding adjustment to the right-of-use asset on the effective date of the modification. The deferrals varied as to the timing of repayment but all agreements required repayment of the deferrals over the remaining lease terms.

Leases

LEASES

Leases

The Company has operating and finance leases for corporate and sales offices, and certain vehicles and equipment. The components of lease expense were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Operating lease cost	$	9,475	$	9,707	$	28,255	$	28,212
Short-term lease cost	218		397		1,007		910
Variable lease cost	663		715		1,818		2,405
Finance lease cost:
Amortization	17		67		94		186
Interest on lease liabilities	4		5		11		12
Total lease cost	$	10,377	$	10,891	$	31,185	$	31,725

Supplemental cash flow information related to leases was as follows:

	Nine Months Ended
	September 30,
	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	19,376	$	28,023
Operating cash flows from finance leases	11		12
Financing cash flows from finance leases	86		182
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	13,711		32,511
Finance leases	60		159

Supplemental balance sheet information related to leases was as follows:

	September 30,			December 31,
	2020			2019
Operating leases:
Operating lease right-of-use assets	$	147,959		$	149,578
Current operating lease liability	$	22,485		$	18,294
Non-current operating lease liability	159,200			156,963
Total operating lease liabilities	$	181,685		$	175,257
Finance leases:
Investments in real estate, net (1)	$	73		$	88
Property, plant and equipment, at cost	$	127		$	127
Accumulated amortization	(38)			(19)
Property and equipment, net	$	89		$	108
Current portion of notes payable and long-term debt	$	59		$	86
Notes payable, long-term debt and other obligations, less current portion	110			108
Total finance lease liabilities	$	169		$	194
Weighted average remaining lease term:
Operating leases	8.09			8.46
Finance leases	2.90			3.01
Weighted average discount rate:
Operating leases	9.28		%	10.75		%
Finance leases	7.75		%	8.61		%

(1)     Included in Investments in real estate, net on the condensed consolidated balance sheets are financing lease equipment, at cost of $748 and $762 and accumulated amortization of $675 and $674 as of September 30, 2020 and December 31, 2019, respectively.

As of September 30, 2020, maturities of lease liabilities were as follows:

	Operating Leases		Finance Leases
Period Ending December 31:
Remainder of 2020	$	6,496	$	19
2021	41,353		66
2022	36,892		61
2023	32,417		35
2024	26,749		8
2025	21,797		—
Thereafter	96,556		—
Total lease payments	262,260		189
Less imputed interest	(80,575)		(20)
Total	$	181,685	$	169

As of September 30, 2020, the Company had $23 in undiscounted lease payments relating to an additional operating lease for equipment that has not yet commenced. The operating lease will commence in the fourth quarter of 2020 with a lease term of 3 years.

Due to the business disruptions and challenges severely affecting the global economy caused by the COVID-19 pandemic, lessors may provide rent deferrals and other lease concessions to lessees. While the lease modification guidance in Topic 842 addresses routine changes to lease terms resulting from negotiations between the lessee and the lessor, this guidance does not contemplate concessions being so rapidly executed to address the sudden liquidity constraints of some lessees arising from the COVID-19 pandemic and restrictions intended to prevent its spread.

In April 2020, the FASB staff issued a question and answer document (the “Lease Modification Q&A”) focused on the application of lease accounting guidance to lease concessions provided as a result of the COVID-19 pandemic. Under existing lease guidance, the Company would have to determine, on a lease by lease basis, if a lease concession was the result of a new arrangement reached with the tenant (treated within the lease modification accounting framework) or if a lease concession was under the enforceable rights and obligations within the existing lease agreement (precluded from applying the lease modification accounting framework). The Lease Modification Q&A allows the Company, if certain criteria have been met, to bypass the lease by lease analysis, and instead elect to either apply the lease modification accounting framework or not, with such election applied consistently to leases with similar characteristics and similar circumstances.

As a result of the COVID-19 pandemic, the Company received lease concessions from landlords mostly in the form of rent deferrals and a few in the form of rent abatements during the nine months ended September 30, 2020. The Company elected to treat these deferrals and abatements as lease modifications and the existing lease liabilities were remeasured with a corresponding adjustment to the right-of-use asset on the effective date of the modification. The deferrals varied as to the timing of repayment but all agreements required repayment of the deferrals over the remaining lease terms.

XML

Inventories

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories consisted of:

	September 30, 2020		December 31, 2019
Leaf tobacco	$	42,448	$	44,516
Other raw materials	5,733		4,669
Work-in-process	645		333
Finished goods	67,211		71,183
Inventories at current cost	116,037		120,701
LIFO adjustments	(21,489)		(21,939)
	$	94,548	$	98,762

All of the Company’s inventories at September 30, 2020 and December 31, 2019 are reported under the LIFO method. The $21,489 LIFO adjustment as of September 30, 2020 decreased the current cost of inventories by $14,761 for Leaf tobacco, $180 for Other raw materials, $24 for Work-in-process and $6,524 for Finished goods. The $21,939 LIFO adjustment as of December 31, 2019 decreased the current cost of inventories by $15,210 for Leaf tobacco, $182 for Other raw materials, $24 for Work-in-process and $6,523 for Finished goods.

The amount of capitalized MSA cost in “Finished goods” inventory was $20,969 and $20,472 at September 30, 2020 and December 31, 2019, respectively. Federal excise tax capitalized in inventory was $27,648 and $27,676 at September 30, 2020 and December 31, 2019, respectively.

At September 30, 2020, Liggett had tobacco purchase commitments of approximately $17,483. Liggett has a single-source supply agreement for reduced ignition propensity cigarette paper through 2022.

XML

Investment Securities

9 Months Ended

Sep. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Investment Securities

INVESTMENT SECURITIES

Investment securities consisted of the following:

	September 30, 2020		December 31, 2019
Debt securities available for sale	$	89,239	$	83,445
Equity securities at fair value:
Marketable equity securities	11,897		23,819
Mutual funds invested in debt securities	22,956		22,377
Long-term investment securities at fair value (1)	31,619		45,781
Total equity securities at fair value	66,472		91,977
Total investment securities at fair value	155,711		175,422
Less:
Long-term investment securities at fair value	31,619		45,781
Current investment securities at fair value	124,092		129,641
Equity-method investments	$	16,240	$	15,942

(1) These assets are measured at net asset value (“NAV”) as a practical expedient under ASC 820.

Net gains (losses) recognized on investment securities were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Net gains (losses) recognized on debt securities available for sale	22		25		(25)		67
Impairment expense	(22)		(6)		(408)		(11)
Net gains (losses) recognized on investment securities	$	2,516	$	(1,487)	$	(4,943)	$	5,601

(a) Debt Securities Available for Sale:

The components of debt securities available for sale at September 30, 2020 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	88,336	$	903	$	—	$	89,239

The table below summarizes the maturity dates of debt securities available for sale at September 30, 2020.

Investment Type:	Fair Value		Under 1 Year		1 Year up to 5 Years		More than 5 Years
U.S. Government securities	$	11,412	$	9,068	$	2,344	$	—
Corporate securities	58,481		28,863		29,618		—
U.S. mortgage-backed securities	5,759		114		5,645		—
Commercial paper	13,587		13,587		—		—
Total debt securities available for sale by maturity dates	$	89,239	$	51,632	$	37,607	$	—

The components of debt securities available for sale at December 31, 2019 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	82,714	$	731	$	—	$	83,445

There were no available-for-sale debt securities with continuous unrealized losses for less than 12 months and 12 months or greater at September 30, 2020 and December 31, 2019, respectively.

Gross realized gains and losses on debt securities available for sale were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Gross realized gains on sales	$	23	$	27	$	193	$	74
Gross realized losses on sales	(1)		(2)		(218)		(7)
Net gains (losses) recognized on debt securities available for sale	$	22	$	25	$	(25)	$	67
Impairment expense	$	(22)	$	(6)	$	(408)	$	(11)

Although management generally does not have the intent to sell any specific securities at the end of the period, in the ordinary course of managing the Company’s investment securities portfolio, management may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements.

(b) Equity Securities at Fair Value:

The following is a summary of unrealized and realized net gains and losses recognized in net income on equity securities at fair value during the three and nine months ended September 30, 2020 and 2019, respectively:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Less: Net (losses) gains recognized on equity securities sold	(2)		58		(19)		468
Net unrealized gains (losses) recognized on equity securities still held at the reporting date	$	2,518	$	(1,564)	$	(4,491)	$	5,077

The Company’s marketable equity securities and mutual funds invested in debt securities are classified as Level 1 under the fair value hierarchy disclosed in Note 12. Their fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.

The Company received cash distributions of $30,358 and recognized a receivable of $2,438 of in-transit redemptions as of September 30, 2020 related to its long-term investment securities at fair value. The Company classified $30,255 of these distributions as investing cash inflows for the nine months ended September 30, 2020. The remaining distributions were classified as operating cash inflows.

(c) Equity-Method Investments:

Equity-method investments consisted of the following:

	September 30, 2020		December 31, 2019
Mutual fund and hedge funds	$	16,240	$	15,509
Ladenburg Thalmann Financial Services Inc. (“LTS”)	—		433
	$	16,240	$	15,942

At September 30, 2020, the Company’s ownership percentages in the mutual fund and hedge funds accounted for under the equity method ranged from 6.24% to 36.70%. The Company’s ownership percentage in these investments meets the threshold for equity-method accounting.

In November 2019, LTS entered into an Agreement and Plan of Merger with Advisor Group whereby each LTS common share would be converted into the right to receive $3.50 per common share. On February 14, 2020, the merger was completed and the Company received proceeds of $53,169 in exchange for the Company’s 15,191,205 common shares of LTS. The Company also tendered 240,000 shares of LTS 8% Series A Cumulative Redeemable Preferred Stock (Liquidation Preference $25.00 Per Share) for redemption and received an additional $6,009 in March 2020. At the closing of the transaction, the Company’s Executive Vice President resigned as Chairman, President and Chief Executive Officer of LTS, and the Company’s management agreement with LTS was terminated.

Equity in earnings (losses) from investments were:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Mutual fund and hedge funds	$	1,468	$	(632)	$	775	$	(20)
LTS	372		139		53,424		(846)
Other	—		25		—		75
Equity in earnings (losses) from investments	$	1,840	$	(468)	$	54,199	$	(791)

The Company received cash distributions of $53,528 (including the $53,169 received by the Company in exchange for the Company’s 15,191,205 common shares of LTS) and $1,495 from the Company’s equity-method investments for the nine months ended September 30, 2020 and 2019, respectively. The Company classified these cash distributions as operating activities on the condensed consolidated statements of cash flows for the nine months ended September 30, 2020 and September 30, 2019, respectively.

(d) Equity Securities Without Readily Determinable Fair Values That Do Not Qualify for the NAV Practical ExpedientEquity securities without readily determinable fair values that do not qualify for the NAV practical expedient consisted of investments in various limited liability companies at September 30, 2020 and December 31, 2019, respectively. The total carrying value of these investments was $5,200 as of September 30, 2020 and $6,200 as of December 31, 2019, and was included in “Other assets” on the condensed consolidated balance sheets. No impairment or other adjustments related to observable price changes in orderly transactions for identical or similar investments were identified for the three and nine months ended September 30, 2020 and 2019, respectively.

XML

New Valley LLC

9 Months Ended

Sep. 30, 2020

Real Estate [Abstract]

New Valley LLC

NEW VALLEY LLC

Investments in real estate ventures:

The components of “Investments in real estate ventures” were as follows:

	Range of Ownership (1)	September 30, 2020		December 31, 2019
Condominium and Mixed Use Development:
New York City Standard Metropolitan Statistical Area (“SMSA”)	3.1% - 49.5%	$	36,252	$	51,078
All other U.S. areas	15.0% - 77.8%	41,403		55,842
		77,655		106,920
Hotels:
New York City SMSA	1.0% - 18.4%	2,892		2,462
International	49.0%	1,767		2,161
		4,659		4,623
Commercial:
New York City SMSA	49.0%	2,271		1,852
All other U.S. areas	1.6%	6,987		7,634
		9,258		9,486
Other:	15.0% - 49.0%	10,886		10,527
Investments in real estate ventures		$	102,458	$	131,556

______________________

(1) The Range of Ownership reflects New Valley’s estimated current ownership percentage. New Valley’s actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.

Contributions:

The components of New Valley’s contributions to its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,169	$	21,760
All other U.S. areas	4,176		14,000
	5,345		35,760
Apartment Buildings:
All other U.S. areas	76		—
	76		—
Hotels:
New York City SMSA	294		172
	294		172
Other:	524		337
Total contributions	$	6,239	$	36,269

For ventures where New Valley previously held an investment, New Valley contributed its proportionate share of additional capital along with contributions by the other investment partners during the nine months ended September 30, 2020 and September 30, 2019. New Valley’s direct investment percentage for these ventures did not significantly change. 

Distributions:

The components of distributions received by New Valley from its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,735	$	3,380
All other U.S. areas	11,060		1,279
	12,795		4,659
Apartment Buildings:
All other U.S. areas	—		79
	—		79
Hotels:
New York City SMSA	—		21,572
	—		21,572
Commercial:
New York City SMSA	591		13
All other U.S. areas	113		160
	704		173
Other	26		8,088
Total distributions	$	13,525	$	34,571

Of the distributions received by New Valley from its investment in real estate ventures, $1,919 and $3,637 were from distributions of earnings for the nine months ended September 30, 2020 and 2019, respectively, and $11,606 and $30,934 were a return of capital for the nine months ended September 30, 2020 and 2019, respectively. Distributions from earnings are included in cash from operations in the condensed consolidating statements of cash flows, while distributions that are returns of capital are included in cash flows from investing activities in the condensed consolidating statements of cash flows.

Equity in (Losses) Earnings from Real Estate Ventures:

New Valley recognized equity in (losses) earnings from real estate ventures as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	(6,835)	$	2,099	$	(15,286)	$	(1,127)
All other U.S. areas (1)	(618)		4,600		(9,906)		2,234
	(7,453)		6,699		(25,192)		1,107
Apartment Buildings:
All other U.S. areas (1)	(208)		76		(284)		79
	(208)		76		(284)		79
Hotels:
New York City SMSA (1)	(1,119)		(102)		(1,768)		8,132
International	157		434		(394)		70
	(962)		332		(2,162)		8,202
Commercial:
New York City SMSA	783		(149)		1,010		114
All other U.S. areas	(519)		146		(534)		517
	264		(3)		476		631
Other:	(177)		946		(139)		1,983
Equity in (losses) earnings from real estate ventures	$	(8,536)	$	8,050	$	(27,301)	$	12,002

______________________

(1) The Company recognized a liability, classified in Other current liabilities, of $1,302 as a result of recording equity in losses in excess of the joint ventures' carrying value.

During the nine months ended September 30, 2019, New Valley’s Park Lane joint venture sold 80.0% of its interest in the Park Lane Hotel, a hotel located in the New York City SMSA. New Valley recognized equity in earnings of $10,328 from the sale and received distributions of $20,788 for the nine months ended September 30, 2019. The sale reduced New Valley’s direct ownership percentage of the Park Lane Hotel from 5.2% to 1.0%. New Valley continues to account for its investment in the joint venture under the equity method of accounting because its ownership percentage in its direct investment continues to meet the threshold for equity method accounting.

As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair value of three of its New York City SMSA Condominium and Mixed Use Development ventures were less than their carrying value as of September 30, 2020. The Company determined that the impairments were other than temporary. The Company recorded impairment charges as a component of equity in losses from real estate ventures of $6,617 and $10,401 for the three and nine months ended September 30, 2020.

As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair values of three New York City SMSA and one All other U.S. areas Condominium and Mixed Use Development ventures were less than their carrying value as of September 30, 2019. The Company determined that the impairmentw were other than temporary. The Company recorded impairment charges as a component of equity in earnings from real estate ventures of $4,445 and $8,311 for the three and nine months ended September 30, 2019.

VIE Consideration:

The Company has determined that New Valley is the primary beneficiary of two real estate ventures because it controls the activities that most significantly impact economic performance of each of the two real estate ventures. Consequently, New Valley consolidates these variable interest entities (“VIEs”).

The carrying amount of the consolidated assets of the VIEs was $0 and $897 as of September 30, 2020 and December 31, 2019, respectively. Those assets are owned by the VIEs, not the Company. Neither of the two consolidated VIEs had recourse liabilities as of September 30, 2020 and December 31, 2019. A VIE’s assets can only be used to settle obligations of that VIE. The VIEs are not guarantors of the Company’s senior notes and other debts payable.

For the remaining investments in real estate ventures, New Valley determined that the entities were VIEs but New Valley was not the primary beneficiary. Therefore, New Valley’s investment in such real estate ventures has been accounted for under the equity method of accounting.

Maximum Exposure to Loss:

New Valley’s maximum exposure to loss from its investments in real estate ventures consisted of the net carrying value of the venture adjusted for any future capital commitments and/or guarantee arrangements. The maximum exposure to loss was as follows:

	September 30, 2020
Condominium and Mixed Use Development:
New York City SMSA	$	36,252
All other U.S. areas	41,403
	77,655
Hotels:
New York City SMSA	2,892
International	1,767
	4,659
Commercial:
New York City SMSA	2,271
All other U.S. areas	6,987
	9,258
Other	24,461
Total maximum exposure to loss	$	116,033

New Valley capitalized $932 and $3,188 of interest costs into the carrying value of its ventures whose projects were currently under development for the three and nine months ended September 30, 2020. New Valley capitalized $1,703 and $4,706 of interest costs into the carrying value of its ventures whose projects were currently under development for the three and nine months ended September 30, 2019.

Douglas Elliman is engaged by certain developers as a broker for several of the real estate ventures that New Valley invests in. Douglas Elliman earned gross commissions of approximately $8,829 and $15,394 from these projects for the nine months ended September 30, 2020 and 2019, respectively.

Investments in Real Estate, net:

The components of “Investments in real estate, net” were as follows:

	September 30, 2020		December 31, 2019
Escena, net	$	9,786	$	9,972
Sagaponack	—		18,345
Investments in real estate, net	$	9,786	$	28,317

Escena.  The assets of “Escena, net” were as follows:

	September 30, 2020		December 31, 2019
Land and land improvements	$	8,911	$	8,910
Building and building improvements	1,926		1,926
Other	1,670		1,659
	12,507		12,495
Less accumulated depreciation	(2,721)		(2,523)
	$	9,786	$	9,972

New Valley recorded operating losses of $738 and $965 for the three months ended September 30, 2020 and 2019, respectively, from Escena. New Valley recorded operating losses of $1,010 and $633 for the nine months ended September 30, 2020 and 2019, respectively, from Escena. Escena is a master planned community, golf course, and club house in Palm Springs, California.

Investment in Sagaponack. In April 2015, New Valley invested $12,502 in a residential real estate project located in Sagaponack, NY. In August 2020, New Valley sold the project for $20,500 and recognized the revenue in accordance with the scope of ASC Topic 606 since New Valley has no continuing investment or involvement. The sales were presented as revenues and the cost of the investment as cost of goods sold on the condensed consolidated statements of operations.

XML

Notes Payable, Long-Term Debt and Other Obligations

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Notes Payable, Long-Term Debt and Other Obligations

NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS

Notes payable, long-term debt and other obligations consisted of:

	September 30, 2020		December 31, 2019
Vector:
6.125% Senior Secured Notes due 2025	$	850,000	$	850,000
10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392	551,868		551,608
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $0 and $5,276*	—		164,334
Liggett:
Revolving credit facility	—		34,952
Equipment loans	94		347
Other	26,773		30,146
Notes payable, long-term debt and other obligations	1,428,735		1,631,387
Less:
Debt issuance costs	(22,087)		(24,902)
Total notes payable, long-term debt and other obligations	1,406,648		1,606,485
Less:
Current maturities	(10,684)		(209,269)
Amount due after one year	$	1,395,964	$	1,397,216

______________________

* The fair value of the derivatives embedded within the 5.5% Variable Interest Senior Convertible Debentures ($4,999 at December 31, 2019) is separately classified as a derivative liability in the condensed consolidated balance sheets.

6.125% Senior Secured Notes due 2025 — Vector:

As of September 30, 2020, the Company was in compliance with all debt covenants related to its 6.125% Senior Secured Notes due 2025.

10.5% Senior Notes due 2026 — Vector:

As of September 30, 2020, the Company was in compliance with all debt covenants related to its 10.5% Senior Notes due 2026.

5.5% Variable Interest Senior Convertible Debentures due 2020 — Vector:

In April 2020, the Company paid $169,610 of principal as full payment of its 5.5% Variable Interest Senior Convertible Debentures due 2020, which matured on April 15, 2020.

Revolving Credit Agreement — Liggett:

As of September 30, 2020, there was no outstanding balance due under the Third Amended and Restated Credit Agreement (the “Credit Agreement”), all of which was classified as current debt as of September 30, 2020. Availability, as determined under the Credit Agreement, was approximately $58,800 based on eligible collateral at September 30, 2020. As of September 30, 2020, the Company’s applicable subsidiaries were in compliance with all debt covenants under the Credit Agreement.

Other:

Other Notes Payable consist primarily of $26,300 of notes payable issued by New Valley. On December 31, 2018, New Valley acquired the remaining 29.41% interest in Douglas Elliman for a total purchase price of $40,000, which included $10,000 of cash paid and the remaining $30,000 of notes payable to the sellers. Interest on the outstanding principal balance of the notes accrued at the mid-term applicable federal rate (“AFR”) in effect as of December 31, 2018 until January 1, 2020 and thereafter is adjusted to the then-current AFR on each payment date. Principal and interest is payable in installments

through October 1, 2022. $3,750 of principal has been repaid through September 30, 2020 and the remaining principal is due to be repaid as follows: (1) $1,250 in the remainder of 2020; (2) $12,500 in 2021; and (3) $12,500 in 2022.

Non-Cash Interest Expense — Vector:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Amortization of debt discount, net	$	89	$	5,746	$	5,536	$	19,718
Amortization of debt issuance costs	847		1,089		2,894		3,327
	$	936	$	6,835	$	8,430	$	23,045

Fair Value of Notes Payable and Long-Term Debt:

	September 30, 2020				December 31, 2019
	Carrying		Fair		Carrying			Fair
	Value		Value		Value			Value
Senior Notes	$	1,401,868	$	1,419,309	$	1,401,608		$	1,409,920
Variable Interest Senior Convertible Debt	—		—		164,334			176,289
Liggett and other	26,867		26,878		65,445			65,456
Notes payable and long-term debt	$	1,428,735	$	1,446,187	$	1,631,387	(1)	$	1,651,665

______________________

(1) The carrying value does not include the carrying value of the embedded derivative. See Note 12.

Notes payable and long-term debt are carried on the condensed consolidated balance sheets at amortized cost. The fair value determinations disclosed above are classified as Level 2 under the fair value hierarchy disclosed in Note 12 if such liabilities were recorded on the condensed consolidated balance sheets at fair value. The estimated fair value of the Company’s notes payable and long-term debt has been determined by the Company using available market information and appropriate valuation methodologies including the evaluation of the Company’s credit risk as described in the Company’s Form 10-K. The Company used a derived price based upon quoted market prices and trade activity as of September 30, 2020 to determine the fair value of its publicly-traded notes and debentures. The carrying value of the revolving credit facility is equal to fair value. The fair value of the equipment loans and other obligations was determined by calculating the present value of the required future cash flows. However, considerable judgment is required to develop the estimates of fair value and, accordingly, the estimate presented herein is not necessarily indicative of the amount that could be realized in a current market exchange.

XML

Contingencies

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Contingencies

CONTINGENCIES

Tobacco-Related Litigation:

Overview. Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. The cases have generally fallen into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (“Individual Actions”); (ii) lawsuits by individuals requesting the benefit of the Engle ruling (“Engle progeny cases”); (iii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging that use of the terms “lights” and/or “ultra lights” constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (“Class Actions”); and (iv) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (“Health Care Cost Recovery Actions”). The future financial impact of the risks and expenses of litigation are not quantifiable. For the nine months ended September 30, 2020 and 2019, Liggett incurred tobacco product liability legal expenses and costs totaling $4,684 and $5,627, respectively. The tobacco product liability legal expenses and costs are included in the operating, selling, administrative and general expenses and litigation settlement and judgment expense line items in the condensed consolidated statements of operations. Legal defense costs are expensed as incurred.

Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending cases. With the commencement of new cases, the defense costs and the risks relating to the unpredictability of litigation increase. Management reviews on a quarterly basis with counsel all pending litigation and evaluates the probability of a loss being incurred and whether an estimate can be made of the possible loss or range of loss that could result from an unfavorable outcome. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. Damages awarded in tobacco-related litigation can be significant.

Bonds. Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that a majority of states now limit the dollar amount of bonds or require no bond at all. As of September 30, 2020, to obtain a stay of the judgment pending the appeal of the Santoro case, Liggett secured a $535 supersedeas bond.

In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny cases in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. The maximum amount of any such bond for an appeal in the Florida state courts will be no greater than $5,000. In several cases, plaintiffs challenged the constitutionality of the bond cap statute, but to date the courts have upheld the constitutionality of the statute. It is possible that the Company’s consolidated financial position, results of operations, and cash flows could be materially adversely affected by an unfavorable outcome of such challenges.

Accounting Policy. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as discussed in this Note 9: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to reasonably estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.

Although Liggett has generally been successful in managing the litigation filed against it, litigation is subject to uncertainty and significant challenges remain, including with respect to the remaining Engle progeny cases. There can be no assurances that Liggett’s past litigation experience will be representative of future results. Judgments have been entered against Liggett in the past, in Individual Actions and Engle progeny cases, and several of those judgments were affirmed on appeal and satisfied by Liggett. It is possible that the consolidated financial position, results of operations and cash flows of the Company could be materially adversely affected by an unfavorable outcome or settlement of any of the remaining smoking-related litigation. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are and will continue to be vigorously defended. Liggett has

entered into settlement discussions in individual cases or groups of cases where Liggett has determined it was in its best interest to do so, and it may continue to do so in the future. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.

Individual Actions

As of September 30, 2020, there were 70 Individual Actions pending against Liggett, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. The following table lists the number of Individual Actions by state:

State	Number of Cases
Florida	39
Illinois	11
Nevada	7
New Mexico	5
Virgin Islands	5
Louisiana	2
Massachusetts	1

The plaintiffs’ allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity, violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”), state RICO statutes and antitrust statutes. In many of these cases, in addition to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.

Defenses raised in Individual Actions include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, statute of repose, equitable defenses such as “unclean hands” and lack of benefit, failure to state a claim and federal preemption.

Engle Progeny Cases

In May 1994, the Engle case was filed as a class action against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, “have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking.” A trial was held and the jury returned a verdict adverse to the defendants (approximately $145,000,000 in punitive damages, including $790,000 against Liggett). Following an appeal to the Third District Court of Appeal, the Florida Supreme Court in July 2006 decertified the class on a prospective basis and affirmed the appellate court’s reversal of the punitive damages award. Former class members had until January 2008 to file individual lawsuits. As a result, Liggett and the Company, and other cigarette manufacturers, were sued in thousands of Engle progeny cases in both federal and state courts in Florida. Although the Company was not named as a defendant in the Engle case, it was named as a defendant in substantially all of the Engle progeny cases where Liggett was named as a defendant.

Cautionary Statement About Engle Progeny Cases. Since 2009, judgments have been entered against Liggett and other cigarette manufacturers in Engle progeny cases. A number of the judgments were affirmed on appeal and satisfied by the defendants. Many were overturned on appeal. As of September 30, 2020, 25 Engle progeny cases where Liggett was a defendant at trial resulted in verdicts.

There have been 16 verdicts returned in favor of the plaintiffs and nine in favor of Liggett. In five of the cases, punitive damages were awarded against Liggett. Several of the adverse verdicts were overturned on appeal and new trials were ordered. In certain cases, the judgments were entered jointly and severally with other defendants and Liggett may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate

or jury-allocated share of a judgment. As a result, under certain circumstances, Liggett may have to pay more than its proportionate share of any bonding or judgment related amounts. Except as discussed in this Note 9, management is unable to estimate the possible loss or range of loss from the remaining Engle progeny cases as there are currently multiple defendants in each case and, in most cases, discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are in fact Engle class members, the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify the amount of their demand for damages. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.

Engle Progeny Settlements.

In October 2013, the Company and Liggett entered into a settlement with approximately 4,900 Engle progeny plaintiffs and their counsel. Pursuant to the terms of the settlement, Liggett agreed to pay a total of approximately $110,000, with $61,600 paid in an initial lump sum and the balance of $48,000 to be paid in installments over 14 years starting in February 2015. In exchange, the claims of these plaintiffs were dismissed with prejudice against the Company and Liggett. The Company’s future payments will be approximately $3,400 per annum through 2028, with a cost of living increase beginning in 2021.

Liggett subsequently entered into two separate agreements with a total of 152 Engle progeny plaintiffs where Liggett paid a total of $23,150 to settle their claims. On an individual basis, Liggett settled an additional 201 Engle progeny cases for approximately $8,100 in the aggregate.

Notwithstanding the comprehensive nature of the Engle Progeny Settlements, 42 plaintiffs’ claims remain pending in state court. Therefore, the Company and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.

Judgments Paid in Engle Progeny Cases.

As of September 30, 2020, Liggett had paid in the aggregate $39,773, including interest and attorneys’ fees, to satisfy the judgments in the following Engle progeny cases: Lukacs, Campbell, Douglas, Clay, Tullo, Ward, Rizzuto, Lambert and Buchanan. An adverse verdict against Liggett for $265 in Santoro is currently on appeal.

Maryland Cases

Liggett was a defendant in 16 multi-defendant personal injury cases in Maryland alleging claims arising from asbestos and tobacco exposure (“synergy cases”). In July 2016, the Court of Appeals (Maryland’s highest court) ruled that joinder of tobacco and asbestos cases may be possible in certain circumstances, but plaintiffs must demonstrate at the trial court level how such cases may be joined while providing appropriate safeguards to prevent embarrassment, delay, expense or prejudice to defendants and “the extent to which, if at all, the special procedures applicable to asbestos cases should extend to tobacco companies.” The Court of Appeals remanded these issues to be determined at the trial court level. In June 2017, the trial court issued an order dismissing all synergy cases against the tobacco defendants, including Liggett, without prejudice. Plaintiffs may seek appellate review or file new cases against the tobacco companies.

Liggett Only Cases  

There are currently two cases where Liggett is the sole defendant: Cowart, a Florida Individual Action, and Tumin, an Engle progeny case. It is possible that cases where Liggett is the only defendant could increase as a result of the remaining Engle progeny cases and newly filed Individual Actions.

Class Actions

As of September 30, 2020, two actions were pending for which either a class had been certified or plaintiffs were seeking class certification where Liggett is a named defendant. Other cigarette manufacturers are also named in these two cases.

Plaintiffs’ allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.

Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption.

In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, allege they were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. A stay order entered on March 16, 2016 stays the case pending completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.

In February 1998, in Parsons v. AC & S Inc., a purported class action was commenced on behalf of all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy of three of the defendants.

Health Care Cost Recovery Actions

As of September 30, 2020, one Health Care Cost Recovery Action was pending against Liggett, Crow Creek Sioux Tribe v. American Tobacco Company, a South Dakota case filed in 1997, where the plaintiff seeks to recover damages from Liggett and other cigarette manufacturers based on various theories of recovery as a result of alleged sales of tobacco products to minors. The case is dormant.

The claims asserted in health care cost recovery actions vary, but can include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. Although no specific damage amounts are typically pleaded, it is possible that requested damages might be in the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was “unjustly enriched” by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.

Department of Justice Lawsuit

In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover, among other things, an unspecified amount of health care costs paid and to be paid by the federal government for smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants. In August 2006, the trial court entered a Final Judgment against each of the cigarette manufacturing defendants, except Liggett. The judgment was affirmed on appeal. As a result, the cigarette manufacturing defendants, other than Liggett, are now subject to the trial court’s Final Judgment which ordered, among other things, the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “lights” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to environmental tobacco smoke.

Upcoming Trials

As of September 30, 2020, there were three Individual Actions (Gordon, Baron and Feld) and one Engle progeny case (Blocker) scheduled for trial through September 30, 2021, where Liggett (and/or the Company) is a named defendant. Trial dates are subject to change and additional cases could be set for trial during this time.

MSA and Other State Settlement Agreements

In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors.

In November 1998, Philip Morris, R.J. Reynolds and two other companies (the “Original Participating Manufacturers” or “OPMs”) and Liggett and Vector Tobacco (together with any other tobacco product manufacturer that becomes a signatory, the “Subsequent Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are hereinafter referred to jointly as “PMs”)

entered into the Master Settlement Agreement (the “MSA”) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the “Settling States”) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State.

As a result of the MSA, the Settling States released Liggett and Vector Tobacco from:

•all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and

•all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business.

The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of PMs. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each PM to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits PMs from licensing third parties to advertise tobacco brand names in any manner prohibited under the MSA; and prohibits PMs from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities.

The MSA also requires PMs to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of PMs. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA.

Under the payment provisions of the MSA, PMs are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions including a “Non-Participating Manufacturers Adjustment” or “NPM Adjustment”). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each PM and are not the responsibility of any parent or affiliate of a PM.

Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. Liggett and Vector Tobacco’s domestic shipments accounted for approximately 4.0% of the total cigarettes sold in the United States in 2019. If Liggett’s or Vector Tobacco’s market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. On December 30, 2019, Liggett and Vector Tobacco pre-paid $140,000 of their approximate $169,000 2019 MSA obligation, the balance of which was paid in April 2020, subject to applicable disputes or adjustments.

Certain MSA Disputes

NPM Adjustment.  Liggett and Vector Tobacco contend that they are entitled to an NPM Adjustment for each year from 2003 - 2019. The NPM Adjustment is a potential adjustment to annual MSA payments, available when PMs suffer a market share loss to NPMs for a particular year and an economic consulting firm selected pursuant to the MSA determines (or the parties agree) that the MSA was a “significant factor contributing to” that loss. A Settling State that has “diligently enforced” its qualifying escrow statute in the year in question may be able to avoid its allocable share of the NPM Adjustment. For 2003 - 2019, Liggett and Vector Tobacco, as applicable, disputed that they owed the Settling States the NPM Adjustments as calculated by the independent auditor. As permitted by the MSA, Liggett and Vector Tobacco either paid subject to dispute, withheld payment, or paid into a disputed payment account, the amounts associated with these NPM Adjustments.

    In June 2010, after the PMs prevailed in 48 of 49 motions to compel arbitration, the parties commenced the arbitration for the 2003 NPM Adjustment. That arbitration concluded in September 2013. It was followed by various challenges filed in state courts by states that did not prevail in the arbitration. Those challenges resulted in reductions, but not elimination of, the amounts awarded.

    The PMs settled most of the disputed NPM Adjustment years with 37 states representing approximately 75% of the MSA share for 2003 - 2022. The 2004 NPM Adjustment arbitration commenced in 2016, with the final individual state hearings likely to occur in April 2021 and a second phase addressing the effect of the settlements to start thereafter. The parties have also selected an arbitration panel to address the NPM Adjustments for 2005-2007 and initial proceedings in that arbitration are likely to commence in 2021. A separate court proceeding regarding Montana remains pending.

As a result of the settlement charge and arbitration award described above, Liggett and Vector Tobacco reduced cost of sales for years 2013 - 2019 by $48,032 and by $3,899 for the three and nine months ended September 30, 2020. Liggett and Vector Tobacco may be entitled to further adjustments. As of September 30, 2020, Liggett and Vector Tobacco had accrued approximately $13,400 related to the disputed amounts withheld from the non-settling states for 2004 - 2010, which may be subject to payment, with interest, if Liggett and Vector Tobacco lose the disputes for those years. As of September 30, 2020, there remains approximately $41,500 in the disputed payments account relating to Liggett and Vector Tobacco’s 2011 - 2019 NPM Adjustment disputes with the non-settling states. If Liggett and Vector Tobacco lose the disputes for all or any of those years, pursuant to the MSA, no interest would be due on the amounts paid into the disputed payment account.

Other State Settlements.  The MSA replaced Liggett’s prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Except as described below, Liggett’s agreements with these states remain in full force and effect. These states’ settlement agreements with Liggett contained most favored nation provisions which could reduce Liggett’s payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on settlements or resolutions with United States Tobacco Company, Liggett’s payment obligations to those four states were eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each state’s respective settlement with the other major tobacco companies. Therefore, Liggett’s non-economic obligations to all states and territories are now defined by the MSA.

In 2003, as a result of a dispute with Minnesota regarding its settlement agreement, Liggett agreed to pay $100 a year in any year cigarettes manufactured by Liggett are sold in that state. Further, the Attorneys General for Florida, Mississippi and Texas advised Liggett that they believed Liggett had failed to make payments under the respective settlement agreements with those states. In 2010, Liggett settled with Florida and agreed to pay $1,200 and to make further annual payments of $250 for a period of 21 years, starting in March 2011, with the payments from year 12 forward being subject to an inflation adjustment.

In January 2016, the Attorney General for Mississippi filed a motion in Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement (the “1996 Agreement”) alleging that Liggett owes Mississippi at least $27,000 in compensatory damages and additional amounts for interest, punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the 1996 Agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded.  In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration as to two issues concerning damages and stayed the proceedings before the Special Master pending completion of the arbitration. In March 2019, the arbitration panel issued its final arbitration award on the two issues before it: (i) the panel ruled in favor of Liggett, finding that the $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income; and (ii) ruled in favor of Mississippi on the remaining issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement. Following confirmation of the arbitration award, Mississippi voluntarily dismissed with prejudice its claims for punitive damages and attorneys’ fees.

In July 2019, the parties stipulated that the unpaid principal (exclusive of interest) purportedly due from Liggett to Mississippi pursuant to the 1996 Agreement (from inception through 2019) is approximately $15,500, subject to Liggett’s right to litigate and/or appeal the enforceability of the 1996 Agreement (and all issues other than the calculation of such principal amount). In September 2019, the Special Master held a hearing regarding the state’s claim for approximately $17,500 in prejudgment interest as well as post-judgment interest in amounts to be determined. A decision is pending. Liggett continues to believe that the April 2017 Chancery Court order is in error because the most favored nations provision in the 1996 Agreement eliminated all of Liggett’s payment obligations to Mississippi, and it reserved all rights to appeal this and other issues at the conclusion of the case. In the event Liggett appeals an adverse judgment, the posting of a bond may be required.

Liggett may be required to make additional payments to Mississippi and Texas which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.

Cautionary Statement  

Management is not able to reasonably predict the outcome of the litigation pending or threatened against Liggett or the Company. Litigation is subject to many uncertainties. Liggett has been found liable in multiple Engle progeny cases and Individual Actions, several of which were affirmed on appeal and satisfied by Liggett. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may attempt to settle particular cases if it believes it is in its best interest to do so.

Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that Liggett may not be able to meet those requirements. An unfavorable outcome of a pending smoking-related case could encourage the commencement of additional litigation. Except as discussed in this Note 9, management is unable to estimate the loss or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its consolidated financial statements for unfavorable outcomes.

The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional litigation or legislation.

It is possible that the Company’s consolidated financial position, results of operations and cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation.

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2020 was as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2020	$	34,116	$	4,249	$	38,365	$	17,275	$	20,594	$	37,869
Expenses	139,393		28		139,421		—		—		—
Change in MSA obligations capitalized as inventory	32		—		32		—		—		—
Payments	(27,214)		(4,324)		(31,538)		—		—		—
Reclassification to/(from) non-current liabilities	(855)		3,252		2,397		855		(3,252)		(2,397)
Interest on withholding	—		330		330		—		1,422		1,422
Balance as of September 30, 2020	$	145,472	$	3,535	$	149,007	$	18,130	$	18,764	$	36,894

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2019 were as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2019	$	36,561	$	310	$	36,871	$	16,383	$	21,794	$	38,177
Expenses	125,911		895		126,806		—		—		—
Change in MSA obligations capitalized as inventory	2,756		—		2,756		—		—		—
Payments	(31,959)		(355)		(32,314)		—		—		—
Reclassification to/(from) non-current liabilities	(892)		3,338		2,446		892		(3,338)		(2,446)
Interest on withholding	—		187		187		—		1,600		1,600
Balance as of September 30, 2019	$	132,377	$	4,375	$	136,752	$	17,275	$	20,056	$	37,331

Other Matters:

Liggett’s and Vector Tobacco’s management are unaware of any material environmental conditions affecting their existing facilities. Liggett’s and Vector Tobacco’s management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material impact on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco.

Liggett and the Company have received three separate demands for indemnification from Altria Client Services, on behalf of Philip Morris, relating to lawsuits alleging smokers’ use of L&M cigarettes. The indemnification demands are purportedly issued in connection with Eve Holdings’ 1999 sale of certain brands to Philip Morris.

In addition to the foregoing, Douglas Elliman and certain of its subsidiaries are subject to numerous proceedings, lawsuits and claims in connection with their ordinary business activities. Many of these matters are covered by insurance or, in some cases, the Company is indemnified by third parties.

Management is of the opinion that the liabilities, if any, resulting from other proceedings, lawsuits and claims pending against the Company and its consolidated subsidiaries, unrelated to tobacco product liability, should not materially affect the Company’s consolidated financial position, results of operations or cash flows.

XML

Goodwill and Other Intangible Assets

9 Months Ended

Sep. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

The components of Goodwill and other intangible assets, net were as follows:

	December 31, 2019		Impairment Losses		Amortization		September 30, 2020
Goodwill	$	78,008	$	(46,252)	$	—	$	31,756
Indefinite life intangibles:
Intangible asset associated with benefit under the MSA	107,511		—		—		107,511
Trademark - Douglas Elliman	80,000		(12,000)		—		68,000
Intangibles with a finite life, net	474		—		(123)		351
Total goodwill and other intangible assets, net	$	265,993	$	(58,252)	$	(123)	$	207,618

Goodwill is evaluated for impairment annually or whenever the Company identifies certain triggering events or circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Events or circumstances that might indicate an interim evaluation is warranted include, among other things, unexpected adverse business conditions, macro and reporting unit specific economic factors (for example, interest rate and foreign exchange rate fluctuations, and loss of key personnel), supply costs, unanticipated competitive activities, and acts by governments and courts.

During the first quarter of 2020, the Company determined that a triggering event occurred related to the Douglas Elliman reporting unit due to a decline in sales and profitability projections for the reporting unit driven by the COVID-19 pandemic and related economic disruption. The Company utilized third-party valuation specialists to prepare a quantitative assessment of goodwill and trademark intangible asset related to Douglas Elliman.

For the goodwill testing, the Company utilized an income approach (a discounted cash flows “DCF” method) to estimate the fair value of the Douglas Elliman business. The estimated fair value of the trademark indefinite-life intangible asset related to the Douglas Elliman brand name was determined using an approach that values the Company’s cash savings from having a royalty-free license compared to the market rate it would pay for access to use the trade name.

The third-party quantitative assessments of the goodwill and trademark intangible asset reflected management’s assumptions regarding revenue growth rates, economic and market trends including current expectations of deterioration resulting from the COVID-19 pandemic, changes to cost structures and other expectations about the anticipated short-term and long-term operating results of Douglas Elliman. The quantitative assessments resulted in impairment charges to goodwill of $46,252 and to the trademark intangible asset of $12,000. If the Company fails to achieve the financial projections used in the quantitative assessments of fair value or the impacts of COVID-19 are more severe than expected, additional impairment charges could result in future periods, and such impairment charges could be material.

XML

Income Taxes

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The Company’s effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets, and any tax planning opportunities available to the Company. For interim financial reporting, the Company estimates the annual effective income tax rate based on full year projections and applies the annual effective income tax rate against year-to-date pretax income to record income tax expense, adjusted for discrete items, if any. The Company refines annual estimates as new information becomes available. The Company’s tax rate does not bear a relationship to statutory tax rates due to permanent differences, which are primarily related to nondeductible compensation, and state taxes.

The Company’s income tax expense consisted of the following:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Income before provision for income taxes	$	55,962	$	49,744	$	88,443	$	128,292
Income tax expense using estimated annual effective income tax rate	16,784		14,844		26,497		38,378
Changes in effective tax rates	66		(785)		—		—
Impact of discrete items, net	973		(323)		1,264		(434)
Income tax expense	$	17,823	$	13,736	$	27,761	$	37,944

The discrete items for the three months ended September 30, 2020 relate to income tax expense related to changes in value of certain contingent consideration and stock-based compensation. The discrete items for the nine months ended September 30, 2020 relate to income tax expense related to the equity in earnings from investments associated with the one-time gain on sale of LTS partially offset by the goodwill and trademark impairment charges, changes in value of certain contingent consideration, and stock-based compensation. The discrete items for the three and nine months ended September 30, 2019 are related to the release of certain valuation allowances offset by income tax expense related to state tax audits and stock-based compensation.

On March 27, 2020, the President of the United States signed the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act into law. The Act includes several significant tax and payroll-related provisions for corporations, including the usage of net operating losses, bonus depreciation, interest expense, and certain payroll benefits. The Company continues to evaluate the impact this Act will have on its financial statements and required disclosures.

XML

Investments and Fair Value Measurements

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Investments and Fair Value Measurements

INVESTMENTS AND FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities subject to fair value measurements were as follows:

	Fair Value Measurements as of September 30, 2020
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	373,030	$	373,030	$	—	$	—
Commercial paper (1)	39,884		—		39,884		—
Certificates of deposit (2)	2,108		—		2,108		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	11,897		11,897		—		—
Mutual funds invested in debt securities	22,956		22,956		—		—
Total equity securities at fair value	34,853		34,853		—		—
Debt securities available for sale
U.S. government securities	11,412		—		11,412		—
Corporate securities	58,481		—		58,481		—
U.S. government and federal agency	5,759		—		5,759		—
Commercial paper	13,587		—		13,587		—
Total debt securities available for sale	89,239		—		89,239		—
Total investment securities at fair value	124,092		34,853		89,239		—
Long-term investments
Long-term investment securities at fair value (3)	31,619		—		—		—
Total	$	571,268	$	408,418	$	131,231	$	—
Liabilities:
Fair value of contingent liability	$	1,064	$	—	$	—	$	1,064
Total	$	1,064	$	—	$	—	$	1,064

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $7,224 that is included in Other current assets and $1,907 that is included in Other assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

	Fair Value Measurements as of December 31, 2019
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	307,655	$	307,655	$	—	$	—
Commercial paper (1)	47,328		—		47,328		—
Certificates of deposit (2)	2,193		—		2,193		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	23,819		23,819		—		—
Mutual funds invested in debt securities	22,377		22,377		—		—
Total equity securities at fair value	46,196		46,196		—		—
Debt securities available for sale
U.S. government securities	14,660		—		14,660		—
Corporate securities	54,413		—		54,413		—
U.S. government and federal agency	6,816		—		6,816		—
Commercial mortgage-backed securities	382		—		382		—
Commercial paper	5,887		—		5,887		—
Index-linked U.S. bonds	779		—		779		—
Foreign fixed-income securities	508		—		508		—
Total debt securities available for sale	83,445		—		83,445		—
Total investment securities at fair value	129,641		46,196		83,445		—
Long-term investments
Long-term investment securities at fair value (3)	45,781		—		—		—
Total	$	533,133	$	354,386	$	132,966	$	—
Liabilities:
Fair value of contingent liability	$	3,147	$	—	$	—	$	3,147
Fair value of derivatives embedded within convertible debt	4,999		—		—		4,999
Total	$	8,146	$	—	$	—	$	8,146

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $4,423 that is included in current restricted assets and $3,160 that is included in non-current restricted assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

The fair value of the Level 2 certificates of deposit is based on the discounted value of contractual cash flows. The discount rate is the rate offered by the financial institution. The fair value of investment securities at fair value included in Level 1 is based on quoted market prices from various stock exchanges. The Level 2 investment securities at fair value are

based on quoted market prices of securities that are thinly traded, quoted prices for identical or similar assets in markets that are not active or inputs other than quoted prices such as interest rates and yield curves.

The long-term investments are based on NAV per share provided by the partnerships based on the indicated market value of the underlying assets or investment portfolio. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed above because they are measured at fair value using the NAV practical expedient.

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at September 30, 2020:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	September 30, 2020		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of contingent liability	$	1,064	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	169,000
				Risk-free rate for a 2.50 year term	0.14		%
				Leverage-adjusted equity volatility of peer firms	70.78		%

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at December 31, 2019:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2019		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of derivatives embedded within convertible debt	$	4,999	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed remaining cash dividends - Q4 2019 and Q1 2020	$0.40/$0.20
				Stock price	$	13.39
				Convertible trading price (as a percentage of par value)	103.94		%
				Volatility	36.94		%
				Risk-free rate	Term structure of US Treasury Securities
				Implied credit spread	1.0% - 3.0% (2.0%)
Fair value of contingent liability	$	3,147	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	271,500
				Risk-free rate for a 3-year term	1.61		%
				Leverage-adjusted equity volatility of peer firms	35.56		%

In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. The Company had no nonrecurring nonfinancial assets subject to fair value measurements as of September 30, 2020 and December 31, 2019, respectively, except for investments in real estate ventures that were impaired as of September 30, 2020 and December 31, 2019.

The Company’s investments in real estate ventures subject to nonrecurring fair value measurements are as follows:

			Fair Value Measurement Using:
	Three Months Ended September 30, 2020				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	6,617	$	6,901	$	—	$	—	$	6,901

The Company estimated the fair value of its investments in real estate ventures using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the investments in real estate ventures was attributed to the decline in the projected sales prices of the respective real estate venture. The $6,617 of impairment charges were included in equity in losses from real estate ventures for the three months September 30, 2020.

			Fair Value Measurement Using:
	Year Ended December 31, 2019				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	39,757	$	18,335	$	—	$	—	$	18,335

The Company estimated the fair value of its investments in real estate ventures using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the investments in real estate ventures was attributed to the decline in the projected sales prices and the duration of the estimated sell out of the respective real estate ventures. The $39,757 of impairment charges were included in equity in losses from real estate ventures for the year ended December 31, 2019.

XML

Segment Information

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

The Company’s business segments for the three and nine months ended September 30, 2020 and 2019 were Tobacco and Real Estate. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Financial information for the Company’s operations before taxes and non-controlling interests for the three and nine months ended September 30, 2020 and 2019 were as follows:

				Real			Corporate
	Tobacco			Estate			and Other		Total
Three months ended September 30, 2020
Revenues	$	318,850		$	228,981		$	—	$	547,831
Operating income (loss)	91,319		(1)	10,850		(2)	(6,252)		95,917
Equity in losses from real estate ventures	—			(8,536)			—		(8,536)
Depreciation and amortization	1,965			2,167			214		4,346
Three months ended September 30, 2019
Revenues	$	303,260		$	201,530		$	—	$	504,790
Operating income (loss)	72,799		(3)	628			(6,707)		66,720
Equity in earnings from real estate ventures	—			8,050			—		8,050
Depreciation and amortization	1,941			2,240			249		4,430
Nine months ended September 30, 2020
Revenues	$	918,429		$	529,650		$	—	$	1,448,079
Operating income (loss)	239,814		(4)	(63,500)		(5)	(18,504)		157,810
Equity in losses from real estate ventures	—			(27,301)			—		(27,301)
Depreciation and amortization	6,007			6,678			648		13,333
Capital expenditures	3,644			5,160			20		8,824
Nine months ended September 30, 2019
Revenues	$	854,517		$	609,629		$	—	$	1,464,146
Operating income (loss)	201,594		(6)	4,672			(20,712)		185,554
Equity in earnings from real estate ventures	—			12,002			—		12,002
Depreciation and amortization	5,848			6,765			749		13,362
Capital expenditures	3,425			6,733			—		10,158

(1) Operating income includes $286 of expense from MSA settlement.

(2) Operating income includes $320 of restructuring charges.

(3) Operating income includes $240 of litigation settlement and judgment expense.

(4) Operating income includes $286 of expense from MSA settlement and $53 of litigation settlement and judgment expense.

(5) Operating loss includes $58,252 of impairment charges related to the impairments of goodwill and intangible assets and $3,281 of restructuring charges.

(6) Operating income includes $895 of litigation settlement and judgment expense.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation:

The condensed consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.

Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Liggett Vector Brands coordinates Liggett and Vector Tobacco’s sales and marketing efforts. Certain references to “Liggett” refer to the Company’s tobacco operations, including the business of Liggett and Vector Tobacco, unless otherwise specified. New Valley is engaged in the real estate business.

Basis of Accounting

The unaudited, interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair statement of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”). The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year.

Distributions and Dividends on Common Stock

Distributions and Dividends on Common Stock: The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital to the extent paid-in-capital is available and then to accumulated deficit. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all periods presented.

Earnings Per Share (“EPS”)

Earnings Per Share (“EPS”):

Restructuring

Restructuring:In response to the current novel coronavirus pandemic (“COVID-19”), the Company's Real Estate segment, including Douglas Elliman, has commenced a restructuring by realigning its administrative support function and office locations as well as adjusting its business model to more efficiently serve its clients.

Investments in Real Estate Ventures

Investments in Real Estate Ventures:

In accounting for its investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as (a) entities in which the equity investment at risk is not sufficient to finance its activities without additional subordinated financial support; (b) as a group, the equity investors at risk lack 1) the power to direct the activities of a legal entity that most significantly impact the entity’s economic performance, 2) the obligation to absorb the expected losses of the entity, or 3) the right to receive the expected residual returns of the entity; or (c) as a group, the equity investors have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.

The Company’s interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).

Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company’s maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the VIE, any unfunded capital commitments to the VIE, and, in some cases, guarantees in connection with debt on the specific project. The Company’s maximum exposure to loss in its investment in consolidated VIEs is limited to its investment, which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary. On a quarterly basis, the Company evaluates its investments in real estate ventures to determine if there are indicators of impairment. If so, the Company further investigates to determine if an impairment has occurred and whether such impairment is considered temporary or other than temporary. The Company believes that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven.

Restricted Cash

Amounts included in current restricted assets and non-current restricted assets represent cash and cash equivalents required to be deposited into escrow for bonds required to appeal adverse product liability judgments, amounts required for letters of credit related to office leases, and certain deposit requirements for banking arrangements. The restrictions related to the appellate bonds will remain in place until the appeal process has been completed. The restrictions related to the letters of credit will remain in place for the duration of the respective lease. The restrictions related to the banking arrangements will remain in place for the duration of the arrangement.

New Accounting Pronouncements

New Accounting Pronouncements:

In March 2020, the Securities and Exchange Commission (“SEC”) adopted final rules that amend the financial disclosure requirement for guarantors of registered debt securities in Rule 3-10 of Regulation S-X. The new Rule 13-01 of Regulation S-X amends and streamlines the disclosures required by guarantors and issuers of guaranteed securities. Among other things, the new disclosures may be located outside the financial statements. The new rule is effective January 4, 2021, and early adoption is permitted. The Company elected to early adopt the new rule on September 30, 2020. Accordingly, the revised condensed consolidating financial information is presented in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations.

Accounting Standards Updates (“ASU”) adopted in 2020:

In October 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities. The guidance requires indirect interests

held through related parties under common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. The ASU eliminates disclosures such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The ASU also adds new disclosure requirements for Level 3 measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of ASU 2018-13 impacted financial statement disclosure and had no impact on operating results.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), sets forth a current expected credit loss model that changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This guidance is effective for fiscal years beginning after December 15, 2019.

The ASU introduces a new accounting model, the Current Expected Credit Losses model (CECL), which requires earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for notes and other receivables at the time the financial asset is originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaced the previous impairment models in U.S. GAAP, which generally required that a loss be incurred before it is recognized. The new standard applies to receivables arising from revenue transactions such as contract assets and accounts receivables. The adoption of this standard resulted in an increase in stockholders’ deficiency of $2,263, net of tax, attributed to commercial real estate term loans allowance for credit losses of $3,100 as of January 1, 2020.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. Under the amendments of the ASU, an entity should recognize an impairment charge for the amount by which the carrying amount of a reporting unit exceeds its fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendments in this update are effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. This guidance was adopted on January 1, 2020, on a prospective basis. The Company applied the new guidance to evaluate its goodwill during the first quarter of 2020. As a result, a goodwill impairment charge of $46,252 was recorded as the Company's estimated fair value of a reporting unit was less than its book value.

ASUs to be adopted in future periods:

In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans (“ASU 2018-14”). ASU 2018-14 eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. ASU 2018-14 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company will adopt for the period

ending December 31, 2020. The adoption of ASU 2018-14 will impact financial statement disclosure with no impact on operating results.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). This update simplifies various aspects related to accounting for income taxes, removes certain exceptions to the general principles in Accounting Standards Codification (“ASC”) 740, and clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In January 2020, the FASB issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted, including early adoption in an interim period. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements and related disclosures.

In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This ASU is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance is effective for all entities for contract modifications beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The Company has not yet determined the extent to which it will utilize these expedients and exceptions should a modification occur. The Company is currently evaluating the impact of the new guidance on its condensed consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Net income for purposes of determining basic and diluted EPS

Net income for purposes of determining basic EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	84,216

Net income for purposes of determining diluted EPS was as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net income attributed to Vector Group Ltd.	$	38,139	$	36,008	$	60,682	$	90,268
Income attributable to 7.5% Variable Interest Senior Convertible Notes	—		—		—		(1,246)
Income attributed to participating securities	(708)		(2,023)		(1,976)		(6,052)
Net income applicable to common shares attributed to Vector Group Ltd.	$	37,431	$	33,985	$	58,706	$	82,970

Basic and diluted EPS calculation shares

Basic and diluted EPS were calculated using the following common shares:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2020	2019	2020	2019
Weighted-average shares for basic EPS	152,216,118	146,703,766	149,541,642	146,562,252
Plus incremental shares related to convertible debt	—	—	—	961,191
Plus incremental shares related to stock options and non-vested restricted stock	8,470	32,374	32,007	13,782
Weighted-average shares for diluted EPS	152,224,588	146,736,140	149,573,649	147,537,225

Outstanding shares not included in the computation of diluted EPS

The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three and nine months ended September 30, 2020 and 2019, but were not included in the computation of diluted EPS because the impact of the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods and the common shares issuable under the convertible debt were anti-dilutive to EPS.

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Weighted-average shares of non-vested restricted stock	612,538		1,012,285		555,918		1,274,549
Weighted-average expense per share	$	18.29	$	18.03	$	19.54	$	17.95
Weighted-average number of shares issuable upon conversion of debt	—		11,447,061		3,237,522		11,447,061
Weighted-average conversion price	$	—	$	20.27	$	20.27	$	20.27

Summary of restructuring charges

The following table summarizes amounts expensed for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Cash Charges:
Employee severance and benefits	$	186	$	1,785
Other restructuring expenses	64		282
	250		2,067
Non-Cash:
Loss on fixed assets associated with consolidation of sales offices	70		1,214
	70		1,214
Total restructuring charges	$	320	$	3,281

The following table presents the activity under the Real Estate segment restructuring plan for the nine months ended September 30, 2020:

	Employee Severance and Benefits		Other		Non-Cash Loss on Fixed Assets		Total
Accrual balance as of January 1, 2020	$	—	$	—	$	—	$	—
Restructuring charges	1,785		282		1,214		3,281
Utilized	(1,735)		(282)		(1,214)		(3,231)
Accrual balance as of September 30, 2020	$	50	$	—	$	—	$	50

Schedule of other income (loss), net

Other, net consisted of:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Interest and dividend income	$	1,251	$	3,083	$	5,331	$	9,430
Net gains (losses) recognized on investment securities	2,516		(1,487)		(4,943)		5,601
Net periodic benefit cost other than the service costs	(452)		(576)		(1,361)		(1,692)
Credit loss expense	(8,576)		—		(9,008)		—
Other income	165		1,203		1,865		1,105
Other, net	$	(5,096)	$	2,223	$	(8,116)	$	14,444

Schedule of other assets

Other assets consisted of:

	September 30, 2020		December 31, 2019
Restricted assets	$	4,008	$	5,241
Prepaid pension costs	32,467		31,686
Equity-method investments	16,240		15,942
Contract assets, net	26,083		18,443
Other assets	36,250		48,778
Total other assets	$	115,048	$	120,090

Schedule of other current liabilities

Other current liabilities consisted of:

	September 30, 2020		December 31, 2019
Accounts payable	$	11,962	$	10,222
Accrued promotional expenses	45,966		35,900
Accrued excise and payroll taxes payable, net	2,817		18,653
Accrued interest	33,159		35,756
Commissions payable	28,972		18,378
Accrued salary and benefits	19,059		29,464
Contract liabilities	9,725		9,358
Allowance for sales returns	7,857		7,785
Other current liabilities	34,511		23,801
Total other current liabilities	$	194,028	$	189,317

Schedule of components of cash, cash equivalents and restricted cash

The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:

	September 30, 2020		December 31, 2019
Cash and cash equivalents	$	451,071	$	371,341
Restricted cash and cash equivalents included in other current assets	7,224		4,423
Restricted cash and cash equivalents included in other assets	2,461		3,712
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$	460,756	$	379,476

XML

Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

In the following table, revenue is disaggregated by major product line for the Tobacco segment:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Tobacco Segment Revenues:
Core Discount Brands - Eagle 20’s, Pyramid, Montego, Grand Prix, Liggett Select, and Eve	$	300,487	$	283,621	$	864,880	$	798,272
Other Brands	18,363		19,639		53,549		56,245
Total tobacco revenues	$	318,850	$	303,260	$	918,429	$	854,517

In the following table, revenue is disaggregated by major services line and primary geographical market for the Real Estate segment:

	Three months ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	43,039	$	58,909	$	43,883	$	42,000	$	187,831
Commission and other brokerage income - development marketing	4,571		—		5,564		534		10,669
Property management revenue	8,334		250		—		—		8,584
Title fees	358		554		—		—		912
Total Douglas Elliman revenue	56,302		59,713		49,447		42,534		207,996
Other real estate revenues	—		20,500		—		485		20,985
Total real estate revenues	$	56,302	$	80,213	$	49,447	$	43,019	$	228,981

	Three months ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	73,081	$	47,066	$	25,008	$	27,770	$	172,925
Commission and other brokerage income - development marketing	6,920		—		7,614		3,992		18,526
Property management revenue	8,484		184		—		—		8,668
Title fees	—		1,049		—		—		1,049
Total Douglas Elliman revenue	88,485		48,299		32,622		31,762		201,168
Other real estate revenues	—		—		—		362		362
Total real estate revenues	$	88,485	$	48,299	$	32,622	$	32,124	$	201,530

	Nine Months Ended September 30, 2020
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	129,009	$	129,264	$	97,293	$	87,724	$	443,290
Commission and other brokerage income - development marketing	18,195		—		15,033		1,202		34,430
Property management revenue	25,513		682		—		—		26,195
Title fees	1,425		1,186		—		—		2,611
Total Douglas Elliman revenue	174,142		131,132		112,326		88,926		506,526
Other real estate revenues	—		20,500		—		2,624		23,124
Total real estate revenues	$	174,142	$	151,632	$	112,326	$	91,550	$	529,650

	Nine Months Ended September 30, 2019
	New York City		Northeast		Southeast		West		Total
Real Estate Segment Revenues:
Commission and other brokerage income - existing home sales	$	243,061	$	118,057	$	79,303	$	77,952	$	518,373
Commission and other brokerage income - development marketing	41,024		—		10,680		4,021		55,725
Property management revenue	26,699		538		—		—		27,237
Title fees	—		4,682		—		—		4,682
Total Douglas Elliman revenue	310,784		123,277		89,983		81,973		606,017
Other real estate revenues	—		—		—		3,612		3,612
Total real estate revenues	$	310,784	$	123,277	$	89,983	$	85,585	$	609,629

Contract Balances

The following table provides information about contract assets and contract liabilities from development marketing and commercial leasing contracts with customers:

	September 30, 2020		December 31, 2019
Receivables, which are included in accounts receivable - trade, net	$	2,194	$	2,129
Contract assets, net, which are included in other current assets	5,965		8,766
Payables, which are included in other current liabilities	1,544		1,663
Contract liabilities, which are included in other current liabilities	9,725		9,358
Contract assets, net, which are included in other assets	26,083		18,443
Contract liabilities, which are included in other liabilities	28,304		29,045

XML

Current Expected Credit Losses (Tables)

9 Months Ended

Sep. 30, 2020

Credit Loss [Abstract]

Rollforward of Allowance for Credit Losses

The following is the rollforward of the allowance for credit losses for the nine months ended September 30, 2020:

	January 1, 2020		Current Period Provision			Write-offs		Recoveries		September 30, 2020
Allowance for credit losses:
Real estate broker agent receivables	$	6,132	$	1,724	(1)	$	141	$	—	7,715
New Valley term loan receivables	3,100		9,008		(2)	—		—		12,108

______________________

(1) The bad debt expense related to the real estate broker agent receivables is included in Operating, selling, administrative and general expenses on the condensed consolidated statements of operations.

(2) The credit losses related to the New Valley term loan receivables are included in Other, net on the condensed consolidated statements of operations.

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2020

Leases [Abstract]

Lease Expense and Supplemental Cash Flow Information

The components of lease expense were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Operating lease cost	$	9,475	$	9,707	$	28,255	$	28,212
Short-term lease cost	218		397		1,007		910
Variable lease cost	663		715		1,818		2,405
Finance lease cost:
Amortization	17		67		94		186
Interest on lease liabilities	4		5		11		12
Total lease cost	$	10,377	$	10,891	$	31,185	$	31,725

Supplemental cash flow information related to leases was as follows:

	Nine Months Ended
	September 30,
	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	19,376	$	28,023
Operating cash flows from finance leases	11		12
Financing cash flows from finance leases	86		182
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	13,711		32,511
Finance leases	60		159

Supplemental Balance Sheet Information

Supplemental balance sheet information related to leases was as follows:

	September 30,			December 31,
	2020			2019
Operating leases:
Operating lease right-of-use assets	$	147,959		$	149,578
Current operating lease liability	$	22,485		$	18,294
Non-current operating lease liability	159,200			156,963
Total operating lease liabilities	$	181,685		$	175,257
Finance leases:
Investments in real estate, net (1)	$	73		$	88
Property, plant and equipment, at cost	$	127		$	127
Accumulated amortization	(38)			(19)
Property and equipment, net	$	89		$	108
Current portion of notes payable and long-term debt	$	59		$	86
Notes payable, long-term debt and other obligations, less current portion	110			108
Total finance lease liabilities	$	169		$	194
Weighted average remaining lease term:
Operating leases	8.09			8.46
Finance leases	2.90			3.01
Weighted average discount rate:
Operating leases	9.28		%	10.75		%
Finance leases	7.75		%	8.61		%

(1)     Included in Investments in real estate, net on the condensed consolidated balance sheets are financing lease equipment, at cost of $748 and $762 and accumulated amortization of $675 and $674 as of September 30, 2020 and December 31, 2019, respectively.

Maturities of Operating Lease Liabilities

As of September 30, 2020, maturities of lease liabilities were as follows:

	Operating Leases		Finance Leases
Period Ending December 31:
Remainder of 2020	$	6,496	$	19
2021	41,353		66
2022	36,892		61
2023	32,417		35
2024	26,749		8
2025	21,797		—
Thereafter	96,556		—
Total lease payments	262,260		189
Less imputed interest	(80,575)		(20)
Total	$	181,685	$	169

Maturities of Financing Lease Liabilities

As of September 30, 2020, maturities of lease liabilities were as follows:

	Operating Leases		Finance Leases
Period Ending December 31:
Remainder of 2020	$	6,496	$	19
2021	41,353		66
2022	36,892		61
2023	32,417		35
2024	26,749		8
2025	21,797		—
Thereafter	96,556		—
Total lease payments	262,260		189
Less imputed interest	(80,575)		(20)
Total	$	181,685	$	169

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of:

	September 30, 2020		December 31, 2019
Leaf tobacco	$	42,448	$	44,516
Other raw materials	5,733		4,669
Work-in-process	645		333
Finished goods	67,211		71,183
Inventories at current cost	116,037		120,701
LIFO adjustments	(21,489)		(21,939)
	$	94,548	$	98,762

XML

Investment Securities (Tables)

9 Months Ended

Sep. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Investment Securities at Fair Value

Investment securities consisted of the following:

	September 30, 2020		December 31, 2019
Debt securities available for sale	$	89,239	$	83,445
Equity securities at fair value:
Marketable equity securities	11,897		23,819
Mutual funds invested in debt securities	22,956		22,377
Long-term investment securities at fair value (1)	31,619		45,781
Total equity securities at fair value	66,472		91,977
Total investment securities at fair value	155,711		175,422
Less:
Long-term investment securities at fair value	31,619		45,781
Current investment securities at fair value	124,092		129,641
Equity-method investments	$	16,240	$	15,942

(1) These assets are measured at net asset value (“NAV”) as a practical expedient under ASC 820.

Net gains (losses) recognized on investment securities were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Net gains (losses) recognized on debt securities available for sale	22		25		(25)		67
Impairment expense	(22)		(6)		(408)		(11)
Net gains (losses) recognized on investment securities	$	2,516	$	(1,487)	$	(4,943)	$	5,601

The components of debt securities available for sale at September 30, 2020 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	88,336	$	903	$	—	$	89,239

The components of debt securities available for sale at December 31, 2019 were as follows:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable debt securities	$	82,714	$	731	$	—	$	83,445

Schedule of Maturity Dates of Fixed Income Securities

The table below summarizes the maturity dates of debt securities available for sale at September 30, 2020.

Investment Type:	Fair Value		Under 1 Year		1 Year up to 5 Years		More than 5 Years
U.S. Government securities	$	11,412	$	9,068	$	2,344	$	—
Corporate securities	58,481		28,863		29,618		—
U.S. mortgage-backed securities	5,759		114		5,645		—
Commercial paper	13,587		13,587		—		—
Total debt securities available for sale by maturity dates	$	89,239	$	51,632	$	37,607	$	—

Schedule of Realized Gains (Losses)

Gross realized gains and losses on debt securities available for sale were as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Gross realized gains on sales	$	23	$	27	$	193	$	74
Gross realized losses on sales	(1)		(2)		(218)		(7)
Net gains (losses) recognized on debt securities available for sale	$	22	$	25	$	(25)	$	67
Impairment expense	$	(22)	$	(6)	$	(408)	$	(11)

Equity Securities at Fair Value

The following is a summary of unrealized and realized net gains and losses recognized in net income on equity securities at fair value during the three and nine months ended September 30, 2020 and 2019, respectively:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net gains (losses) recognized on equity securities	$	2,516	$	(1,506)	$	(4,510)	$	5,545
Less: Net (losses) gains recognized on equity securities sold	(2)		58		(19)		468
Net unrealized gains (losses) recognized on equity securities still held at the reporting date	$	2,518	$	(1,564)	$	(4,491)	$	5,077

Equity Method Investments

Equity-method investments consisted of the following:

	September 30, 2020		December 31, 2019
Mutual fund and hedge funds	$	16,240	$	15,509
Ladenburg Thalmann Financial Services Inc. (“LTS”)	—		433
	$	16,240	$	15,942

Equity in earnings (losses) from investments were:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Mutual fund and hedge funds	$	1,468	$	(632)	$	775	$	(20)
LTS	372		139		53,424		(846)
Other	—		25		—		75
Equity in earnings (losses) from investments	$	1,840	$	(468)	$	54,199	$	(791)

XML

New Valley LLC (Tables)

9 Months Ended

Sep. 30, 2020

Real Estate [Abstract]

Investments in real estate ventures

The components of “Investments in real estate ventures” were as follows:

	Range of Ownership (1)	September 30, 2020		December 31, 2019
Condominium and Mixed Use Development:
New York City Standard Metropolitan Statistical Area (“SMSA”)	3.1% - 49.5%	$	36,252	$	51,078
All other U.S. areas	15.0% - 77.8%	41,403		55,842
		77,655		106,920
Hotels:
New York City SMSA	1.0% - 18.4%	2,892		2,462
International	49.0%	1,767		2,161
		4,659		4,623
Commercial:
New York City SMSA	49.0%	2,271		1,852
All other U.S. areas	1.6%	6,987		7,634
		9,258		9,486
Other:	15.0% - 49.0%	10,886		10,527
Investments in real estate ventures		$	102,458	$	131,556

______________________

(1) The Range of Ownership reflects New Valley’s estimated current ownership percentage. New Valley’s actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.

Contributions:

The components of New Valley’s contributions to its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,169	$	21,760
All other U.S. areas	4,176		14,000
	5,345		35,760
Apartment Buildings:
All other U.S. areas	76		—
	76		—
Hotels:
New York City SMSA	294		172
	294		172
Other:	524		337
Total contributions	$	6,239	$	36,269

Distributions:

The components of distributions received by New Valley from its investments in real estate ventures were as follows:

	Nine Months Ended
	September 30,
	2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	1,735	$	3,380
All other U.S. areas	11,060		1,279
	12,795		4,659
Apartment Buildings:
All other U.S. areas	—		79
	—		79
Hotels:
New York City SMSA	—		21,572
	—		21,572
Commercial:
New York City SMSA	591		13
All other U.S. areas	113		160
	704		173
Other	26		8,088
Total distributions	$	13,525	$	34,571

Equity in (Losses) Earnings from Real Estate Ventures:

New Valley recognized equity in (losses) earnings from real estate ventures as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Condominium and Mixed Use Development:
New York City SMSA	$	(6,835)	$	2,099	$	(15,286)	$	(1,127)
All other U.S. areas (1)	(618)		4,600		(9,906)		2,234
	(7,453)		6,699		(25,192)		1,107
Apartment Buildings:
All other U.S. areas (1)	(208)		76		(284)		79
	(208)		76		(284)		79
Hotels:
New York City SMSA (1)	(1,119)		(102)		(1,768)		8,132
International	157		434		(394)		70
	(962)		332		(2,162)		8,202
Commercial:
New York City SMSA	783		(149)		1,010		114
All other U.S. areas	(519)		146		(534)		517
	264		(3)		476		631
Other:	(177)		946		(139)		1,983
Equity in (losses) earnings from real estate ventures	$	(8,536)	$	8,050	$	(27,301)	$	12,002

______________________

(1) The Company recognized a liability, classified in Other current liabilities, of $1,302 as a result of recording equity in losses in excess of the joint ventures' carrying value.

Maximum Exposure to Loss:

New Valley’s maximum exposure to loss from its investments in real estate ventures consisted of the net carrying value of the venture adjusted for any future capital commitments and/or guarantee arrangements. The maximum exposure to loss was as follows:

	September 30, 2020
Condominium and Mixed Use Development:
New York City SMSA	$	36,252
All other U.S. areas	41,403
	77,655
Hotels:
New York City SMSA	2,892
International	1,767
	4,659
Commercial:
New York City SMSA	2,271
All other U.S. areas	6,987
	9,258
Other	24,461
Total maximum exposure to loss	$	116,033

Investments in real estate, net

Investments in Real Estate, net:

The components of “Investments in real estate, net” were as follows:

	September 30, 2020		December 31, 2019
Escena, net	$	9,786	$	9,972
Sagaponack	—		18,345
Investments in real estate, net	$	9,786	$	28,317

Escena.  The assets of “Escena, net” were as follows:

	September 30, 2020		December 31, 2019
Land and land improvements	$	8,911	$	8,910
Building and building improvements	1,926		1,926
Other	1,670		1,659
	12,507		12,495
Less accumulated depreciation	(2,721)		(2,523)
	$	9,786	$	9,972

XML

Notes Payable, Long-Term Debt and Other Obligations (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Notes payable, long-term debt and other obligations

Notes payable, long-term debt and other obligations consisted of:

	September 30, 2020		December 31, 2019
Vector:
6.125% Senior Secured Notes due 2025	$	850,000	$	850,000
10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392	551,868		551,608
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $0 and $5,276*	—		164,334
Liggett:
Revolving credit facility	—		34,952
Equipment loans	94		347
Other	26,773		30,146
Notes payable, long-term debt and other obligations	1,428,735		1,631,387
Less:
Debt issuance costs	(22,087)		(24,902)
Total notes payable, long-term debt and other obligations	1,406,648		1,606,485
Less:
Current maturities	(10,684)		(209,269)
Amount due after one year	$	1,395,964	$	1,397,216

______________________

* The fair value of the derivatives embedded within the 5.5% Variable Interest Senior Convertible Debentures ($4,999 at December 31, 2019) is separately classified as a derivative liability in the condensed consolidated balance sheets.

Schedule of non-cash interest expense - Vector

Non-Cash Interest Expense — Vector:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Amortization of debt discount, net	$	89	$	5,746	$	5,536	$	19,718
Amortization of debt issuance costs	847		1,089		2,894		3,327
	$	936	$	6,835	$	8,430	$	23,045

Schedule of fair value of notes payable and long-term debt

Fair Value of Notes Payable and Long-Term Debt:

	September 30, 2020				December 31, 2019
	Carrying		Fair		Carrying			Fair
	Value		Value		Value			Value
Senior Notes	$	1,401,868	$	1,419,309	$	1,401,608		$	1,409,920
Variable Interest Senior Convertible Debt	—		—		164,334			176,289
Liggett and other	26,867		26,878		65,445			65,456
Notes payable and long-term debt	$	1,428,735	$	1,446,187	$	1,631,387	(1)	$	1,651,665

______________________

(1) The carrying value does not include the carrying value of the embedded derivative. See Note 12.

XML

Contingencies (Tables)

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Schedule of contingencies

The following table lists the number of Individual Actions by state:

State	Number of Cases
Florida	39
Illinois	11
Nevada	7
New Mexico	5
Virgin Islands	5
Louisiana	2
Massachusetts	1

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2020 was as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2020	$	34,116	$	4,249	$	38,365	$	17,275	$	20,594	$	37,869
Expenses	139,393		28		139,421		—		—		—
Change in MSA obligations capitalized as inventory	32		—		32		—		—		—
Payments	(27,214)		(4,324)		(31,538)		—		—		—
Reclassification to/(from) non-current liabilities	(855)		3,252		2,397		855		(3,252)		(2,397)
Interest on withholding	—		330		330		—		1,422		1,422
Balance as of September 30, 2020	$	145,472	$	3,535	$	149,007	$	18,130	$	18,764	$	36,894

The activity in the Company’s accruals for the MSA and tobacco litigation for the nine months ended September 30, 2019 were as follows:

	Current Liabilities						Non-Current Liabilities
	Payments due under Master Settlement Agreement		Litigation Accruals		Total		Payments due under Master Settlement Agreement		Litigation Accruals		Total
Balance as of January 1, 2019	$	36,561	$	310	$	36,871	$	16,383	$	21,794	$	38,177
Expenses	125,911		895		126,806		—		—		—
Change in MSA obligations capitalized as inventory	2,756		—		2,756		—		—		—
Payments	(31,959)		(355)		(32,314)		—		—		—
Reclassification to/(from) non-current liabilities	(892)		3,338		2,446		892		(3,338)		(2,446)
Interest on withholding	—		187		187		—		1,600		1,600
Balance as of September 30, 2019	$	132,377	$	4,375	$	136,752	$	17,275	$	20,056	$	37,331

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill and Other Intangible Assets

The components of Goodwill and other intangible assets, net were as follows:

	December 31, 2019		Impairment Losses		Amortization		September 30, 2020
Goodwill	$	78,008	$	(46,252)	$	—	$	31,756
Indefinite life intangibles:
Intangible asset associated with benefit under the MSA	107,511		—		—		107,511
Trademark - Douglas Elliman	80,000		(12,000)		—		68,000
Intangibles with a finite life, net	474		—		(123)		351
Total goodwill and other intangible assets, net	$	265,993	$	(58,252)	$	(123)	$	207,618

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Income tax expense (benefit)

The Company’s income tax expense consisted of the following:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Income before provision for income taxes	$	55,962	$	49,744	$	88,443	$	128,292
Income tax expense using estimated annual effective income tax rate	16,784		14,844		26,497		38,378
Changes in effective tax rates	66		(785)		—		—
Impact of discrete items, net	973		(323)		1,264		(434)
Income tax expense	$	17,823	$	13,736	$	27,761	$	37,944

XML

Investments and Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Company's recurring financial assets and liabilities subject to fair value measurements

The Company’s financial assets and liabilities subject to fair value measurements were as follows:

	Fair Value Measurements as of September 30, 2020
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	373,030	$	373,030	$	—	$	—
Commercial paper (1)	39,884		—		39,884		—
Certificates of deposit (2)	2,108		—		2,108		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	11,897		11,897		—		—
Mutual funds invested in debt securities	22,956		22,956		—		—
Total equity securities at fair value	34,853		34,853		—		—
Debt securities available for sale
U.S. government securities	11,412		—		11,412		—
Corporate securities	58,481		—		58,481		—
U.S. government and federal agency	5,759		—		5,759		—
Commercial paper	13,587		—		13,587		—
Total debt securities available for sale	89,239		—		89,239		—
Total investment securities at fair value	124,092		34,853		89,239		—
Long-term investments
Long-term investment securities at fair value (3)	31,619		—		—		—
Total	$	571,268	$	408,418	$	131,231	$	—
Liabilities:
Fair value of contingent liability	$	1,064	$	—	$	—	$	1,064
Total	$	1,064	$	—	$	—	$	1,064

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $7,224 that is included in Other current assets and $1,907 that is included in Other assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

	Fair Value Measurements as of December 31, 2019
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds (1)	$	307,655	$	307,655	$	—	$	—
Commercial paper (1)	47,328		—		47,328		—
Certificates of deposit (2)	2,193		—		2,193		—
Money market funds securing legal bonds (2)	535		535		—		—
Investment securities at fair value
Equity securities at fair value
Marketable equity securities	23,819		23,819		—		—
Mutual funds invested in debt securities	22,377		22,377		—		—
Total equity securities at fair value	46,196		46,196		—		—
Debt securities available for sale
U.S. government securities	14,660		—		14,660		—
Corporate securities	54,413		—		54,413		—
U.S. government and federal agency	6,816		—		6,816		—
Commercial mortgage-backed securities	382		—		382		—
Commercial paper	5,887		—		5,887		—
Index-linked U.S. bonds	779		—		779		—
Foreign fixed-income securities	508		—		508		—
Total debt securities available for sale	83,445		—		83,445		—
Total investment securities at fair value	129,641		46,196		83,445		—
Long-term investments
Long-term investment securities at fair value (3)	45,781		—		—		—
Total	$	533,133	$	354,386	$	132,966	$	—
Liabilities:
Fair value of contingent liability	$	3,147	$	—	$	—	$	3,147
Fair value of derivatives embedded within convertible debt	4,999		—		—		4,999
Total	$	8,146	$	—	$	—	$	8,146

(1)     Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $4,423 that is included in current restricted assets and $3,160 that is included in non-current restricted assets.

(2)    Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheets.

(3)    In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

Unobservable inputs related to the valuations of the Level 3 liabilities

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at September 30, 2020:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	September 30, 2020		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of contingent liability	$	1,064	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	169,000
				Risk-free rate for a 2.50 year term	0.14		%
				Leverage-adjusted equity volatility of peer firms	70.78		%

The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at December 31, 2019:

	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2019		Valuation Technique	Unobservable Input	Range (Actual)
Fair value of derivatives embedded within convertible debt	$	4,999	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed remaining cash dividends - Q4 2019 and Q1 2020	$0.40/$0.20
				Stock price	$	13.39
				Convertible trading price (as a percentage of par value)	103.94		%
				Volatility	36.94		%
				Risk-free rate	Term structure of US Treasury Securities
				Implied credit spread	1.0% - 3.0% (2.0%)
Fair value of contingent liability	$	3,147	Monte Carlo simulation model	Estimated fair value of the Douglas Elliman reporting unit	$	271,500
				Risk-free rate for a 3-year term	1.61		%
				Leverage-adjusted equity volatility of peer firms	35.56		%

Nonrecurring fair value measurements

The Company’s investments in real estate ventures subject to nonrecurring fair value measurements are as follows:

			Fair Value Measurement Using:
	Three Months Ended September 30, 2020				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	6,617	$	6,901	$	—	$	—	$	6,901

The Company estimated the fair value of its investments in real estate ventures using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the investments in real estate ventures was attributed to the decline in the projected sales prices of the respective real estate venture. The $6,617 of impairment charges were included in equity in losses from real estate ventures for the three months September 30, 2020.

			Fair Value Measurement Using:
	Year Ended December 31, 2019				Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Description	Impairment Charge		Total
Assets:
Investments in real estate ventures	$	39,757	$	18,335	$	—	$	—	$	18,335

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Financial information for the company's operations before taxes

Financial information for the Company’s operations before taxes and non-controlling interests for the three and nine months ended September 30, 2020 and 2019 were as follows:

				Real			Corporate
	Tobacco			Estate			and Other		Total
Three months ended September 30, 2020
Revenues	$	318,850		$	228,981		$	—	$	547,831
Operating income (loss)	91,319		(1)	10,850		(2)	(6,252)		95,917
Equity in losses from real estate ventures	—			(8,536)			—		(8,536)
Depreciation and amortization	1,965			2,167			214		4,346
Three months ended September 30, 2019
Revenues	$	303,260		$	201,530		$	—	$	504,790
Operating income (loss)	72,799		(3)	628			(6,707)		66,720
Equity in earnings from real estate ventures	—			8,050			—		8,050
Depreciation and amortization	1,941			2,240			249		4,430
Nine months ended September 30, 2020
Revenues	$	918,429		$	529,650		$	—	$	1,448,079
Operating income (loss)	239,814		(4)	(63,500)		(5)	(18,504)		157,810
Equity in losses from real estate ventures	—			(27,301)			—		(27,301)
Depreciation and amortization	6,007			6,678			648		13,333
Capital expenditures	3,644			5,160			20		8,824
Nine months ended September 30, 2019
Revenues	$	854,517		$	609,629		$	—	$	1,464,146
Operating income (loss)	201,594		(6)	4,672			(20,712)		185,554
Equity in earnings from real estate ventures	—			12,002			—		12,002
Depreciation and amortization	5,848			6,765			749		13,362
Capital expenditures	3,425			6,733			—		10,158

(1) Operating income includes $286 of expense from MSA settlement.

(2) Operating income includes $320 of restructuring charges.

(3) Operating income includes $240 of litigation settlement and judgment expense.

(4) Operating income includes $286 of expense from MSA settlement and $53 of litigation settlement and judgment expense.

(5) Operating loss includes $58,252 of impairment charges related to the impairments of goodwill and intangible assets and $3,281 of restructuring charges.

(6) Operating income includes $895 of litigation settlement and judgment expense.

XML

Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Jan. 01, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Embedded Derivative [Line Items]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Impact of adoption of new accounting standards		$ 669,204	$ 662,119	$ 685,016	$ 628,673	$ 606,696	$ 547,366
Goodwill impairment charge		$ 46,252
Accounting Standards Update 2016-13
Embedded Derivative [Line Items]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Accounting Standards Update 2017-04
Embedded Derivative [Line Items]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201704Member
Impact of adoption of new accounting standards
Embedded Derivative [Line Items]
Impact of adoption of new accounting standards	$ 2,263			$ 2,263			$ 1,550
Allowance for credit losses	$ 3,100
Goodwill impairment charge			$ 46,252

XML

Summary of Significant Accounting Policies (Net Income (Loss) for Purposes of Determining Basic and Diluted EPS) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Net income attributed to Vector Group Ltd.	$ 38,139	$ 36,008	$ 60,682	$ 90,268
Income attributed to participating securities, basic	(708)	(2,023)	(1,976)	(6,052)
Net income applicable to common shares attributed to Vector Group Ltd., basic	37,431	33,985	58,706	84,216
Income attributed to participating securities, diluted	(708)	(2,023)	(1,976)	(6,052)
Net income applicable to common shares attributed to Vector Group Ltd., diluted	37,431	33,985	58,706	82,970
Variable Interest Senior Convertible Debt | 7.5% Variable Interest Senior Convertible Notes
Debt Instrument [Line Items]
Income attributable to Variable Interest Senior Convertible Notes	$ 0	$ 0	$ 0	$ (1,246)
Interest rate	7.50%		7.50%

XML

Summary of Significant Accounting Policies (Basic and Diluted Earnings Per Share (in shares)) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Weighted-average shares for basic EPS (in shares)	152,216,118	146,703,766	149,541,642	146,562,252
Plus incremental shares related to convertible debt (in shares)	0	0	0	961,191
Plus incremental shares related to stock options and non-vested restricted stock (in shares)	8,470	32,374	32,007	13,782
Weighted-average shares for diluted EPS (in shares)	152,224,588	146,736,140	149,573,649	147,537,225

XML

Summary of Significant Accounting Policies (Antidilutive Securities Excluded from Earnings Per Share) (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Weighted-average shares of non-vested restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation (in shares)	612,538	1,012,285	555,918	1,274,549
Weighted-average expense per share (in dollars per share)	$ 18.29	$ 18.03	$ 19.54	$ 17.95
Weighted-average number of shares issuable upon conversion of debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation (in shares)	0	11,447,061	3,237,522	11,447,061
Weighted-average conversion price (in dollars per share)	$ 0	$ 20.27	$ 20.27	$ 20.27

XML

Summary of Significant Accounting Policies (Restructuring) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Reduction of staff, as a percentage	25.00%
Employee severance and benefits		$ 186		$ 1,785
Other restructuring expenses		64		282
Cash charges		250		2,067
Loss on fixed assets associated with consolidation of sales offices		70		1,214
Total restructuring charges		$ 320	$ 0	$ 3,281	$ 0

XML

Summary of Significant Accounting Policies (Real Estate Segment Restructuring Plan) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Restructuring Reserve [Roll Forward]
Restructuring charges	$ 250	$ 2,067
Real estate
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2020		0
Restructuring charges		3,281
Utilized		(3,231)
Accrual balance as of June 30, 2020	50	50
Real estate | Employee Severance and Benefits
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2020		0
Restructuring charges		1,785
Utilized		(1,735)
Accrual balance as of June 30, 2020	50	50
Real estate | Other
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2020		0
Restructuring charges		282
Utilized		(282)
Accrual balance as of June 30, 2020	0	0
Real estate | Non-Cash Loss on Fixed Assets
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2020		0
Restructuring charges		1,214
Utilized		(1,214)
Accrual balance as of June 30, 2020	$ 0	$ 0

XML

Summary of Significant Accounting Policies (Schedule of Other, Net) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Interest and dividend income	$ 1,251	$ 3,083	$ 5,331	$ 9,430
Net gains (losses) recognized on investment securities	2,516	(1,487)	(4,943)	5,601
Net periodic benefit cost other than the service costs	(452)	(576)	(1,361)	(1,692)
Credit loss expense	(8,576)	0	(9,008)	0
Other income	165	1,203	1,865	1,105
Other, net	$ (5,096)	$ 2,223	$ (8,116)	$ 14,444

XML

Summary of Significant Accounting Policies (Other Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Restricted assets	$ 4,008	$ 5,241
Prepaid pension costs	32,467	31,686
Equity-method investments	16,240	15,942
Contract assets, net	26,083	18,443
Other assets	36,250	48,778
Total other assets	$ 115,048	$ 120,090

XML

Summary of Significant Accounting Policies (Other Current Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Accounts payable	$ 11,962	$ 10,222
Accrued promotional expenses	45,966	35,900
Accrued excise and payroll taxes payable, net	2,817	18,653
Accrued interest	33,159	35,756
Commissions payable	28,972	18,378
Accrued salary and benefits	19,059	29,464
Contract liabilities	9,725	9,358
Allowance for sales returns	7,857	7,785
Other current liabilities	34,511	23,801
Total other current liabilities	$ 194,028	$ 189,317

XML

Summary of Significant Accounting Policies (Reconciliation of Cash, Cash Equivalents, and Restricted Cash) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and cash equivalents	$ 451,071	$ 371,341
Restricted cash and cash equivalents included in other current assets	7,224	4,423
Restricted cash and cash equivalents included in other assets	2,461	3,712
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	$ 460,756	$ 379,476	$ 327,418	$ 591,729

XML

Revenue Recognition (Disaggregation of Revenue) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Tobacco
Disaggregation of Revenue [Line Items]
Revenues	$ 318,850	$ 303,260	$ 918,429	$ 854,517
Tobacco | Core Discount Brands - Eagle 20’s, Pyramid, Montego, Grand Prix, Liggett Select, and Eve
Disaggregation of Revenue [Line Items]
Revenues	300,487	283,621	864,880	798,272
Tobacco | Other Brands
Disaggregation of Revenue [Line Items]
Revenues	18,363	19,639	53,549	56,245
Real estate
Disaggregation of Revenue [Line Items]
Total real estate revenues	228,981	201,530	529,650	609,629
Real estate | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	56,302	88,485	174,142	310,784
Real estate | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	80,213	48,299	151,632	123,277
Real estate | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	49,447	32,622	112,326	89,983
Real estate | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	43,019	32,124	91,550	85,585
Real estate | Commission and other brokerage income - existing home sales
Disaggregation of Revenue [Line Items]
Total real estate revenues	187,831	172,925	443,290	518,373
Real estate | Commission and other brokerage income - existing home sales | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	43,039	73,081	129,009	243,061
Real estate | Commission and other brokerage income - existing home sales | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	58,909	47,066	129,264	118,057
Real estate | Commission and other brokerage income - existing home sales | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	43,883	25,008	97,293	79,303
Real estate | Commission and other brokerage income - existing home sales | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	42,000	27,770	87,724	77,952
Real estate | Commission and other brokerage income - development marketing
Disaggregation of Revenue [Line Items]
Total real estate revenues	10,669	18,526	34,430	55,725
Real estate | Commission and other brokerage income - development marketing | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	4,571	6,920	18,195	41,024
Real estate | Commission and other brokerage income - development marketing | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Commission and other brokerage income - development marketing | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	5,564	7,614	15,033	10,680
Real estate | Commission and other brokerage income - development marketing | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	534	3,992	1,202	4,021
Real estate | Property management revenue
Disaggregation of Revenue [Line Items]
Total real estate revenues	8,584	8,668	26,195	27,237
Real estate | Property management revenue | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	8,334	8,484	25,513	26,699
Real estate | Property management revenue | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	250	184	682	538
Real estate | Property management revenue | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Property management revenue | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Title fees
Disaggregation of Revenue [Line Items]
Total real estate revenues	912	1,049	2,611	4,682
Real estate | Title fees | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	358	0	1,425	0
Real estate | Title fees | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	554	1,049	1,186	4,682
Real estate | Title fees | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Title fees | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Total Douglas Elliman revenue
Disaggregation of Revenue [Line Items]
Total real estate revenues	207,996	201,168	506,526	606,017
Real estate | Total Douglas Elliman revenue | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	56,302	88,485	174,142	310,784
Real estate | Total Douglas Elliman revenue | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	59,713	48,299	131,132	123,277
Real estate | Total Douglas Elliman revenue | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	49,447	32,622	112,326	89,983
Real estate | Total Douglas Elliman revenue | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	42,534	31,762	88,926	81,973
Real estate | Other real estate revenues
Disaggregation of Revenue [Line Items]
Total real estate revenues	20,985	362	23,124	3,612
Real estate | Other real estate revenues | New York City
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Other real estate revenues | Northeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	20,500	0	20,500	0
Real estate | Other real estate revenues | Southeast
Disaggregation of Revenue [Line Items]
Total real estate revenues	0	0	0	0
Real estate | Other real estate revenues | West
Disaggregation of Revenue [Line Items]
Total real estate revenues	$ 485	$ 362	$ 2,624	$ 3,612

XML

Revenue Recognition (Contract Balances) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Receivables, which are included in accounts receivable - trade, net	$ 2,194		$ 2,194		$ 2,129
Contract assets, net, which are included in other current assets	5,965		5,965		8,766
Payables, which are included in other current liabilities	1,544		1,544		1,663
Contract liabilities, which are included in other current liabilities	9,725		9,725		9,358
Contract assets, net, which are included in other assets	26,083		26,083		18,443
Contract liabilities, which are included in other liabilities	28,304		28,304		$ 29,045
Revenue recognized on contract liabilities	$ 1,451		$ 8,109
Revenue recognized relating to performance obligations satisfied or partially satisfied in prior periods		$ 4,722		$ 9,753

XML

Current Expected Credit Losses (Narrative) (Details) $ in Thousands	Jan. 01, 2020 USD ($)	Sep. 30, 2020 USD ($) loan	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2018 USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Impact of adoption of new accounting standards		$ (662,119)	$ (669,204)	$ (685,016)	$ (628,673)	$ (606,696)	$ (547,366)
New Valley LLC
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses		$ 12,108		3,100
Number of loans | loan		2
Total amortized cost basis		$ 15,928		15,276
Interest receivable		6,428		5,776
Impact of adoption of new accounting standards
Financing Receivable, Allowance for Credit Loss [Line Items]
Impact of adoption of new accounting standards	$ (2,263)			(2,263)			$ (1,550)
Allowance for credit losses	$ 3,100
Real estate broker agent receivables
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses		$ 7,715		$ 6,132

XML

Current Expected Credit Losses (Rollforward) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
New Valley LLC
Financing Receivable, Allowance for Credit Loss [Roll Forward]
January 1, 2020	$ 3,100
Current Period Provision	9,008
Write-offs	0
Recoveries	0
September 30, 2020	12,108
Real estate broker agent receivables
Financing Receivable, Allowance for Credit Loss [Roll Forward]
January 1, 2020	6,132
Current Period Provision	1,724
Write-offs	141
Recoveries	0
September 30, 2020	$ 7,715

XML

Leases (Lease Expense and Cash Outflows from Operating and Finance Leases) (Details) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Operating lease cost	$ 9,475	$ 9,707	$ 28,255	$ 28,212
Short-term lease cost	218	397	1,007	910
Variable lease cost	663	715	1,818	2,405
Amortization	17	67	94	186
Interest on lease liabilities	4	5	11	12
Total lease cost	$ 10,377	$ 10,891	31,185	31,725
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases			19,376	28,023
Operating cash flows from finance leases			11	12
Financing cash flows from finance leases			86	182
Right-of-use assets obtained in exchange for lease obligations:
Operating leases			13,711	32,511
Finance leases			$ 60	$ 159

XML

Leases (Supplemental Balance Sheet Information) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Operating leases:
Operating lease right-of-use assets	$ 147,959	$ 149,578
Current operating lease liability	22,485	18,294
Non-current operating lease liability	159,200	156,963
Total operating lease liabilities	181,685	175,257
Finance leases:
Finance lease at cost	127	127
Accumulated amortization	(38)	(19)
Finance lease net	89	108
Current portion of notes payable and long-term debt	59	86
Notes payable, long-term debt and other obligations, less current portion	110	108
Total finance lease liabilities	$ 169	$ 194
Weighted average remaining lease term:
Operating leases	8 years 1 month 2 days	8 years 5 months 15 days
Finance leases	2 years 10 months 24 days	3 years 3 days
Weighted average discount rate:
Operating leases	9.28%	10.75%
Finance leases	7.75%	8.61%
Financing lease equipment
Finance leases:
Finance lease at cost	$ 748	$ 762
Accumulated amortization	(675)	(674)
Finance lease net	$ 73	$ 88

XML

Leases (Maturities of Operating and Financing Lease Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Operating Leases
Remainder of 2020	$ 6,496
2021	41,353
2022	36,892
2023	32,417
2024	26,749
2025	21,797
Thereafter	96,556
Total lease payments	262,260
Less imputed interest	(80,575)
Total	181,685	$ 175,257
Finance Leases
Remainder of 2020	19
2021	66
2022	61
2023	35
2024	8
2025	0
Thereafter	0
Total lease payments	189
Less imputed interest	(20)
Total	$ 169	$ 194

XML

Leases (Narrative) (Details) $ in Thousands	Sep. 30, 2020 USD ($)
Leases [Abstract]
Lease not yet commenced	$ 23
Operating lease terms	3 years

XML

Inventories (Schedule of Inventories) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Leaf tobacco	$ 42,448	$ 44,516
Other raw materials	5,733	4,669
Work-in-process	645	333
Finished goods	67,211	71,183
Inventories at current cost	116,037	120,701
LIFO adjustments	(21,489)	(21,939)
Inventory, net	$ 94,548	$ 98,762

XML

Inventories (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Inventory [Line Items]
LIFO adjustments	$ 21,489	$ 21,939
Capitalized MSA cost in finished goods inventory	20,969	20,472
Inventories
Inventory [Line Items]
Federal excise tax in inventory	27,648	27,676
Liggett | Inventories
Inventory [Line Items]
Purchase commitments	17,483
Leaf tobacco
Inventory [Line Items]
LIFO adjustments	14,761	15,210
Other raw materials
Inventory [Line Items]
LIFO adjustments	180	182
Work-in-process
Inventory [Line Items]
LIFO adjustments	24	24
Finished goods
Inventory [Line Items]
LIFO adjustments	$ 6,524	$ 6,523

XML

Investment Securities (Investment Securities at Fair Value Schedule) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt and Equity Securities, FV-NI [Line Items]
Debt securities available for sale	$ 89,239	$ 83,445
Total equity securities at fair value	66,472	91,977
Long-term investment securities at fair value	31,619	45,781
Total investment securities at fair value	155,711	175,422
Current investment securities at fair value	124,092	129,641
Equity-method investments	16,240	15,942
Marketable equity securities
Debt and Equity Securities, FV-NI [Line Items]
Total equity securities at fair value	11,897	23,819
Mutual funds invested in debt securities
Debt and Equity Securities, FV-NI [Line Items]
Total equity securities at fair value	$ 22,956	$ 22,377

XML

Investment Securities (Net Gains (Losses) Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Net gains (losses) recognized on equity securities	$ 2,516	$ (1,506)	$ (4,510)	$ 5,545
Net gains (losses) recognized on debt securities available for sale	22	25	(25)	67
Impairment expense	(22)	(6)	(408)	(11)
Net gains (losses) recognized on investment securities	$ 2,516	$ (1,487)	$ (4,943)	$ 5,601

XML

Investment Securities (Components of Debt Securities Available for Sale) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Fair Value	$ 89,239	$ 83,445
Marketable debt securities
Debt Securities, Available-for-sale [Line Items]
Cost	88,336	82,714
Gross Unrealized Gains	903	731
Gross Unrealized Losses	0	0
Fair Value	$ 89,239	$ 83,445

XML

Investment Securities (Maturity Dates of Marketable Debt Securities) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Market Value	$ 89,239	$ 83,445
Under 1 Year	51,632
1 Year up to 5 Years	37,607
More than 5 Years	0
U.S. Government securities
Debt Securities, Available-for-sale [Line Items]
Market Value	11,412
Under 1 Year	9,068
1 Year up to 5 Years	2,344
More than 5 Years	0
Corporate securities
Debt Securities, Available-for-sale [Line Items]
Market Value	58,481
Under 1 Year	28,863
1 Year up to 5 Years	29,618
More than 5 Years	0
U.S. mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Market Value	5,759
Under 1 Year	114
1 Year up to 5 Years	5,645
More than 5 Years	0
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Market Value	13,587
Under 1 Year	13,587
1 Year up to 5 Years	0
More than 5 Years	$ 0

XML

Investment Securities (Gross Realized Gains and Losses on Debt Securities Available for Sale) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Gross realized gains on sales	$ 23	$ 27	$ 193	$ 74
Gross realized losses on sales	(1)	(2)	(218)	(7)
Net gains (losses) recognized on debt securities available for sale	22	25	(25)	67
Impairment expense	$ (22)	$ (6)	$ (408)	$ (11)

XML

Investment Securities (Equity Securities at Fair Value) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Net gains (losses) recognized on equity securities	$ 2,516	$ (1,506)	$ (4,510)	$ 5,545
Less: Net gains (losses) recognized on equity securities sold	(2)	58	(19)	468
Net unrealized gains (losses) recognized on equity securities still held at the reporting date	$ 2,518	$ (1,564)	$ (4,491)	$ 5,077

XML

Investment Securities (Narrative) (Details) - USD ($)		1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 14, 2020	Mar. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Nov. 11, 2019
Debt Securities, Available-for-sale [Line Items]
Cash distributions received					$ 53,528,000	$ 1,495,000
Proceeds from sale or liquidation of long-term investments					30,255,000	0
Equity securities without readily determinable fair value			$ 5,200,000		5,200,000		$ 6,200,000
Impairment and other adjustments			0	$ 0	0	$ 0
NAV
Debt Securities, Available-for-sale [Line Items]
Cash distributions received					30,358,000
In-transit redemptions			$ 2,438,000		$ 2,438,000
Optika Fund LLC (“Optika”)
Debt Securities, Available-for-sale [Line Items]
Equity-method ownership percentage			6.24%		6.24%
Boyar Value Fund (“Boyar”)
Debt Securities, Available-for-sale [Line Items]
Equity-method ownership percentage			36.70%		36.70%
Common Stock | Equity Method Investee | LTS Common Stock | Ladenburg Thalmann Financial Services Inc. (“LTS”)
Debt Securities, Available-for-sale [Line Items]
Sale of stock (in dollars per share)								$ 3.50
Proceeds from common shares	$ 53,169,000
Common shares of LTS (in shares)	15,191,205
Redeemable Preferred Stock | Equity Method Investee | LTS Preferred | Ladenburg Thalmann Financial Services Inc. (“LTS”)
Debt Securities, Available-for-sale [Line Items]
Proceeds from common shares		$ 6,009,000
Common shares of LTS (in shares)			240,000		240,000
Dividend percentage of preferred stock					8.00%
Liquidation preference (in dollars per share)			$ 25.00		$ 25.00

XML

Investment Securities (Equity-Method Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Equity-method investments	$ 16,240	$ 15,942
Mutual fund and hedge funds
Debt Securities, Available-for-sale [Line Items]
Equity-method investments	16,240	15,509
Ladenburg Thalmann Financial Services Inc. (“LTS”)
Debt Securities, Available-for-sale [Line Items]
Equity-method investments	$ 0	$ 433

XML

Investment Securities (Equity in Earnings of Investments) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Schedule of Equity Method Investments [Line Items]
Equity in earnings (losses) from investments	$ 1,840	$ (468)	$ 54,199	$ (791)
Mutual fund and hedge funds
Schedule of Equity Method Investments [Line Items]
Equity in earnings (losses) from investments	1,468	(632)	775	(20)
Ladenburg Thalmann Financial Services Inc. (“LTS”)
Schedule of Equity Method Investments [Line Items]
Equity in earnings (losses) from investments	372	139	53,424	(846)
Other
Schedule of Equity Method Investments [Line Items]
Equity in earnings (losses) from investments	$ 0	$ 25	$ 0	$ 75

XML

New Valley LLC (Investment in Real Estate Ventures) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($) venture	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) venture	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($) venture	Dec. 31, 2018
Schedule of Investments [Line Items]
Investments in real estate ventures	$ 102,458		$ 102,458		$ 131,556
Contributions to real estate ventures			6,239	$ 36,269
Distributions from real estate ventures, distributions of earnings			1,919	3,637
Distributions from investments in real estate ventures			11,606	30,934
Equity in (losses) earnings from real estate ventures	(8,536)	$ 8,050	(27,301)	12,002
Other current liabilities	194,028		194,028		189,317
Identifiable assets	1,442,978		1,442,978		1,505,089
New Valley LLC
Schedule of Investments [Line Items]
Investments in real estate ventures	102,458		102,458		131,556
Contributions to real estate ventures			6,239	36,269
Distributions from real estate ventures			13,525	34,571
Equity in (losses) earnings from real estate ventures	(8,536)	8,050	(27,301)	12,002
Total maximum exposure to loss	116,033		116,033
Interest costs capitalized	932	1,703	3,188	4,706
New Valley LLC | Condominium and Mixed Use Development
Schedule of Investments [Line Items]
Investments in real estate ventures	77,655		77,655		106,920
Contributions to real estate ventures			5,345	35,760
Distributions from real estate ventures			12,795	4,659
Equity in (losses) earnings from real estate ventures	(7,453)	6,699	(25,192)	1,107
Total maximum exposure to loss	77,655		77,655
New Valley LLC | Condominium and Mixed Use Development | New York City SMSA
Schedule of Investments [Line Items]
Investments in real estate ventures	36,252		36,252		51,078
Contributions to real estate ventures			1,169	21,760
Distributions from real estate ventures			1,735	3,380
Equity in (losses) earnings from real estate ventures	(6,835)	2,099	(15,286)	(1,127)
Impairment of long-term investments	10,401		10,401
Total maximum exposure to loss	$ 36,252		$ 36,252
New Valley LLC | Condominium and Mixed Use Development | New York City SMSA | Minimum
Schedule of Investments [Line Items]
Range of ownership	3.10%		3.10%
New Valley LLC | Condominium and Mixed Use Development | New York City SMSA | Maximum
Schedule of Investments [Line Items]
Range of ownership	49.50%		49.50%
New Valley LLC | Condominium and Mixed Use Development | All other U.S. areas
Schedule of Investments [Line Items]
Investments in real estate ventures	$ 41,403		$ 41,403		55,842
Contributions to real estate ventures			4,176	14,000
Distributions from real estate ventures			11,060	1,279
Equity in (losses) earnings from real estate ventures	(618)	4,600	(9,906)	2,234
Total maximum exposure to loss	$ 41,403		$ 41,403
New Valley LLC | Condominium and Mixed Use Development | All other U.S. areas | Minimum
Schedule of Investments [Line Items]
Range of ownership	15.00%		15.00%
New Valley LLC | Condominium and Mixed Use Development | All other U.S. areas | Maximum
Schedule of Investments [Line Items]
Range of ownership	77.80%		77.80%
New Valley LLC | Apartment Buildings
Schedule of Investments [Line Items]
Contributions to real estate ventures			$ 76	0
Distributions from real estate ventures			0	79
Equity in (losses) earnings from real estate ventures	$ (208)	76	(284)	79
New Valley LLC | Apartment Buildings | All other U.S. areas
Schedule of Investments [Line Items]
Contributions to real estate ventures			76	0
Distributions from real estate ventures			0	79
Equity in (losses) earnings from real estate ventures	(208)	76	(284)	79
New Valley LLC | Hotels
Schedule of Investments [Line Items]
Investments in real estate ventures	4,659		4,659		4,623
Contributions to real estate ventures			294	172
Distributions from real estate ventures			0	21,572
Equity in (losses) earnings from real estate ventures	(962)	332	(2,162)	8,202
Total maximum exposure to loss	4,659		4,659
New Valley LLC | Hotels | New York City SMSA
Schedule of Investments [Line Items]
Investments in real estate ventures	2,892		2,892		2,462
Contributions to real estate ventures			294	172
Distributions from real estate ventures			0	21,572
Equity in (losses) earnings from real estate ventures	(1,119)	(102)	(1,768)	8,132
Other current liabilities	1,302		1,302
Total maximum exposure to loss	$ 2,892		$ 2,892
New Valley LLC | Hotels | New York City SMSA | Minimum
Schedule of Investments [Line Items]
Range of ownership	1.00%		1.00%
New Valley LLC | Hotels | New York City SMSA | Maximum
Schedule of Investments [Line Items]
Range of ownership	18.40%		18.40%
New Valley LLC | Hotels | International
Schedule of Investments [Line Items]
Range of ownership	49.00%		49.00%
Investments in real estate ventures	$ 1,767		$ 1,767		2,161
Equity in (losses) earnings from real estate ventures	157	434	(394)	70
Total maximum exposure to loss	1,767		1,767
New Valley LLC | Commercial
Schedule of Investments [Line Items]
Investments in real estate ventures	9,258		9,258		9,486
Distributions from real estate ventures			704	173
Equity in (losses) earnings from real estate ventures	264	(3)	476	631
Total maximum exposure to loss	$ 9,258		$ 9,258
New Valley LLC | Commercial | New York City SMSA
Schedule of Investments [Line Items]
Range of ownership	49.00%		49.00%
Investments in real estate ventures	$ 2,271		$ 2,271		1,852
Distributions from real estate ventures			591	13
Equity in (losses) earnings from real estate ventures	783	(149)	1,010	114
Total maximum exposure to loss	$ 2,271		$ 2,271
New Valley LLC | Commercial | All other U.S. areas
Schedule of Investments [Line Items]
Range of ownership	1.60%		1.60%
Investments in real estate ventures	$ 6,987		$ 6,987		7,634
Distributions from real estate ventures			113	160
Equity in (losses) earnings from real estate ventures	(519)	146	(534)	517
Total maximum exposure to loss	6,987		6,987
New Valley LLC | Other
Schedule of Investments [Line Items]
Investments in real estate ventures	10,886		10,886		$ 10,527
Contributions to real estate ventures			524	337
Distributions from real estate ventures			26	8,088
Equity in (losses) earnings from real estate ventures	(177)	$ 946	(139)	1,983
Total maximum exposure to loss	$ 24,461		$ 24,461
New Valley LLC | Other | Minimum
Schedule of Investments [Line Items]
Range of ownership	15.00%		15.00%
New Valley LLC | Other | Maximum
Schedule of Investments [Line Items]
Range of ownership	49.00%		49.00%
Douglas Elliman Realty, LLC
Schedule of Investments [Line Items]
Proceeds from commissions received			$ 8,829	15,394
Variable Interest Entity, Primary Beneficiary
Schedule of Investments [Line Items]
Distributions from real estate ventures, distributions of earnings				$ 20,788
Sale of ownership interest in real estate				80.00%
Recognized equity in earnings from sale				$ 10,328
Variable Interest Entity, Primary Beneficiary | New Valley LLC
Schedule of Investments [Line Items]
Range of ownership		1.00%		1.00%		5.20%
Number of real estate ventures | venture	2		2		2
Identifiable assets	$ 0		$ 0		$ 897

XML

New Valley LLC (Investments in Real Estate, net) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended
	Aug. 31, 2020	Apr. 30, 2015	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Schedule of Investments [Line Items]
Real estate investment, net			$ 9,786		$ 9,786		$ 28,317
New Valley LLC
Schedule of Investments [Line Items]
Real estate investment, net			9,786		9,786		28,317
New Valley LLC | Escena
Schedule of Investments [Line Items]
Land and land improvements			8,911		8,911		8,910
Building and building improvements			1,926		1,926		1,926
Other			1,670		1,670		1,659
Investments in real estate, gross			12,507		12,507		12,495
Less accumulated depreciation			(2,721)		(2,721)		(2,523)
Real estate investment, net			9,786		9,786		9,972
Operating losses			(738)	$ (965)	(1,010)	$ (633)
New Valley LLC | Sagaponack
Schedule of Investments [Line Items]
Real estate investment, net			$ 0		$ 0		$ 18,345
Payments to acquire real estate		$ 12,502
Proceeds from sale of real estate	$ 20,500

XML

Notes Payable, Long-Term Debt and Other Obligations (Components of Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 1,428,735	$ 1,631,387
Less: Debt issuance costs	(22,087)	(24,902)
Total notes payable, long-term debt and other obligations	1,406,648	1,606,485
Less: Current maturities	(10,684)	(209,269)
Amount due after one year	1,395,964	1,397,216
Senior Notes | 6.125% Senior Secured Notes due 2025
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 850,000	850,000
Interest rate	6.125%
Senior Notes | 10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392
Debt Instrument [Line Items]
Interest rate	10.50%
Variable Interest Senior Convertible Debt | 10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 551,868	551,608
Unamortized discount	$ 3,132	3,392
Interest rate	10.50%
Variable Interest Senior Convertible Debt | 5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $0 and $5,276*
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 0	164,334
Unamortized discount	$ 0	5,276
Interest rate	5.50%
Fair value of derivatives embedded within convertible debt		4,999
Revolving credit facility | Revolving credit facility | Liggett
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 0	34,952
Equipment loans | Liggett
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	94	347
Other
Debt Instrument [Line Items]
Notes payable, long-term debt and other obligations	$ 26,773	$ 30,146

XML

Notes Payable, Long-Term Debt and Other Obligations (Senior Notes, Revolving Credit Facility, and Other) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended		12 Months Ended
	Apr. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Purchase price, cash paid		$ 0	$ 323
Senior Notes | 10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392
Debt Instrument [Line Items]
Interest rate		10.50%
Variable Interest Senior Convertible Debt | 10.5% Senior Notes due 2026, net of unamortized discount of $3,132 and $3,392
Debt Instrument [Line Items]
Interest rate		10.50%
Variable Interest Senior Convertible Debt | 5.5% Variable Interest Senior Convertible Debentures due 2020
Debt Instrument [Line Items]
Interest rate		5.50%
Face amount of debt paid	$ 169,610
Other Notes Payable | Douglas Elliman notes payable to sellers
Debt Instrument [Line Items]
Debt issued		$ 26,300
Principal repaid in year to date		3,750
Due to be repaid in the remainder of 2020		1,250
Due to be repaid in 2021		12,500
Due to be repaid in 2022		12,500
Liggett | Revolving credit facility
Debt Instrument [Line Items]
Amount outstanding		0
Current borrowing capacity		$ 58,800
Douglas Elliman
Debt Instrument [Line Items]
Voting interest acquired				29.41%
Purchase price				$ 40,000
Purchase price, cash paid				10,000
Purchase price, notes payable to sellers				$ 30,000

XML

Notes Payable, Long-Term Debt and Other Obligations (Non-Cash Interest Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Amortization of debt discount, net	$ 89	$ 5,746	$ 5,536	$ 19,718
Amortization of debt issuance costs	847	1,089	2,894	3,327
Non-cash interest expense	$ 936	$ 6,835	$ 8,430	$ 23,045

XML

Notes Payable, Long-Term Debt and Other Obligations (Fair Value of Notes Payable and Long Term Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	$ 1,428,735	$ 1,631,387
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	1,446,187	1,651,665
Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	1,401,868	1,401,608
Senior Notes | Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	1,419,309	1,409,920
Variable Interest Senior Convertible Debt | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	0	164,334
Variable Interest Senior Convertible Debt | Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	0	176,289
Liggett and other | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	26,867	65,445
Liggett and other | Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes payable and long-term debt	$ 26,878	$ 65,456

XML

Contingencies (Overview and Bonds) (Details) - Liggett - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2009
Loss Contingencies [Line Items]
Tobacco product liability legal expenses and costs	$ 4,684	$ 5,627
Engle Progeny Cases | Florida
Loss Contingencies [Line Items]
Maximum bond required for judgments on appeal			$ 200,000
Bonds | Santoro v. R.J. Reynolds
Loss Contingencies [Line Items]
Security posted for appeal of judgment	$ 535

XML

Contingencies (Individual Actions) (Details)	Sep. 30, 2020 case
Individual Actions Cases
Loss Contingencies [Line Items]
Cases pending	70
Liggett
Loss Contingencies [Line Items]
Cases pending	2
Liggett | Individual Actions Cases | Florida
Loss Contingencies [Line Items]
Cases pending	39
Liggett | Individual Actions Cases | Illinois
Loss Contingencies [Line Items]
Cases pending	11
Liggett | Individual Actions Cases | Nevada
Loss Contingencies [Line Items]
Cases pending	7
Liggett | Individual Actions Cases | New Mexico
Loss Contingencies [Line Items]
Cases pending	5
Liggett | Individual Actions Cases | Virgin Islands
Loss Contingencies [Line Items]
Cases pending	5
Liggett | Individual Actions Cases | Louisiana
Loss Contingencies [Line Items]
Cases pending	2
Liggett | Individual Actions Cases | Massachusetts
Loss Contingencies [Line Items]
Cases pending	1

XML

Contingencies (Cautionary Statement About Engle Progeny Cases) (Details) - Engle Progeny Cases $ in Thousands		1 Months Ended
	Nov. 21, 1996 USD ($)	Dec. 31, 2016 USD ($)	Oct. 31, 2013 USD ($)	Sep. 30, 2020 case
Loss Contingencies [Line Items]
Amount of litigation settlement awarded to other party | $	$ 145,000,000
Liggett
Loss Contingencies [Line Items]
Amount of litigation settlement awarded to other party | $	$ 790,000	$ 23,150	$ 110,000
Cases with verdicts				25
Cases with verdicts in favor of plaintiffs				16
Cases with verdicts in favor of defendants				9
Cases with verdicts in favor of plaintiffs and punitive damages awarded				5

XML

Contingencies (Engle Progeny Cases and Settlements) (Details)		1 Months Ended			6 Months Ended
	Nov. 21, 1996 USD ($)	Dec. 31, 2016 USD ($) case	Feb. 28, 2015	Oct. 31, 2013 USD ($) case	Jun. 30, 2020 USD ($) case	Sep. 30, 2020 case
Engle Progeny Cases
Loss Contingencies [Line Items]
Amount of litigation settlement awarded to other party	$ 145,000,000,000
Individual Actions Cases
Loss Contingencies [Line Items]
Cases pending | case						70
Liggett
Loss Contingencies [Line Items]
Cases pending | case						2
Liggett | Engle Progeny Cases
Loss Contingencies [Line Items]
Cases settled | case		152		4,900
Amount of litigation settlement awarded to other party	$ 790,000,000	$ 23,150,000		$ 110,000,000
Litigation settlement amount paid in lump sum				61,600,000
Litigation settlement amount paid in installment payments				48,000,000
Litigation settlement, installment term			14 years
Litigation settlement amount of estimated future payments per annum				$ 3,400,000
Payments for legal settlements					$ 8,100,000
Liggett and Vector Tobacco | Engle Progeny Cases
Loss Contingencies [Line Items]
Cases settled | case					201
Cases pending | case						42

XML

Contingencies (Appeals of Engle Progeny Judgments, Maryland and Liggett-Only Cases) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($) case
Individual Actions Cases
Loss Contingencies [Line Items]
Cases pending	70
Liggett
Loss Contingencies [Line Items]
Cases pending	2
Liggett | Lukacs, Campbell, Douglas, Clay, Tullo, Ward Rizzuto, Lambert and Buchanan
Loss Contingencies [Line Items]
Payments for legal settlements | $	$ 39,773
Maryland | Liggett | Individual Actions Cases
Loss Contingencies [Line Items]
Cases pending	16
Litigation Accruals | Liggett | Santoro v. R.J. Reynolds
Loss Contingencies [Line Items]
Amount of litigation settlement awarded to other party | $	$ 265

XML

Contingencies (Class Actions, Health Care Cost Recovery Actions, and Upcoming Trials) (Details)	Sep. 30, 2020 case defendant
Parsons v. AC & S Inc.
Loss Contingencies [Line Items]
Number of defendants in bankruptcy | defendant	3
Individual Actions Cases
Loss Contingencies [Line Items]
Cases pending	70
Pending claims scheduled for trial	3
Engle Progeny Cases
Loss Contingencies [Line Items]
Pending claims scheduled for trial	1
Liggett
Loss Contingencies [Line Items]
Cases pending	2
Liggett | Class Actions
Loss Contingencies [Line Items]
Cases pending	2
Liggett | Crow Creek Sioux Tribe v. American Tobacco Company
Loss Contingencies [Line Items]
Cases pending	1

XML

Contingencies (MSA and Other State Settlement Agreements) (Details)		9 Months Ended	25 Months Ended
	Dec. 28, 2017 USD ($)	Sep. 30, 2020 USD ($) sponsorship	Mar. 31, 1998 USD ($) state
Health Care Cost Recovery Actions
Loss Contingencies [Line Items]
Number of states with settled litigation | state			46
Number of brand name sponsorships allowed | sponsorship		1
Brand name sponsorship period		12 months
Annual payment requirement			$ 9,000,000,000
Liggett
Loss Contingencies [Line Items]
Number of states with settled litigation | state			45
Liggett | Health Care Cost Recovery Actions
Loss Contingencies [Line Items]
Estimated litigation liability		$ 0
Percentage of cigarettes sales exceeds market share exemption		1.65%
Vector Tobacco | Health Care Cost Recovery Actions
Loss Contingencies [Line Items]
Estimated litigation liability		$ 0
Percentage of cigarettes sales exceeds market share exemption		0.28%
Liggett and Vector Tobacco | Health Care Cost Recovery Actions
Loss Contingencies [Line Items]
Estimated litigation liability		$ 169,000,000
Payments for legal settlements	$ 140,000,000
Product Concentration Risk | Sales Revenue | Liggett and Vector Tobacco
Loss Contingencies [Line Items]
Concentration risk percentage		4.00%

XML

Contingencies (Certain MSA Disputes) (Details) $ in Thousands	3 Months Ended	9 Months Ended	84 Months Ended
	Sep. 30, 2020 USD ($) state	Sep. 30, 2020 USD ($) state	Dec. 31, 2019 USD ($)
2003 NPM Adjustment
Loss Contingencies [Line Items]
Number of states agreed to single arbitration | state		48
Aggregate number of settling states | state		49
Number of settling states with diligence not contested | state	37	37
Combined allocable share, percentage		75.00%
Liggett and Vector Tobacco | 2004-2010 NPM Adjustment
Loss Contingencies [Line Items]
Amounts accrued | $	$ 13,400	$ 13,400
Liggett and Vector Tobacco | Cost of Sales | Health Care Cost Recovery Actions, NPM Adjustment
Loss Contingencies [Line Items]
Settlement adjustment credit | $	3,899	3,899	$ 48,032
Liggett | 2011-2015 NPM Adjustment
Loss Contingencies [Line Items]
Amounts accrued | $	$ 41,500	$ 41,500

XML

Contingencies (Other State Settlements) (Details) - Health Care Cost Recovery Actions	1 Months Ended			12 Months Ended		25 Months Ended
	Sep. 30, 2019 USD ($)	Jul. 31, 2019 USD ($)	Jan. 31, 2016 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2003 USD ($)	Mar. 31, 1998 USD ($) state	Mar. 21, 2019
Loss Contingencies [Line Items]
Annual payment requirement						$ 9,000,000,000
Liggett
Loss Contingencies [Line Items]
Number of states not included in settlement agreement | state						4
Minnesota | Liggett
Loss Contingencies [Line Items]
Annual payment requirement					$ 100,000
Florida | Liggett
Loss Contingencies [Line Items]
Annual payment requirement				$ 250,000
Amount of litigation settlement awarded to other party				$ 1,200,000
Years annual payments required				21 years
Years annual payments required that are subject to inflation adjustment				12 years
Mississippi | Liggett
Loss Contingencies [Line Items]
Damages sought	$ 17,500,000	$ 15,500,000	$ 27,000,000
Proceeds that should not be included in income	$ 294,000,000
Percent of income entitled							0.50%

XML

Contingencies (Activity in Accruals for MSA and Tobacco Litigation Schedule) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Loss Contingency Accrual [Roll Forward]
Current liabilities, beginning balance	$ 38,365	$ 36,871
Expenses	139,421	126,806
Change in MSA obligations capitalized as inventory	32	2,756
Payments	(31,538)	(32,314)
Reclassification to/(from) non-current liabilities	2,397	(2,446)
Interest on withholding	330	187
Current liabilities, ending balance	149,007	136,752
Noncurrent liabilities, beginning balance	37,869	38,177
Expenses	0	0
Payments	0	0
Interest on withholding	1,422	1,600
Noncurrent liabilities, ending balance	36,894	37,331
Payments due under Master Settlement Agreement
Loss Contingency Accrual [Roll Forward]
Current liabilities, beginning balance	34,116	36,561
Expenses	139,393	125,911
Change in MSA obligations capitalized as inventory	32	2,756
Payments	(27,214)	(31,959)
Reclassification to/(from) non-current liabilities	(855)	892
Interest on withholding	0	0
Current liabilities, ending balance	145,472	132,377
Noncurrent liabilities, beginning balance	17,275	16,383
Expenses	0	0
Payments	0	0
Interest on withholding	0	0
Noncurrent liabilities, ending balance	18,130	17,275
Litigation Accruals
Loss Contingency Accrual [Roll Forward]
Current liabilities, beginning balance	4,249	310
Expenses	28	895
Change in MSA obligations capitalized as inventory	0	0
Payments	(4,324)	(355)
Reclassification to/(from) non-current liabilities	3,252	(3,338)
Interest on withholding	330	187
Current liabilities, ending balance	3,535	4,375
Noncurrent liabilities, beginning balance	20,594	21,794
Expenses	0	0
Payments	0	0
Interest on withholding	1,422	1,600
Noncurrent liabilities, ending balance	$ 18,764	$ 20,056

XML

Goodwill and Other Intangible Assets (Components of Goodwill and Other Intangible Assets, Net) (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill and Intangible Assets [Roll Forward]
Goodwill, beginning balance				$ 78,008
Impairment Losses		$ (46,252)
Goodwill, ending balance	$ 31,756			31,756
Finite-lived Intangible Assets [Roll Forward]
Intangibles with a finite life, net, beginning balance				474
Impairment Losses				0
Amortization				(123)
Intangibles with a finite life, net, ending balance	351			351
Goodwill and Intangible Assets [Roll Forward]
Goodwill and other intangible assets, net, beginning balance				265,993
Impairments of goodwill and intangible assets	0		$ 0	(58,252)	$ 0
Amortization				(123)
Goodwill and other intangible assets, net, ending balance	207,618			207,618
Impact of adoption of new accounting standards
Goodwill and Intangible Assets [Roll Forward]
Impairment Losses				(46,252)
Intangible asset associated with benefit under the MSA
Indefinite-lived Intangible Assets [Roll Forward]
Indefinite life intangibles, beginning balance				107,511
Impairment Losses				0
Indefinite life intangibles, ending balance	107,511			107,511
Trademark - Douglas Elliman
Indefinite-lived Intangible Assets [Roll Forward]
Indefinite life intangibles, beginning balance				80,000
Impairment Losses		$ 12,000		(12,000)
Indefinite life intangibles, ending balance	$ 68,000			$ 68,000

XML

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2020	Sep. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment charge	$ 46,252
Intangible asset associated with benefit under the MSA
Finite-Lived Intangible Assets [Line Items]
Intangible assets impairment		$ 0
Trademark - Douglas Elliman
Finite-Lived Intangible Assets [Line Items]
Intangible assets impairment	$ (12,000)	$ 12,000

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 55,962	$ 49,744	$ 88,443	$ 128,292
Income tax expense using estimated annual effective income tax rate	16,784	14,844	26,497	38,378
Changes in effective tax rates	66	(785)	0	0
Impact of discrete items, net	973	(323)	1,264	(434)
Income tax expense	$ 17,823	$ 13,736	$ 27,761	$ 37,944

XML

Investments and Fair Value Measurements (Fair Value Measurements) (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Assets:
Total equity securities at fair value	$ 66,472,000	$ 91,977,000
Debt securities available for sale	89,239,000	83,445,000
Investment securities at fair value	124,092,000	129,641,000
Long-term investment securities at fair value	31,619,000	45,781,000
Total	571,268,000	533,133,000
Liabilities:
Fair value of contingent liability	1,064,000	3,147,000
Fair value of derivatives embedded within convertible debt		4,999,000
Total	1,064,000	8,146,000
Nonrecurring nonfinancial assets subject to fair value measurements	0	0
Marketable equity securities
Assets:
Total equity securities at fair value	11,897,000	23,819,000
Mutual funds invested in debt securities
Assets:
Total equity securities at fair value	22,956,000	22,377,000
Total equity securities at fair value
Assets:
Total equity securities at fair value	34,853,000	46,196,000
U.S. Government securities
Assets:
Debt securities available for sale	11,412,000
Corporate securities
Assets:
Debt securities available for sale	58,481,000
U.S. mortgage-backed securities
Assets:
Debt securities available for sale	5,759,000
Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Long-term investment securities at fair value	0	0
Total	408,418,000	354,386,000
Liabilities:
Fair value of contingent liability	0	0
Fair value of derivatives embedded within convertible debt		0
Total	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Marketable equity securities
Assets:
Total equity securities at fair value	11,897,000	23,819,000
Quoted Prices in Active Markets for Identical Assets (Level 1) | Mutual funds invested in debt securities
Assets:
Total equity securities at fair value	22,956,000	22,377,000
Quoted Prices in Active Markets for Identical Assets (Level 1) | Total equity securities at fair value
Assets:
Total equity securities at fair value	34,853,000	46,196,000
Significant Other Observable Inputs (Level 2)
Assets:
Long-term investment securities at fair value	0	0
Total	131,231,000	132,966,000
Liabilities:
Fair value of contingent liability	0	0
Fair value of derivatives embedded within convertible debt		0
Total	0	0
Significant Other Observable Inputs (Level 2) | Marketable equity securities
Assets:
Total equity securities at fair value	0	0
Significant Other Observable Inputs (Level 2) | Mutual funds invested in debt securities
Assets:
Total equity securities at fair value	0	0
Significant Other Observable Inputs (Level 2) | Total equity securities at fair value
Assets:
Total equity securities at fair value	0	0
Significant Unobservable Inputs (Level 3)
Assets:
Long-term investment securities at fair value	0	0
Total	0	0
Liabilities:
Fair value of contingent liability	1,064,000	3,147,000
Fair value of derivatives embedded within convertible debt		4,999,000
Total	1,064,000	8,146,000
Significant Unobservable Inputs (Level 3) | Marketable equity securities
Assets:
Total equity securities at fair value	0	0
Significant Unobservable Inputs (Level 3) | Mutual funds invested in debt securities
Assets:
Total equity securities at fair value	0	0
Significant Unobservable Inputs (Level 3) | Total equity securities at fair value
Assets:
Total equity securities at fair value	0	0
Fair Value, Measurements, Recurring
Assets:
Investment securities at fair value	124,092,000	129,641,000
Fair Value, Measurements, Recurring | U.S. Government securities
Assets:
Debt securities available for sale	11,412,000	14,660,000
Fair Value, Measurements, Recurring | Corporate securities
Assets:
Debt securities available for sale	58,481,000	54,413,000
Fair Value, Measurements, Recurring | U.S. mortgage-backed securities
Assets:
Debt securities available for sale	5,759,000	6,816,000
Fair Value, Measurements, Recurring | Commercial mortgage-backed securities
Assets:
Debt securities available for sale		382,000
Fair Value, Measurements, Recurring | Commercial paper
Assets:
Debt securities available for sale		5,887,000
Fair Value, Measurements, Recurring | Index-linked U.S. bonds
Assets:
Debt securities available for sale		779,000
Fair Value, Measurements, Recurring | Foreign fixed-income securities
Assets:
Debt securities available for sale		508,000
Fair Value, Measurements, Recurring | Total debt securities available for sale
Assets:
Debt securities available for sale	89,239,000	83,445,000
Fair Value, Measurements, Recurring | Money market funds
Assets:
Cash and cash equivalents	373,030,000	307,655,000
Fair Value, Measurements, Recurring | Commercial paper
Assets:
Cash and cash equivalents	39,884,000	47,328,000
Fair Value, Measurements, Recurring | Commercial paper | Current Restricted Assets
Assets:
Cash and cash equivalents	7,224,000	4,423,000
Fair Value, Measurements, Recurring | Commercial paper | Restricted Assets
Assets:
Cash and cash equivalents	1,907,000	3,160,000
Fair Value, Measurements, Recurring | Certificates of deposit
Assets:
Cash and cash equivalents	2,108,000	2,193,000
Fair Value, Measurements, Recurring | Money market funds securing legal bonds
Assets:
Cash and cash equivalents	535,000	535,000
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Investment securities at fair value	34,853,000	46,196,000
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Government securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. mortgage-backed securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Commercial mortgage-backed securities
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Commercial paper
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Index-linked U.S. bonds
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign fixed-income securities
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Total debt securities available for sale
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds
Assets:
Cash and cash equivalents	373,030,000	307,655,000
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Commercial paper
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Certificates of deposit
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds securing legal bonds
Assets:
Cash and cash equivalents	535,000	535,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Assets:
Investment securities at fair value	89,239,000	83,445,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | U.S. Government securities
Assets:
Debt securities available for sale	11,412,000	14,660,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Corporate securities
Assets:
Debt securities available for sale	58,481,000	54,413,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | U.S. mortgage-backed securities
Assets:
Debt securities available for sale	5,759,000	6,816,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Commercial mortgage-backed securities
Assets:
Debt securities available for sale		382,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Commercial paper
Assets:
Debt securities available for sale		5,887,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Index-linked U.S. bonds
Assets:
Debt securities available for sale		779,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Foreign fixed-income securities
Assets:
Debt securities available for sale		508,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Total debt securities available for sale
Assets:
Debt securities available for sale	89,239,000	83,445,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Money market funds
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Commercial paper
Assets:
Cash and cash equivalents	39,884,000	47,328,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Certificates of deposit
Assets:
Cash and cash equivalents	2,108,000	2,193,000
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Money market funds securing legal bonds
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Assets:
Investment securities at fair value	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | U.S. Government securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Corporate securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | U.S. mortgage-backed securities
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Commercial mortgage-backed securities
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Commercial paper
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Index-linked U.S. bonds
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Foreign fixed-income securities
Assets:
Debt securities available for sale		0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Total debt securities available for sale
Assets:
Debt securities available for sale	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Money market funds
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Commercial paper
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Certificates of deposit
Assets:
Cash and cash equivalents	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Money market funds securing legal bonds
Assets:
Cash and cash equivalents	$ 0	$ 0

XML

Investments and Fair Value Measurements (Quantitative Information about Level 3 Fair Value Measurements) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($) $ / shares	Sep. 30, 2020 USD ($)	Mar. 31, 2020 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of contingent liability	$ 3,147	$ 1,064
Significant Unobservable Inputs (Level 3)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of contingent liability	3,147	1,064
Estimated fair value of the Douglas Elliman reporting unit		$ 169,000
Discounted cash flow | Significant Unobservable Inputs (Level 3)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt	$ 4,999
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Assumed annual stock dividend
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input	0.05
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Assumed remaining cash dividends - Q4 2019 and Q1 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input | $ / shares	0.40		0.20
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input | $ / shares	13.39
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Convertible trading price (as a percentage of par value)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input	1.0394
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input	0.3694
Estimated fair value of the Douglas Elliman reporting unit	$ 271,500
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Implied credit spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input	0.00020
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Implied credit spread | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input		0.00010
Discounted cash flow | Significant Unobservable Inputs (Level 3) | Implied credit spread | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of derivatives embedded within convertible debt, measurement input	0.00030
Monte Carlo Simulation Model | Significant Unobservable Inputs (Level 3) | Risk-free rate for a 3-year term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of contingent liability, measurement input term	3 years
Fair value of contingent liability, measurement input	0.0161	0.0014
Monte Carlo Simulation Model | Significant Unobservable Inputs (Level 3) | Leverage-adjusted equity volatility of peer firms
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value of contingent liability, measurement input	0.3556	0.7078

XML

Investments and Fair Value Measurements (Nonrecurring Measurements) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in real estate ventures, fair value	$ 102,458	$ 131,556
Fair Value, Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in real estate ventures impairment charge	6,617	39,757
Investments in real estate ventures, fair value	6,901	18,335
Fair Value, Nonrecurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in real estate ventures, fair value	0	0
Fair Value, Nonrecurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in real estate ventures, fair value	0	0
Fair Value, Nonrecurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in real estate ventures, fair value	$ 6,901	$ 18,335

XML

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 547,831	$ 504,790	$ 1,448,079	$ 1,464,146
Operating income (loss)	95,917	66,720	157,810	185,554
Equity in (losses) earnings from real estate ventures	(8,536)	8,050	(27,301)	12,002
Depreciation and amortization	4,346	4,430	13,333	13,362
Capital expenditures			8,824	10,158
Litigation settlement and judgment expense	0	240	53	895
Restructuring charges	320	0	3,281	0
Impairments of goodwill and intangible assets	0	0	58,252	0
Corporate and Other
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Operating income (loss)	(6,252)	(6,707)	(18,504)	(20,712)
Equity in (losses) earnings from real estate ventures	0	0	0	0
Depreciation and amortization	214	249	648	749
Capital expenditures			20	0
Tobacco
Segment Reporting Information [Line Items]
Revenues	318,850		918,429
Tobacco | Operating Segments
Segment Reporting Information [Line Items]
Revenues		303,260		854,517
Operating income (loss)	91,319	72,799	239,814	201,594
Equity in (losses) earnings from real estate ventures	0	0	0	0
Depreciation and amortization	1,965	1,941	6,007	5,848
Capital expenditures			3,644	3,425
Tobacco | Operating Segments | MSA settlement
Segment Reporting Information [Line Items]
Litigation settlement and judgment expense	286
Real estate | Operating Segments
Segment Reporting Information [Line Items]
Revenues	228,981	201,530	529,650	609,629
Operating income (loss)	10,850	628	(63,500)	4,672
Equity in (losses) earnings from real estate ventures	(8,536)	8,050	(27,301)	12,002
Depreciation and amortization	$ 2,167	$ 2,240	6,678	6,765
Capital expenditures			$ 5,160	$ 6,733